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Cellular DNA replication and repair pathways conclude with faithful rejoining of broken 
phosphodiester bonds by DNA ligases. Therefore, a thorough dissection of the molecular 
underpinnings of DNA ligation is crucial to a comprehensive understanding of genomic 
maintenance. To this end, we performed biochemical and biophysical studies detailing the 
interactions occurring between human DNA ligase 1 (LIG1) and DNA throughout ligation. Our 
study led to the identification and preliminary characterization of two distinct conformational 
changes preceding ligation. We posit that the observed steps are distortions of the two DNA ends 
of the nick site, induced by LIG1 to properly align the ends for ligation. Using crystallographic 
data, we identified two unique sets of interactions between the DNA ends and LIG1. One such 
interaction is mediated through a conserved metal-binding site, which our data suggests 
influences the ability of LIG1 to ligate damaged or mismatched upstream ends. At the 
downstream end of the nick, we identified a phenylalanine residue positioned near the sugar 
moiety of the 5’-deoxyribose. Mutagenesis of the residue renders LIG1 unable to discriminate 
between a downstream deoxyribonucleotide and a downstream ribonucleotide, demonstrating its 
role in preventing ligation of DNA-RNA hybrids. Both mechanisms appear to influence fidelity 
by restricting flexibility of the downstream and upstream DNA ends. To understand how 
positioning of the ends contributes to ligation, we mutagenized conserved residues in the enzyme 
active site that were identified as putative metal ligands. Biochemical studies of the mutated 
residues uncovered a cooperative network of magnesium-mediated interactions between the three
 viii 
conserved active site residues and the DNA substrate. A biochemical characterization of two 
LIG1 mutations, both identified in patients suffering from broad immunological disorders, 
illustrates how disruption of this network of interactions can impact human health. Our study 
reveals that the patient-derived mutations have diminished magnesium affinity, elevating the 
abortive ligation burden and likely causing significant delays in DNA replication and repair. The 
work detailed in this thesis significantly expands our knowledge of the complex interactions 
between DNA ligases and their substrates, furthering our understanding of how DNA ligation fits 





First evidenced by the work of Rosalind Franklin1,2, the structure of the DNA double 
helix is one of the most well-known scientific discoveries, setting the basis for our understanding 
of the genetic code. Although DNA is often considered as a stable macromolecule, genomic 
DNA is susceptible to damage from endogenous and exogenous sources, challenging the cell to 
constantly maintain genomic integrity. As a consequence of this, tens of thousands of breaks are 
made throughout the genome3, which, if allowed to persist, can become mutagenic and likely 
cytotoxic. Much of molecular biology attempts to address how the genome is maintained despite 
such challenges, leading to discoveries of conserved DNA repair mechanisms throughout 
evolution. One such discovery was that of the DNA ligase enzyme4-7. First isolated from 
bacteriophage-infected E. coli cells, DNA ligase was shown to be capable of joining adjacent 
DNA ends and, therefore, assumed to be essential for repairing DNA breaks caused by cellular 
DNA replication and repair pathways. DNA ligases quickly became ubiquitous in molecular 
cloning techniques, appreciated for their versatile ability to stitch DNA strands back together. 
Even as a key enzyme in important cellular pathways and in modern-day biotechnology, much 
about DNA ligases remains largely unknown. The work documented here serves to fill gaps in 
our knowledge through extensive study of the structure-function relationship in DNA ligase I 
(LIG1), the main replicative human DNA ligase. My thesis broadly explores substrate binding 
and recognition by LIG1, addressing how the enzyme avoids ligation of damaged and 
mismatched ends, and explores how ligase dysfunction can lead to immunological disease. 
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Figure 1.1. Mechanism of DNA ligation. Preceding nick-binding, DNA ligase binds to and utilizes ATP (or NAD+) to form a 
covalent lysine-AMP intermediate. Following enzyme adenylylation, the DNA ligase is able to bind to DNA and search for 
breaks in the helix. Once bound to a site of nicked DNA, the AMP group is transferred to the downstream 5’-PO4, generating an 
activated DNA end. In the final step of ligation, the upstream 3’-OH attacks the 5’-PO4, releasing the AMP group and the sealed 
DNA. 
 
DNA Ligase Function and Structure 
Mechanism of DNA Ligation 
DNA ligases were first discovered in 1967 as a component of the T4 bacteriophage 
proteome capable of catalyzing the covalent linkage of DNA strands in E. coli cells4. Soon after, 
the E. coli homolog was isolated and characterized8, marking DNA ligases as a common 
component in both bacteria and viruses. The discovery of T4 and E. coli DNA ligases also 
uncovered evidence of evolutionary divergence, as ligation by T4 DNA ligase is dependent on 
ATP4,6, whereas the E. coli ligase requires NAD+ for catalytic activity8,9. To date, no eukaryotic 
DNA ligase has been identified to be NAD+-dependent; only prokaryotic and some viral ligases 
utilize NAD+, with several able to utilize both cofactors10.  
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Both ATP and NAD+ are utilized for enzyme adenylylation, where a covalent bond is 
formed between AMP and the N-ζ of an active site lysine (Figure 1.1). The enzyme-
adenylylation step is critical for stimulating the nick-recognition ability of DNA ligases11-13, 
although there is evidence pointing to the ability of deadenylylated T4 DNA ligase to bind 
nicked DNA14. The exact mechanism for nick recognition remains unknown, but structural 
studies have posited that a conformational change triggered by enzyme adenylylation is required 
to prime the enzyme for DNA-binding13,15. A similar conformational change has been 
documented in mRNA capping enzymes, where a large conformational change after enzyme 
guanylylation precedes RNA binding 16,17. Upon nick recognition, the adenylyl group is 
transferred from the enzyme to the 5’-PO4 on the downstream strand, activating it for attack by 
the upstream 3’-OH. 
The catalytic activity of DNA ligases, both ATP- and NAD+-dependent, is largely 
attributed to residues in the conserved nucleotidyl transferase (NTase), also referred to as the 
adenylylation domain (AdD), and oligonucleotide-binding fold (OB-fold) domains. The two 
domains—collectively referred to as the catalytic core—are also conserved in mRNA capping 
enzymes18,19. Structural and sequence similarities between DNA ligases and mRNA capping 
enzymes led to the identification of five motifs in the catalytic core, referred to as motif I, III, 
IIIa, IV and V, required for ligation or capping activity20-22. An additional motif, motif VI, is 
found in the OB-fold of both ATP-dependent DNA ligases and mRNA capping enzymes. 
Residues in motif VI provide critical contacts with the β- and γ-phosphates of bound NTPs, 
stabilizing the pyrophosphate leaving group prior to enzyme adenylylation20-22. Consistent with 
this, motif VI is notably absent from the NAD+-dependent ligases. Crystal structures of both 
NAD+- and ATP-dependent DNA ligases have revealed a conserved mechanism among DNA 
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ligases of distorting an upstream region of the DNA helix into a more A-form-like structure, 
presumably to allow for better positioning of the nick in the enzyme active site13,15,23-26   
Domain Architecture of NAD+-Dependent Ligases 
The structure of NAD+-dependent ligases is best exemplified by the E. coli DNA ligase, 
LigA23 (Figure 1.3). On either side of the catalytic core, LigA contains structural elements 
unique to prokaryotic DNA ligases; most notable is the Ia domain located near the N-terminus. 
Conserved in all NAD+-dependent ligases, the Ia domain is required for binding NAD+ and 
subsequent formation of the enzyme-adenylylate intermediate27,28. However, the Ia domain has 
been shown to be dispensable for phosphodiester bond synthesis. Indeed, a crystal structures of 
LigA revealed contacts between the Ia domain and the NMN moiety of NAD+ but not the DNA 
substrate23,29.  
Downstream of the LigA catalytic core lie the zinc-finger (ZnF), helix-hairpin-helix 
(HhH) and BRCT domains. Despite not making extensive contacts with the DNA substrate23, 
mutations of conserved residues in the ZnF domain of E. coli LigA render the enzyme unable to 
complement DNA ligase-deficient yeast cells and significantly decreases in vitro activity30,31. 
Positioned between the OB-fold and HhH domains, the ZnF domain most likely is essential for 
bridging these two domains and for supporting enzyme stability. The HhH domain, consisting of 
tandem HhH motifs, functions as a scaffold for the DNA, making numerous contacts along the 
minor grooves of the helix23. Additionally, hydrogen-bonding interactions made between the  
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Figure 1.2. Domain architecture of DNA ligases. DNA ligases share a common catalytic core composed of a nucleotidyl-
transferase (NTase) and an oligonucleotide-binding fold (OB-fold) domain. E. coli LigA represents the prototypical NAD+-
dependent DNA ligase, consisting of an N-terminal Ia domain, as well as a zinc-finger (ZnF), helix-hairpin-helix (HhH) and 
BRCT domain. The DNA ligase from the Chlorella virus (ChVLig) is the smallest of the ATP-dependent DNA ligases known, 
consisting of the conserved catalytic core and a region in the OB-fold known as the latch region. The latch domain is notably 
absent in the Vaccinia virus DNA ligase, which instead makes use of an N-terminal DNA-binding domain (DBD). Humans have 
three families of ATP-dependent DNA ligases—DNA ligase I, III and IV—that all contain a DNA-binding domain towards the 
N-terminus. DNA ligase I (LIG1) is the simplest of the three ligases with the N-terminal region containing both a nuclear-
localization signal (NLS) and a PCNA interaction protein motif (commonly known as a PIP box). DNA ligase III (LIG3) has a 
more complex architecture, containing an N-terminal ZNF domain and—depending on the splicing isoform—either a BRCT 
domain (LIG3α) or an NLS (LIG3β) towards the C-terminus. Additional forms of both LIG3α and LIG3β containing a 
mitochondrial localization sequence (MLS) also exist but are not shown. DNA ligase IV (LIG4) mimics LIG1 with the exception 
of tandem BRCT domains located near the C-terminus. 
 
HhH and NTase domains appear to help LigA encircle the DNA helix (Figure 1.3). The role of 
the LigA BRCT domain remains unknown, partially due to the lack of structural information23,32. 
Studies have demonstrated that the BRCT domain contributes to in vitro ligation activity and 
DNA-binding33, but the mechanism by which it affects both remains unclear. BRCT domains are 
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often implicated in facilitating protein-protein interactions34, suggesting that the domain may 
also play a larger role in how LigA interacts with cellular machinery. 
Figure 1.3. DNA ligases encircle the DNA double helix. Crystal structures of ChVLig (left), human LIG1 (center) and E. coli 
LigA (right). All enzymes are complexed with a nicked DNA double helix. The individual domains are color-coded according to 
the schematics underneath each enzyme structure. Both the N-terminal region of LIG1 and the BRCT domain of LigA were not 
present in the original X-ray crystallographic experiments. Crystal structure coordinates were obtained from the Protein Data 
Bank35 using the following accession IDs: 2Q2T13 (ChVLig), 1X9N15 (LIG1) and 2OWO23 (LigA). 
 
Domain Architecture of ATP-Dependent Ligases 
Insight into the biochemistry of ATP-dependent ligases relies heavily on the study of 
viral DNA ligases, most notably from the Chlorella and Vaccinia viruses. The Chlorella virus 
DNA ligase, abbreviated as ChVLig, represents the simplest domain architecture among the 
ATP-dependent ligases19,36,37. ChVLig contains the canonical DNA ligase catalytic core but is 
devoid of any larger structured domains. Early crystal structures of ChVLig in the absence of 
DNA resemble structures of mRNA capping enzymes, albeit for ~22 amino acids within the OB-
fold domain that were not resolved in the early ChVLig structures12,38. These residues were 
previously shown to be protected by limited proteolysis when bound to nicked DNA, suggesting 
a role in DNA-binding39. Subsequent structures of ChVLig•DNA complexes revealed that this 
unique region—known as the “latch” region—contacts both the DNA substrate and the N-
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terminal NTase domain, facilitating the encircling of the DNA substrate by ChVLig13(Figure 
1.3).  The latch region is absent from the Vaccinia virus DNA ligase, which instead has an N-
terminal DNA-binding domain (DBD)40 similar to those found in the DNA ligases of higher 
eukaryotes36,37. Although dispensable for the chemistry of nick ligation, the DBD of the Vaccinia 
virus DNA ligase contributes to its ability to bind to a nicked DNA substrate40.  
Structural Divergence in Mammalian DNA Ligases 
Extensive study of viral DNA ligases has given way to the study of the DNA ligases in 
higher eukaryotes. All higher eukaryotic DNA ligases utilize a large N-terminal DNA-binding 
domain (DBD) to aide in binding a DNA substrate37. The DBD interacts with the C-terminal OB-
fold domain, helping to bridge the two domains and encircle the DNA substrate15,24,25. While 
eukaryotic DNA ligases mostly resemble their viral homologs, eukaryotes have evolved to utilize 
at least two different DNA ligases, while some eukaryotes, such as vertebrates, have a third DNA 
ligase that is critical for mitochondrial DNA replication. 
The three DNA ligase families in mammalian cells are DNA ligase I (LIG1), III (LIG3) 
and IV (LIG4). While all three of these DNA ligases share the conserved catalytic core and the 
presence of a variable DBD, the N- and C-terminal regions contain elements that define specific 
cellular roles. LIG1 represents the simplest of the three, containing only an extended N-terminal 
region with a PCNA interaction protein motif (PIP box) and a nuclear localization sequence 
(NLS). While not required for catalytic activity15,41, the PIP box is essential for tethering LIG1 to 
PCNA and, therefore, to the replication machinery42. In place of a PIP box near the N-terminus, 
LIG3 contains a zinc-finger domain (ZnF), which is thought to aid in tight binding to nicked 
DNA substrates43,44. The LIG3 gene also undergoes alternative splicing events, generating 
different forms of the LIG3 protein45-47. All mammalian cells contain a LIG3 variant with a N-
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terminal mitochondrial localization sequence to guide the enzyme to the mitochondria, where it 
is the only DNA ligase present. LIG3α contains a single C-terminal BRCT domain adjacent to 
its OB-fold, which facilitates interactions with XRCC1, a nuclear scaffolding protein48-51. 
LIG3β, which does not contain this BRCT domain, has a shorter C-terminal region containing 
only a nuclear localization signal. LIG4 contains an extended C-terminal region consisting of 
two BRCT domains, which help facilitate interactions with the protein XRCC452. 
 
Cellular function of human DNA ligases 
The diversity of the mammalian DNA ligase N-and C-terminal regions is key to defining 
the specific cellular roles of the individual enzymes. Since many processes necessitate the 
breakage of phosphodiester bonds, DNA ligases are ubiquitous in many essential cellular 
pathways. Many prokaryotic cells have multifunctional DNA ligases, such as LigD, which is 
able to act as a DNA ligase, polymerase and phosphodiesterase53. For simplification, the 
following section will only focus on the cellular roles of the human DNA ligase families.  
DNA ligase function in replication 
The discovery of DNA ligases coincided with the first evidence of Okazaki fragment 
formation, one of the initial studies validating the model of discontinuous DNA replication54,55. 
This turned out to be serendipitous for the study of DNA replication, as the recently discovered 
DNA ligases quickly became candidates for the cellular component responsible for sealing 
adjacent Okazaki fragments54. Indeed, subsequent studies were able to show that aberrant 
Okazaki fragment accumulation in cells can be caused by the absence of proper ligase function55. 
Cell cycle mutants were used to identify the ligase responsible for sealing Okazaki fragments in 
yeast, which resulted in the characterization of Cdc9, a LIG1 homolog, as the main replicative 
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DNA ligase in yeast56-58. The direct participation of human LIG1 in Okazaki fragment 
maturation, and consequently in replication, was first demonstrated in vivo59, later being 
demonstrated to associate with the replication machinery in eukaryotic cells60,61.  
Targeting of LIG1 to the nucleus and to the replication fork requires the presence of the 
N-terminal PIP box, presumably to tether LIG1 to PCNA 62,63. Direct interactions between LIG1 
and PCNA have been demonstrated in vitro, confirming the role of the PIP box in facilitating this 
interaction64,65. In vivo results have suggested that this interaction is limited to the G1 and S 
phases of the cell cycle through a regulation mechanism thought to be controlled by 
phosphorylation of the LIG1 N-terminal region66-68. Due to the biochemical similarity of LIG1 
and LIG3, it is often thought that the two enzymes function in a redundant manner. As evidence 
for this, studies have shown that LIG1-deficient cells are still viable69-71, implying that another 
ligase, presumably LIG3, is acting in its place. LIG1 is still considered to be the main replicative 
DNA ligase, as no direct role for LIG3 in Okazaki fragment maturation has been uncovered72,73. 
DNA ligase function in DNA repair 
Defects in DNA ligase activity are often associated with increased sensitivity to DNA 
damaging agents. Indeed, the major repair pathways in the cell—base excision, nucleotide 
excision and mismatch repair—all require ligation as the final step of repair (Figure 1.4). Due to 
the ability of both LIG3 and LIG4 to participate in double-strand break ligation, these two ligases 
are also found as participants in the cell’s double-strand break response—most notably in 
nonhomologous end-joining (NHEJ) and alternative NHEJ (alt-NHEJ).  
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Figure 1.4. Single-strand DNA repair pathways in mammalian cells. Schematic representations of the three major DNA 
repair pathways for single-strand repair. Base excision repair (BER, left) begins with the recognition and excision of a damaged 
base by a DNA glycosylase, producing an abasic or apurinic (AP) site74. In the short-patch sub-pathway, the resulting 5’-
deoxyribose phosphate (dRP) is removed by a dRP lyase and the remaining gap is filled by DNA polymerase β (Polβ), 
concluding with ligation by either LIG1 or the LIG3α•XRCC1 complex. The long-patch sub-pathway relies on strand-
displacement synthesis by Polβ or either of the replicative polymerases (Polδ and Polε). A 5’-flap is created by strand 
displacement and is subsequently cleaved by FEN1, allowing for LIG1-dependent ligation. The long-patch pathway is also 
dependent on the presence of PCNA, which tethers the polymerase, FEN1 and LIG1 to the site of damage. Mismatch repair 
(MMR, middle) begins with recognition of mispaired bases by the MutSα complex, which recruits MutLα75. Incisions are made 
on the nascent DNA strand at sites both upstream and downstream of the mismatch, allowing for the removal of the damaged 
strand. Resynthesis of the excised DNA is performed by either Polδ or Polε, followed by LIG1- or LIG3-dependent ligation. 
Nucleotide excision repair (NER, right) is the main pathway for removing bulky DNA lesions in the cell76,77. Recognition of the 
damaged nucleotide can either occur due to RNA polymerase stalling during transcription or through a pathway mediated by 
XPC-RAD23B, XPA and RPA. The XPD and XPB helicases are recruited to the damaged site and unwind the DNA double 
helix. Dual excision is performed by XPG at the 3’ end and XPF-ERCC1 at the 5’ end, allowing for the damaged strand to be 
removed. Akin to MMR, resynthesis is performed by either of the replicative polymerases, and either LIG1 or LIG3 can perform 
the final ligation step.  
 
Base excision repair (BER) is the main repair pathway in the cell for the removal of non-
helix-distorting base lesions from genomic DNA74. Most base lesions recognized and repaired by 
BER are those resulting from deamination, alkylation and oxidation. BER is initiated by the 
action of a DNA glycosylase, which recognizes and excises damaged bases, leaving behind an 
abasic/apurinic site. Single-strand breaks in the phosphodiester bond are then created by AP 
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endonuclease (APE1) and the resulting 5’-deoxyribose phosphate (5’-dRP) is removed by the 
action of a dRP lyase. Some glycosylases, such as human OGG1 and NEIL-family glycosylases, 
are bifunctional and able to catalyze the cleavage of the phosphodiester backbone without APE1 
present74. Following removal of the 5’-dRP, DNA polymerase β (Polβ) performs gap-filling, 
allowing for ligation of the adjacent strands by LIG1 or the LIG3•XRCC1 complex78-80. This 
pathway, known as short-patch BER, occurs both in the mitochondria and the nucleus, but is 
only critical for mitochondrial DNA repair81. An alternative BER pathway known as long-patch 
BER is observed in cells undergoing replication82-84. In place of dRP lyase activity, one of the 
replicative polymerases, Polδ and Polε, performs strand displacement synthesis, creating a 5’ 
DNA flap85,86. The flapped DNA strand is then excised by the action of the flap endonuclease 
FEN1, resulting in a 5’-phosphorylated nick that is ligated by LIG1. Long-patch BER is known 
to require the presence of PCNA, which facilitates strand-displacement synthesis and tethers 
both FEN1 and LIG1 to the site of damage65,87,88.  
Mismatch repair (MMR) is tasked with removing mismatched bases that arise during 
replication75. Initiation of MMR is predominantly the role of the Msh2 and Msh6 proteins, which 
form a complex referred to as MutSα. A second complex known as MutLα is recruited to the site 
of damage and is activated by PCNA to stimulate 5’- and 3’-incisions in the nascent DNA strand. 
The incised strand is removed through one of two mechanisms75, allowing for resynthesis and 
ligation. Consistent with LIG1 interacting with PCNA and being the major ligase involved in 
replication, LIG1 is thought to be the main ligase involved in MMR89. 
Nucleotide excision repair (NER) is specialized towards removing entire nucleotides that 
are damaged by UV-radiation or other environmental mutagens—including chemotherapeutic 
agents—resulting in bulky DNA lesions76,77,90. NER is initiated by the action of a complex of 
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proteins that recognize the bulky DNA lesion and facilitate the unwinding of the DNA strands at 
the site of damage. Following unwinding, XPF and XPG catalyze incision at sites both 5’ and 3’ 
to the damaged nucleotide. Resynthesis of the incised strand is then performed by a DNA 
polymerase and the newly synthesized strand is joined to the adjacent strand by the action of a 
DNA ligase. There is strong evidence showing that this final ligation event is performed 
primarily by the LIG3α-XRCC1 complex. Indeed, in cells lacking proper LIG1 function, 
efficient NER is still present48. However, the dominance of LIG3 in NER is not as clear in 
proliferating cells since both LIG1 and the LIG3α-XRCC1 complex colocalize with the NER 
machinery. 
More complex mechanisms are employed in the cell to handle double-strand breaks in the 
DNA helix. The challenge of repairing double-strand breaks mostly lies within having to 
accurately detect the two broken ends. While all three DNA ligases can perform double-strand 
break repair to some extent, only DNA ligase IV is a member of a larger group of end-bridging 
proteins capable of repairing blunt ends or ends with short or incompatible overhangs37. LIG1 
and LIG3 only appear to be able to repair double-strand breaks that result in homologous 
overhangs longer than ~2 bases; this form of end joining is known as alternative end-joining (a-
EJ) or microhomology mediated end-joining (MMEJ) and is mainly observed in the absence of 
LIG491-94. 
Two more common methods for joining broken DNA ends are homologous 
recombination and non-homologous end joining (NHEJ). Homologous recombination (HR) is 
the dominant pathway during the S and G2 phases of the cell cycle and relies on available sister 
chromatids for precise DSB repair. NHEJ, on the other hand, is active throughout the cell cycle 
and considered to be error-prone91,95,96. NHEJ begins with recognition of either blunt or 
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overhanging ends by Ku, followed by recruitment of the DNA protein kinase catalytic subunit 
(DNA-PKcs) to form the DNA-PK complex. Depending on the nature of the two DNA ends, 
various forms of end processing, such as DNA resectioning, polymerization or 
dephosphorylation, may be required prior to end joining. In all cases, LIG4-catalyzed ligation is 
the final step in resealing the DSBs96-98.  
DNA ligase function in DNA recombination 
DNA recombination is often thought of as simply the use of a sister chromatid for 
repairing homologous strands of DNA or as a method for increasing genetic diversity at certain 
alleles. DNA recombination is also an essential tool for the adaptive immune response, which 
utilizes two types of somatic recombination, V(D)J and class-switch recombination, to increase 
the versatility of the immune system. B and T cells undergo V(D)J recombination in the early 
stages of maturation to diversify the immunoglobulins (Igs) and T cell receptors (TCRs), while 
class-switch recombination (CSR) changes the type of immunoglobulin produced by a B 
cell99,100. Both processes operate by through the excision of specific regions in DNA, 
necessitating the rejoining of DNA strands by a DNA ligase. 
The primary pathway for both V(D)J recombination and CSR concludes with ligation 
through the NHEJ pathway, mediated by LIG4. In the absence of core NHEJ components—
however—CSR is still observed, pointing to a role for a-EJ in CSR. Cells containing either only 
LIG1 or only LIG3 as the nuclear ligase exhibit CSR at levels comparable to those in cells 
containing LIG492,94. V(D)J recombination does not show the same adaptability, however, since 




DNA ligases and human disease 
LIG1 syndrome 
The first reported case of LIG1 syndrome was also the first reported case of a human 
disease caused by a defective DNA ligase. The afflicted patient was developmentally delayed, 
susceptible to recurrent infections and had skin hypersensitivity to sunlight exposure102,103. The 
patient was determined to be immunocompromised, exhibiting decreased IgA and IgG levels, as 
well as poorly proliferative T and B cells. Despite the severity of their symptoms, the patient 
lived until the age of 19 when they died as the result of pneumonia. Initially, the patient was 
thought to have Bloom’s Syndrome, which is an inherited disease caused by mutations in the 
helicase RecQ2, but later tests disproved this diagnosis102,104. The patient instead had two mutant 
LIG1 alleles, giving rise to two missense mutations and, consequently, a biallelic loss of 
function. One of the ligase variants, E566K LIG1, reverses the charge of a conserved residue in 
the enzyme active site, ablating enzyme activity. Early investigation of the other variant, R771W 
LIG1, revealed delayed enzymatic activity, resulting in a delay in DNA repair and in Okazaki 
fragment joining105. Novel inherited mutations in the LIG1 gene have recently been identified106 
and are the focus of a biochemical characterization of detailed in Chapter 6. 
LIG4 syndrome 
LIG4 syndrome is used to describe LIG4 mutations that are known to result in disease. 
Most of these mutations are in the catalytic core of the enzyme, but patients have mutant LIG4 
alleles impacting the DNA-binding and BRCT domains107. Like both LIG1 syndrome and 
AOA1, the prevalence of LIG4 syndrome is low. Patients suffering from LIG4 syndrome are 
afflicted with a combined immunodeficiency (CID), with some patients suffering from a severe 
combined immunodeficiency (SCID), consistent with the abrogated levels of V(D)J 
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recombination often seen in LIG4 syndrome patients108. Increased sensitivity to ionizing 
radiation has been observed in the cells of all reported LIG4 patients, owing to the unique role of 
LIG4 in double-strand break repair through the NHEJ pathways. Due to the broad symptomology 
of LIG4 syndrome, no single treatment for the disease exists and symptoms are instead treated on 
an individual basis.  
Ataxia with oculomotor apraxia type 1 
AOA1 is a form of ataxia that results in severe neuropathy, as well as abnormal and 
uncontrolled eye movements, known as oculomotor apraxia. The disease has an early onset, with 
obvious symptoms of ataxia appearing in early childhood, frequently leaving the afflicted patient 
wheelchair-bound in early adolescence109. AOA1 is not caused by a defect in DNA ligation per 
se but is instead caused by defects in the protein aprataxin (APTX), which repairs the products of 
abortive ligation110-112.  
Abortive ligation occurs when a DNA ligase fails to complete ligation, instead releasing 
the adenylylated reaction intermediate before nick sealing can be completed. Upon release of the 
adenylylated intermediate, the active site lysines of DNA ligases are thought to be rapidly re-
adenylylated, preventing the adenylylated enzyme from binding to and ligating the abortive 
ligation product. APTX can recognize these abortive products and catalyze their deadenylation, 
either giving the ligase another chance at successful ligation or allowing other proteins to repair 
the nicked DNA strand112. Although the BER pathway is also capable of repairing abortive 
ligation products113, APTX is thought to be the predominant repair pathway in quiescent cells, 
such as neurons. Several mutations in APTX are associated with AOA1, causing a range of 
biochemical consequences, such as decreased catalytic activity or protein stability114,115.  
 
 16 
Mechanism and specificity of human DNA ligase I 
The work detailed in this dissertation centers around expanding our knowledge of DNA 
ligation through extensive study of human DNA ligase I. Our understanding of human DNA 
ligase structure and function has relied heavily on insights gained from viral DNA ligases, which 
do not share some of the complexities of their human counterparts. Additionally, research into 
the mechanisms of DNA replication and repair have been mostly focused on steps prior to 
ligation, limiting our knowledge of how the replication and repair pathways are concluded.  
Chapter 2 focuses on the investigation of the initial DNA binding steps of the LIG1 
catalytic pathway. Although many studies have been aimed at understanding the chemistry 
behind DNA ligation, the binding and recognition mechanisms utilized by DNA ligases are 
largely unknown. Using a reporter substrate and intrinsic protein fluorescence, we were able to 
monitor interactions between LIG1 and its DNA substrate, characterizing previously unknown 
steps preceding adenylyl transfer by LIG1. As a result, we identified two distinct conformational 
changes that LIG1 induces in the DNA substrate, helping to position the nick in the active site 
for catalysis.  
We also sought to understand how LIG1 achieves specificity for undamaged nicks with 
proper Watson-Crick pairing. LIG1 is known to be able to discriminate against nicks containing 
damaged or mispaired bases. Additionally, ligases have evolved a tolerance for ribonucleotides 
at the 3’ end while heavily discriminating against a ribonucleotide at the 5’ end. In pursuit of 
understanding this inherent discrimination, we have uncovered two novel mechanisms utilized 
by LIG1 to maintain fidelity. Chapter 3 will primarily focus on mismatch discrimination at the 3’ 
end. X-ray crystallographic data revealed a novel magnesium-binding site that appears to tune 
the tolerance for 3’ mismatches. Mutagenesis of this conserved metal site allows LIG1 to better 
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accommodate mismatches in the active site. The results of this study suggest that the novel metal 
site plays a role in stimulating abortive ligation to prevent incorporation of damaged DNA into 
the genome. 
Chapter 4 is focused on the mechanism behind ribonucleotide discrimination at the 5’ end 
of the nick. To investigate this, we performed mutagenesis of a conserved phenylalanine residue 
positioned near the sugar of the 5’ nucleotide. The positioning of the phenylalanine residue 
suggested that it may prevent the accommodation of the 2’-OH found in ribonucleotides and, 
therefore, may be key for precluding ligation of downstream RNA. Substituting the 
phenylalanine with either alanine or leucine significantly impacts all steps of ligation on the 
canonical ligation substrate. The alanine substitution, however, renders LIG1 unable to 
discriminate between DNA and RNA at the 5’ end, while a leucine substitution appears to 
enforce stricter discrimination against RNA. In addition, our results suggest that the 
phenylalanine residue has a role in helping to properly align the 5’ end for catalysis.  
Chapter 5 is focused on identifying the catalytic metal ligands for ligation. The initial 
report of the LIG1 structure suggested a network of interactions between conserved carboxylate 
residues in the active site that coordinate two catalytic magnesium ions. In contrast, only one 
magnesium ion is observed in coordination with the three residues in more recent high-resolution 
structures of LIG1. To test the role of these conserved residues, we biochemically characterized 
mutations at each of the three positions. The mutants exhibited differing degrees of catalytic 
defects, but all three mutations caused a dramatic decrease in magnesium affinity. Additionally, 
our evidence suggests that one residue plays an outsized role in stabilizing ATP and AMP in the 
active site. 
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Finally, we sought to gain a better understanding of the connection between mutations in 
the LIG1 gene and the onset of disease. A recent cohort of patients were identified as having 
novel mutations in their LIG1 gene, causing symptoms like those found in a previous patient 
suffering from LIG1 syndrome. Using site-directed mutagenesis, we made recombinant versions 
of two of the patient-derived mutants. Combining biophysical and biochemical techniques, we 
demonstrated that the two mutations decrease the efficiency of ligation by LIG1. Additionally, 
we found that the two mutants exhibit dramatic decreases in magnesium affinity, leading to an 
increase in the amount of abortive ligation. Preliminary crystallographic studies suggest that the 
biochemical defects result from the inability of the mutants to stably position the DNA substrate 
for catalysis, which remains to be tested directly. 
 The work contained in this dissertation represents a significant step toward a more 
comprehensive understanding of the mechanism and specificity of ligation by LIG1. 
Collectively, this work defines the molecular interactions between LIG1 and the DNA substrate 
prior to catalysis, demonstrating how these early interactions help to determine ligation fidelity. 
These interactions contribute to how the DNA ends are positioned in the enzyme active site, 
influencing how the catalytic magnesium ion is coordinated. Due to the ubiquity of LIG1 in 
DNA replication and repair, perturbations of the molecular interactions between LIG1 and its 
substrates can cause a cascade effect, ultimately resulting in disease. Future work is still 
necessary to understand the full scope of ligation fidelity and how this may contribute to the 




Mechanism of DNA-binding by LIG1 
 
Restoration of phosphodiester bonds necessitates rapid binding and recognition of the 
break by DNA ligases to avoid deterioration of the exposed DNA ends. While it is well-known 
that protein partners are often involved in guiding the localization of DNA ligases to sites of 
replication and repair49,64, nick recognition is thought to occur by an undefined mechanism that is 
intrinsic to DNA ligases. Crystal structures of DNA ligases uncovered that the enzymes distort 
the DNA helix upon binding, compressing the upstream strand into an A-form-like helical 
arrangement, resembling an intermediate state between an A- and B-form helix13,15. This is 
thought to be important for arranging the 3’ end of the nick into a catalytically favorable 
conformation in the enzyme active site. As detailed in Chapter 3, stabilization of this distorted 
helix also appears to help enforce ligation fidelity in human DNA ligase 1. Similarly, binding 
interactions at the 5’ end of the nick are thought to contribute to fidelity by enforcing preference 
for deoxyribonucleotides at this position; further study of this particular mechanism is described 
in Chapter 4. While studies into the fidelity mechanisms employed by DNA ligases are important 
for understanding the enzyme in the larger biological context, these studies are limited by a lack 
of knowledge regarding the binding steps preceding them.  
Requirements for nick binding and recognition by DNA ligase have largely been derived 
from studies of small viral DNA ligases, such as those found in the Vaccinia and Chlorella 
viruses. An early study of the Vaccinia virus DNA ligase demonstrated discrimination against
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 binding to DNA nicks lacking a 5’-phosphate11. Additionally, deadenylylated forms of the viral 
DNA ligase are unable to tightly associate with nicked DNA, suggesting that adenylylation of 
the active site lysine is a prerequisite for nick recognition. Studies of the Chlorella virus DNA 
ligase have demonstrated a tolerance for ribonucleotides in the upstream strand of a nicked DNA 
substrate116, lending some biochemical evidence to the later observation made with LIG1 that 
DNA ligases enforce an A-form-like helical structure upstream of the nick15.  
More recent studies of the T4 bacteriophage DNA ligase (T4Dnl) used stopped-flow 
spectroscopy to monitor fluorescence changes associated with DNA-binding and catalysis14. This 
study utilized a nicked DNA substrate containing a deoxythymidine-conjugated fluorescein 
(TFAM) at the 3’ end of the nick, which was shown to be sensitive to interactions between the 
ligase and the substrate. This modification is well-tolerated by T4Dnl, enabling reactions 
between the enzyme and the reporter DNA to be observed using real-time fluorescence. 
Employing the TFAM reporter substrate provided the first evidence of a multi-step binding 
mechanism for a DNA ligase, which the authors conclude is a transition between two different 
conformational states of the T4Dnl•DNA complex.  
While many questions still linger with respect to the binding mechanism employed by 
T4Dnl, this study provided us with a viable technique to probe the DNA-binding mechanism of a 
human DNA ligase. Here we report the characterization of the initial interactions between LIG1 
and the nicked DNA substrate, using both TFAM and intrinsic protein fluorescence. We propose 
a model for DNA binding by LIG1 (Figure 2.1a) wherein LIG1 first associates with the DNA in 
a non-specific manner. Translocation of the enzyme along the DNA helix halts when a nick is 
encountered, resulting in the formation of a specific recognition complex. From crystallographic 
evidence and results from the T4Dnl study, we hypothesize that specific recognition is followed 
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by a conformational change in LIG1 and/or the substrate, allowing catalysis to occur. The 
following study represents the first characterization of the full kinetic mechanism of DNA-
binding and ligation by a human DNA ligase. 
 
Figure 2.1. Probing the LIG1 DNA-binding mechanism using a reporter substrate. (a) Schematic of the hypothetical model 
of DNA-binding by LIG1. LIG1 interacts in a non-specific manner with the DNA double-helix (1), translocating along the helix 
until a nick site is found (2). Nick recognition is followed by a hypothetical remodeling step (3), where the DNA helix is distorted 
to align the nick in the active site for catalysis (4). Following formation of the sealed DNA product, the DNA is released (5), 
allowing LIG1 to bind and hydrolyze ATP (6) in preparation for a subsequent ligation event. (b) DNA substrates used in the 
determination of the LIG1 binding mechanism. Variations of both the 28mer and the 44mer containing a 3’-FAM label on the 
downstream strand are used in standard gel-based ligation assays. (c) A 44mer variant containing a deoxythymine-linked FAM 
(TFAM) label at the 3’-end of the nick is used to detect DNA-binding by LIG1. The position of the TFAM label is colored 
orange in both b and c. 
 
Materials and Methods 
Preparation and purification of materials. The catalytic core of human DNA ligase I 
(residues 232-919) was expressed in E. coli and purified as previously reported106. The 
concentration of the adenylylated enzyme was determined by active site titration against a fixed 
concentration of the nicked 28mer substrate. Substrate oligonucleotides were synthesized by 
Integrated DNA Technologies (IDT) and the Keck Biotechnology Resource Laboratory at Yale 
University. Lyophilized oligos were dissolved in 8 M urea and 1X Tris/Borate/EDTA (TBE) 
before being gel-purified on denaturing polyacrylamide gels, as previously described41. The 
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oligo sequences used for this study are shown in Figure 2.1b and Figure S2.8. Both the 28mer 
and 44mer substrates contain a 6-FAM label (IDT) on the 3’ end of the downstream oligo. The 
TFAM-44mer is identical to the 44mer substrate with the exception of the fluorescein reporter 
linked to the 3’ thymine on the upstream strand instead of at the end of the downstream oligo 
(Figure 2.1c). A double-labeled variant of the TFAM-44mer containing both the internal TFAM 
label and the downstream 3’ 6-FAM was used in single-turnover experiments to follow the 
adenylylated intermediate species. An additional variant of the TFAM-44mer lacking a 5’-PO4 
on the downstream strand was used in equilibrium-binding studies. An unlabeled 28mer and 
28mer variant containing an all ribonucleotide upstream strand were used in stopped-flow 
experiments monitored using tryptophan fluorescence. 
Gel-based ligation assays. All ligation assays were performed at 37°C with a standard 
reaction buffer containing 50 mM NaMOPS pH 7.5 (adjusted at 25°C), 0.1 mM dithiothreitol, 
0.05 mg/mL BSA and varying amounts of NaCl to maintain a constant ionic strength of 150 mM. 
Steady-state ligation assays were quenched with an equal volume of the gel-loading solution 
containing 50 mM EDTA/90% formamide. Quenched reactions were heated to 95°C prior to 
loading on 15-20% (wt/vol) polyacrylamide gels containing 6.6-8 M urea. The fluorescein-
labeled species were detected using either a Typhoon Trio+ or a Typhoon 5 imager (GE 
Healthcare) and quantified using the ImageQuant software (GE Healthcare) as previously 
described41.  
Steady-state ligation assays. DNA-dependences were performed in the presence of either 
20 mM MgCl2 and 0.2 mM ATP or 2 mM MgCl2 and 1 mM ATP. Reactions with 2 mM MgCl2 
contain 1 mM Mg2+free due to chelation of magnesium by ATP41. Reactions contained 0.1-10 nM 
LIG1 and increasing concentrations of either the 28mer or TFAM-44mer substrate. Initial rates 
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of reaction were obtained from the slopes of linear fits to the fraction of product as a function of 
time, which were then plotted as a function of substrate concentration. Values for kcat and KM 
were obtained from fits of the data to the Michaelis-Menten equation (Equation 2.1). 





Rapid-quench flow ligation assays. Single-turnover assays were carried out using a 
KinTek RQF-3 apparatus. Ligation reactions were prepared by loading one sample syringe with 
1.6 µM LIG1 and the other with 160 nM of one of the three tested DNA substrates. Both 
syringes contained varying amounts of MgCl2. Ligation was initiated upon mixing of the 
solutions in a 1:1 ratio, followed by quenching of the reaction at various timepoints with a 
solution containing 1 N H2SO4/0.25% SDS117. After quenching, 20 µL of the quenched sample 
was immediately neutralized in a solution containing 300 mM Tris base, 15 mM EDTA and 0.5X 
loading buffer. Rates for the adenylyl-transfer and nick-sealing steps were obtained from fits of 
the data using a two-step irreversible model in Berkeley-Madonna as previously described41. 
Steady-state fluorescence binding assays. Fluorescence intensity and anisotropy 
measurements were collected using a FluoroMax 3 fluorometer (Horiba) controlled by the 
DataMax software. Data were collected using excitation and emission wavelengths of 495 nm 
and 515 nm, respectively. Binding assays were performed at 37°C by titration of increasing 
amounts of LIG1 against a 2.5 mL solution containing 1-2 nM of the TFAM-44mer and the 
standard reaction buffer with 0.1 mM EDTA. After addition of LIG1, samples were allowed to 
equilibrate for 30 seconds to 1 minute before measurements were taken. Anisotropy and relative 
fluorescence are plotted as a function of added [LIG1] and the data was fit to a hyperbolic 
binding curve (Equation 2.2) to derive KD values.  




Where y is either anisotropy or fluorescence intensity, Ymax is the anisotropy or fluorescence 
value at the plateau and C is a constant. 
Stopped-flow kinetic experiments. Transient kinetic experiments were performed using 
the Hi-Tech SF-61DSX2 stopped-flow instrument controlled by the Kinetic Studio (TgK 
Scientific) software, with a circulating water bath maintaining temperature at 37°C. A minimum 
of 5-6 shots were performed and averaged for each concentration tested. Fluorescein 
fluorescence was measured using an excitation wavelength of 495 nm and two 515 nm longpass 
filters. For experiments looking at tryptophan fluorescence, an excitation wavelength of 295 nm 
and two 320 longpass filters. All stopped-flow reactions were performed in the standard ligation 
buffer, except for experiments monitored by tryptophan fluorescence, for which BSA was 
omitted from the buffer. Data from both PMT detectors were combined and averaged for each 
shot. The resulting traces were either fit to a single exponential or a series of exponentials, 
depending on the number of observed phases (Equation 2.3). 
  Equation 2.3   𝑦𝑦 = 𝑎𝑎1𝑒𝑒−𝑘𝑘1∗𝑡𝑡 + ….. 𝑎𝑎𝑛𝑛𝑒𝑒−𝑘𝑘𝑖𝑖∗𝑡𝑡 + 𝑐𝑐 
Where y is fluorescence intensity, a is the amplitude of the phase and C is a constant. All 
observed rates (k) were plotted as a function of the concentration of whichever component was 
varied throughout the experiment. The resulting data plots were fit either by linear regression or 
with a hyperbola to determine the maximal rates and K1/2 values.  
 The TFAM-44mer was fixed at a constant concentration of 20 nM for measurements of 
the transient kinetic dependence on the concentration of LIG1. Reactions were performed with a 
concentration of LIG1 ranging from 0–5 µM and in the standard reaction buffer supplemented 
with either 0.1 mM EDTA or 20 mM MgCl2. For experiments monitored by tryptophan 
fluorescence, the concentration of LIG1 was kept constant at either 0.5 or 1 µM. In the absence 
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of magnesium, the concentration of the 28mer DNA substrate was varied from 1 – 10 µM in the 
standard reaction buffer supplemented with 0.1 mM EDTA. To characterize the magnesium 
dependence, LIG1 was kept at a concentration of either 0.5 or 1 µM, with the substrate held at a 
concentration of either 5 or 10 µM.  To measure the rate of product release as a function of ATP 
concentration, 1.1 µM LIG1 and 1 µM 28mer were mixed prior to loading in the stopped-flow 
apparatus in the presence of 0.1 mM EDTA to prevent catalysis. Reactions were initiated by 
rapid-mixing of the LIG1•DNA complex and a solution containing 2 mM MgCl2 and increasing 
amounts of ATP.  
Results 
LIG1 performs efficient steady-state ligation of the TFAM reporter substrate 
Investigation of the DNA-binding mechanism of LIG1 required a reliable assay for 
monitoring interactions between LIG1 and a nicked DNA substrate. Previous study of the T4 
DNA ligase binding mechanism made use of a substrate containing a deoxythymidine-linked 
fluorescein (TFAM) at the 3’ end of the nick, which did not cause major perturbations to ligation 
kinetics. This is in contrast to the placement of the TFAM moiety at the 5’ end, which strongly 
inhibited T4 DNA ligase kinetics14. Due these findings, we chose to incorporate the TFAM 
reporter at the 3’ end of a 44mer ligation substrate (Figure 2.1b) composed of an AT-rich 
sequence to avoid fluorescence quenching by guanine bases118. The TFAM is situated at the -1 
position in the substrate to maximize the chances of observing fluorescence changes due to direct 
interactions between the protein and DNA (Figure 2.1c).  
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Figure 2.2. TFAM-label impacts catalytic rate but not overall catalytic efficiency. Steady-state substrate dependences were 
performed with increasing amounts of both the 28mer and TFAM-44mer substrates and 0.1-10 nM LIG1, in the presence of 
either 20 mM Mg2+ and 0.2 mM ATP (a) or 1 mM Mg2+ and 1 mM ATP (b). Data were fit using the Michaelis-Menten equation 
and best-fit parameters are shown in Table 2.1. (c) Plot of the kcat/KM values for ligation of both the 28mer and TFAM-44mer 
substrates highlighting that LIG1 ligates both substrates with similar efficiency. Data for the TFAM-44mer are preliminary and 
only reflects the results of two replicate experiments. The steady-state dependences for the 28mer are adapted from the study 
detailed in Chapter 3. 
  
To test whether the presence of this fluorophore at the nick perturbs ligation by LIG1, we 
compared steady-state DNA substrate dependences for the TFAM-44mer substrate and a 
previously characterized 28mer substrate (Figure 2.2)41. At both saturating and physiological 
concentrations of Mg2+, LIG1 ligates the TFAM-44mer at a slower rate than the 28mer substrate. 
While the decrease in kcat is only ~2-fold in the presence of 20 mM MgCl2, the decreased rate is 
more pronounced at low Mg2+, where kcat is ~5-fold slower for the TFAM-44mer than for the 
28mer (Table 2.1). This change in kcat is paired with a decrease in KM,DNA for the TFAM-44mer 
substrate, making the overall efficiency of TFAM-44mer ligation roughly equal to that of the 
28mer in the presence of both high and low MgCl2 (Figure 2.2c, Table 2.1).  
 
Sequence-dependent changes in the chemical steps of ligation 
Due to the decrease in kcat for the ligation of our reporter substrate, we posited that the 
DNA-dependent chemical steps—adenylyl transfer and nick sealing—may be impacted by the 
presence of the TFAM fluorophore. To investigate this, we performed single-turnover 
experiments to compare the microscopic rates of ligation of the TFAM-44mer and 28mer 
substrates (Figure 2.3). Single-turnover experiments were carried out in the presence of 
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increasing amounts of magnesium, using a rapid quench-flow apparatus to observe the formation 
of the adenylylated ligation intermediate and its subsequent conversion into sealed DNA. The 
maximal rates and KMg2+ values for the adenylyl-transfer and nick-sealing steps were obtained 
from hyperbolic fits of the rates at increasing magnesium concentrations (Table 2.1).  
The single-turnover characterization of the 28mer substrate is in agreement with previous 
reports of LIG1-dependent ligation of this substrate41 (Figure 2.3b-c). The magnesium affinities 
of the two chemical steps differ, with the KMg2+ value in the sub-millimolar range for adenylyl 
transfer and ~5 mM for nick sealing (Table 2.1). Despite a tighter magnesium affinity, the 
maximal rate for adenylyl transfer is roughly 6-fold slower than that of nick sealing, making 
adenylyl transfer rate-limiting in the presence of magnesium concentrations at or exceeding 
physiological concentrations (≥ 1 mM)41. Meanwhile, the TFAM modification does appear to 
have significant impacts on the chemical steps of ligation (Figure 2.3b-c).  The magnesium 
dependence on ligation of the TFAM substrate illustrates ~20-fold increases in the KMg2+ values 
for adenylyl transfer and nick sealing relative to those for ligation of the 28mer. Additionally, the 
maximal rates of both steps appear to be much faster, although much higher concentrations of 
MgCl2 would be required to observe these rates for ligation of the TFAM-44mer substrate (Table 
2.1).  
In addition to the TFAM modification, the sequence composition of the two substrates is 
also different, raising the question of whether the TFAM modification itself is responsible for 
these changes or if this behavior is due to the change in sequence context. To test this, we 
repeated our magnesium dependence assay to look at ligation of the 44mer substrate without the 
TFAM modification (Figure 2.3b-c). Overall, single-turnover parameters for ligation of the 
44mer substrate are noticeably different from those obtained with either the 28mer or TFAM-
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44mer substrates (Table 2.1). This divergence between the three substrates seems to indicate that 
sequence context impacts ligation by LIG1. The sequence composition of the four nucleotides at 
the nick has been shown to impact ligation by other DNA ligases119,120 
Figure 2.3. The TFAM label significantly impacts the individual chemical steps of ligation. (a) Schematic of the DNA-
dependent ligation steps. Ligation consists of two chemical steps, starting with transfer of the adenylyl group from LIG1 to the 
5’-PO4 at the nick. The adenylylated DNA intermediate is then sealed after attack of the 5’-PO4 by the adjacent 3’-OH, resulting 
in release of AMP and the sealed DNA. Single-turnover reactions were carried out in the presence of increasing amounts of 
MgCl2, 800 nM LIG1 and 80 nM the DNA substrate. The individual rates of adenylyl transfer (b) and nick sealing (c) were 
derived from fits of the data using a two-step irreversible model in Berkeley-Madonna. Magnesium dependences were 
determined for ligation of the 28mer, TFAM-44mer and 44mer substrates, which all fit to a hyperbolic dependence on the 
magnesium concentration. Best-fit parameters for the maximal rates and magnesium affinities are shown in Table 2.1. Data for 
the 28mer is adapted from the study in Chapter 3, while the data for the TFAM-44mer and 44mer represents a single 
experimental replicate. Representative single-turnover traces are presented in Figure S2.1. 
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Table 2.1. Best-fit parameters from 
gel-based ligation assays. (a) Steady-
state parameters determined from the 
substrate dependences in Figure 2.2, 
displayed as the mean ± S.D. Values 
for the TFAM-44mer are only derived 
from duplicate experiments. (b) 
Single-turnover parameters 
determined by hyperbolic fits of the 
data in Figure 2.3. Values for the two 
44mer substrates are based on a single 
experiment. All data for the 28mer 
substrate in a and b are adapted from 
the study detailed in Chapter 3. 
 
The TFAM substrate reports on nick-specific binding 
Despite the obvious effects of the TFAM fluorophore on ligation, we reasoned that the 
reporter may still be a viable tool and sought to test its ability to report on specific interactions 
between LIG1 and the nick. To this end, we performed equilibrium-binding experiments by 
titrating increasing amounts of LIG1 against fixed concentrations of either the TFAM-44mer 
substrate or a variation lacking a 5’-phosphate at the nick site in the absence of magnesium 
(Figure 2.4a-b). Binding was observed by fluorescence quenching and anisotropy, which were 
both fit to binding hyperbolas to define the KD for the two oligos. While we observed a tight 
interaction between LIG1 and the phosphorylated TFAM-44mer (KD ≈ 5 nM), binding to the 
dephosphorylated nick is much weaker, with a KD closer to 4 µM (Table 2.2). Our results 
indicate that the tight binding measured for the phosphorylated substrate is likely a measurement 
of specific affinity for the nick site.  
We next performed stopped-flow spectroscopy experiments to measure the kinetics of 
binding in the absence of catalytic magnesium. Representative traces resulting from the rapid-
mixing of an increasing excess of LIG1 with the reporter substrate are shown in Figure 2.4c. 
Observed rates constants were obtained from single-exponential fits to the fluorescence traces 
and are plotted as a function of increasing amounts of LIG1 (Figure 2.4d). Observed rate 
constants are linearly dependent on the concentration of LIG1, indicating that this fluorescence 
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decrease corresponds to the bimolecular association with a kon,app of 6.7 ± 1.3 x 107 M-1s-1 and a 
koff ,app of 29 ± 13 s-1. Using these estimates gives a KD value close to 0.4 µM, which is 
substantially higher than what was measured via equilibrium binding. Without further 
experimentation, it is likely that this discrepancy is due to the presence of a two-step association, 
in which one step is spectroscopically invisible. If true, then the equilibrium binding 
measurement would then represent the dissociation constant for both steps combined, while only 












Figure 2.4. TFAM-label reports on nick-specific interactions between DNA and LIG1. Equilibrium-binding experiments 
were performed by titration of LIG1 against a fixed concentration of either the TFAM-44mer substrate (a) or a variation of the 
substrate lacking the 5’-PO4 group at the nick (b) in the absence of Mg2+. Increases in anisotropy and fluorescence quenching are 
plotted as a function of the total concentration of added LIG1, which are fit to hyperbolic binding models to determine the 
binding affinities for each substrate. (c) Stopped-flow experiments were performed by rapidly mixing increasing amounts of 
LIG1 with 20 nM of the TFAM-44mer substrate in the absence of magnesium. Representative traces are shown for experiments 
with 0-4 µM of the enzyme. All traces were fit using a single-exponential, and the individual rate constants are plotted as a 





Catalysis on the reporter substrate can be monitored via real-time fluorescence 
We next investigated how the presence of magnesium affects the LIG1•DNA interactions 
by repeating stopped-flow experiments in the presence of 20 mM MgCl2. The resulting 
fluorescence traces contain an initial fluorescence decrease, followed by two distinct 
fluorescence recovery phases (Figure 2.5a). Using a four-exponential fit, we were able 
to obtain rate constants for the observed fluorescence changes (Figure 2.5; Table 2.2). The first 
two phases—contained within an elongated fluorescence decrease—are dependent on the 
concentration of added LIG1 (Figure 2.5b-c). The first phase is linearly dependent on enzyme 
concentration, most likely describing the same initial binding step as seen in the absence of 
magnesium. Indeed, the slope of the resulting linear fit gives a bimolecular rate constant of 2.0 ± 
0.8 x 108 M-1s-1, which is similar to the value of 6.7 x 107 M-1s-1 measured in the absence of 
magnesium, indicating that magnesium is likely not affecting formation of the initial LIG1•DNA 
complex.  
Figure 2.5. Magnesium initiates an unknown step preceding catalysis. (a) Stopped-flow experiments were performed by 
rapidly mixing increasing amounts of LIG1 with 20 nM of the TFAM-44mer substrate in the presence of 20 mM MgCl2. 
Representative traces are shown for experiments with 0-4 µM of the enzyme. The observed phases are mapped onto the proposed 
model, beginning with LIG1 binding to the nicked DNA substrate (nDNA). The second phase either reports on adenylyl transfer 
or an unknown conformational change in the DNA, indicated by DNA*. The third phase matches the single-turnover rate for nick 
sealing. The final step is similar to the steady-state kcat value for the TFAM substrate and likely represents full product release. 
All traces were fit using a four-exponential model and the individual rates of each phase are plotted as a function of [LIG1] in b-
d. kobs,1 and kobs,2 show a linear and hyperbolic dependence on the concentration of added LIG1, respectively. All values are 
shown as the mean ± S.D. of at least three replicate experiments and are reported in Table 2.2.  
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The cause of the second phase of the fluorescence decrease—exhibiting a hyperbolic 
dependence on enzyme concentration—is less clear (Figure 2.5c). With a kobs of 10 ± 1 s-1, this 
phase could be attributed to adenylyl transfer, which saturates at ~10 s-1 in the presence of 20 
mM MgCl2 in our gel-based ligation assays (Table 2.1). Since we have no indication that the 3’-
TFAM fluorophore is sensitive to adenylylation of the 5’-PO4, this phase may instead represent 
an uncharacterized reversible conformational change in either LIG1 or the DNA. Subsequent 
experiments designed to test this possibility are described in more detail in the discussion. 
The two LIG1-independent phases observed in the latter half of our fluorescence traces 
likely reflect product formation and release. Across all tested LIG1 concentrations, kobs,3 is 
roughly equal to the rate constant for nick sealing, which, at about 3-5 s-1, is the rate-limiting 
chemical step for ligation of the TFAM-44mer in the presence of 20 mM MgCl2 (Figure 2.5d). 
Increased signal is presumably not a direct result of nick sealing itself, but likely results from 
LIG1 translocating away from the sealed nick and, therefore, away from the TFAM fluorophore. 
kobs,4 is a likely candidate for the final product release step, where LIG1 fully disengages the 
sealed DNA product (Figure 2.5e). In support of this, we observed that kobs,4 is close to the 
turnover number (kcat) measured in steady-state ligation assays with the TFAM-44mer substrate, 
which would indicate that product release is rate-limiting for steady-state ligation of the TFAM 
substrate (Table 2.2).  
 
Intrinsic tryptophan fluorescence reports on the initial binding interactions 
Although the TFAM reporter provided us with robust signal with which to characterize 
the initial binding steps, the peculiar effects of the reporter on catalysis did give us some pause in 
drawing conclusions from data collected with the substrate. Due to this, we sought to verify our 
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findings using an alternative method that did not carry the same caveats as the TFAM substrate. 
Since LIG1 has a tryptophan residue—W742—in its active site pocket (Figure S2.3a-b), we 
reasoned that internal tryptophan fluorescence may be a viable method for measuring 
interactions between the nick site and LIG1. It is worth noting that LIG1 contains a total of six 
tryptophan residues—two in each of the three domains—but only W742 appears as though it 
would be impacted by interactions between LIG1 and DNA (Figure S2.3c-d).  
 
 
Figure 2.6. Intrinsic tryptophan fluorescence reports on DNA binding. (a) Stopped-flow experiments containing an 
increasing amount of the 28mer DNA substrate and 0.5-1 µM LIG1 were monitored using intrinsic protein tryptophan 
fluorescence with an excitation wavelength of 295 nm and a 320 nm cutoff longpass filter. Representative traces are shown from 
the rapid mixing of LIG1 with 0-4 µM DNA. Single exponential fits of the individual traces gave rate constants that are linearly 
dependent on the concentration of added DNA substrate (b). All values are shown as the mean ± S.D. of at least three replicate 
experiments and are reported in Table 2.2. 
 
The advantage of using tryptophan fluorescence is that it did not require us to alter either 
the protein or the DNA substrate. Because of this, we were able to repeat stopped-flow 
experiments with the well-defined 28mer substrate41. Instead of monitoring the fluorescence 
changes as a function of increasing LIG1, we were required to use an increasing excess of the 
28mer substrate for observable signal changes. However, multiple turnovers were avoided since 
ATP was not included in the stopped-flow reaction mixes. In the absence of magnesium, rapid 
mixing of LIG1 with increasing amounts of the 28mer substrate resulted in single-exponential 
decreases in tryptophan fluorescence (Figure 2.6). We were able to determine a linear 
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dependence of the rate constants on substrate concentration, with a kon nearly equal to the value 
obtained using the TFAM-44mer substrate, indicating that the TFAM fluorophore may not have 
impacted initial binding by LIG1 (Table 2.2).  
Figure 2.7. Magnesium dependence reveals two magnesium-dependent steps preceding catalysis. (a) Tryptophan 
fluorescence was monitored upon mixing of 1 µM [LIG1] with 5 µM of the 28mer substrate and increasing amounts of MgCl2. 
Representative traces are shown from mixing of LIG1 either with DNA or buffer in the presence of 10 mM [MgCl2]. 
Representative traces at multiple concentrations of MgCl2 are shown in Figure S3. The individual phases are mapped onto a 
hypothetical model. Unlike the model in Figure 2.5, we observe two phases (kobs,2, kobs,3) that do not match the known chemical 
steps for ligation and are attributed to two distinct conformational changes. Traces were fit to four-exponentials and the 
corresponding rate constants are plotted as a function of [Mg2+] in b-d, except for kobs,1, which was omitted due to poor resolution 
of the first phase in the fluorescence traces. All observed rate constants have a hyperbolic dependence on [Mg2+] resulting in 
magnesium affinities in the low millimolar range. All values are shown as the mean ± S.D. of at least three replicate experiments 
and are reported in Table 2.2.  
 
Intrinsic tryptophan fluorescence reveals putative conformational changes 
The amplitudes of the tryptophan fluorescence changes are much smaller than those 
observed with fluorescein, likely due to increased background signal from other tryptophan 
residues and an inner filter effect caused by excess DNA. While this did not significantly affect 
data collection in experiments lacking magnesium, it did hinder our ability to accurately monitor 
the initial binding event—kobs,1—in the presence of magnesium (Figure 2.7a). Due to this, we 
focused on characterizing the magnesium-dependence of the steps subsequent to initial binding.  
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The resulting traces from the stopped-flow Mg2+-dependence exhibit a similar behavior 
to those seen using the TFAM reporter (Figure 2.7a). As stated above, the first phase—
corresponding to the initial binding event—is poorly defined but does not appear to be dependent 
on magnesium concentration (Figure S2.4). The following three phases all show a hyperbolic 
dependence on the concentration of magnesium.  kobs,2 was not seen using TFAM fluorescence 
and is much higher than that of any chemical steps of ligation (Figure 2.7b). The subsequent 
phase—corresponding to kobs,3—is also not seen in the TFAM fluorescence trace and saturates at 
a low concentration of magnesium, with a KMg2+ value of ~0.1 mM (Figure 2.7c). While further 
experiments are needed to directly address these two phases, it is plausible that they correspond 
to changes in the DNA or protein upon formation of the Michaelis complex. It is well-known 
that DNA ligases distort the helix in order to properly position the nick in the enzyme active site 
and the active site tryptophan may be sensitive to these events. Since both the 3’-OH and the 5’-
PO4 need to be properly aligned for catalysis, these two phases could represent the independent 
positioning of the two ends of the nick. Evidence supporting this model is explained further in 
the discussion. 
Plotting kobs,4 as a function of magnesium concentration gives a maximal rate constant 
and a KMg2+ value that both match those of the adenylyl-transfer step of ligation of the 28mer 
substrate (Figure 2.7c, Figure S2.5). The signal change for this phase likely results from release 
of AMP following catalysis, with both the rates of nick sealing and AMP release being much 
faster than adenylyl transfer. While not well-resolved in the magnesium dependence traces, a 
final phase—kobs,5—is observed and is likely a final product release step. Defining this phase is 
the focus of more recent experiments, discussed below in more detail. 
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Ligation of upstream ribonucleotides enhances kobs,3 
Our observations with both TFAM and tryptophan fluorescence demonstrate that multiple 
steps occur after DNA-binding but prior to ligation by LIG1. One such phase is an unidentified 
step in our tryptophan fluorescence traces—kobs,3—which is magnesium dependent and does not 
obviously correspond to any of the chemical steps (Figure 2.7a,c). Since the upstream helix is 
known to be distorted into a more A-form-like helix, we created a variant of the 28mer 
containing an upstream strand composed of all ribonucleotide bases with the thought that a 
DNA-RNA hybrid should be more amenable to this type of remodeling by LIG1. Indeed, pilot 
stopped-flow experiments with this 28mer variant mimicked those with the DNA-only 28mer, 
except for kobs,3, which is roughly 2-fold faster with the DNA-RNA hybrid (Figure 2.8, Table 
2.2). We also observe this upstream remodeling step with the TFAM-44mer substrate (kobs,2 in 
Figure 2.5). The AT-rich nature of the TFAM-44mer substrate may lower the barrier for this 
remodeling to occur, consistent with the faster rate observed with the TFAM-44mer substrate.  
Figure 2.8. Upstream ribonucleotides enhance the rate of a step preceding chemistry. (a) Representative stopped-flow traces 
from experiments with a variant of the 28mer containing an all-ribonucleotide sequence upstream of the nick. Data shown for the 
DNA-only 28mer are adapted from Figure 2.7. (b-d) Observed rate constants from ligation of the 28mer and the upstream ribo-
28mer have similar magnesium dependences, except for kobs,3, which is 2-fold faster with the ribo-28mer. Data for the ribo-28mer 
are the result of duplicate experiments and the best-fit values are shown as the mean ± S.D. in Table 2.2.  
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With this in mind, we believe that another of the phases observed using tryptophan 
fluorescence, designated as kobs,2 (Figure 2.7a-b), could be reporting on interactions between 
LIG1 and the 5’ end of the nick. We have demonstrated that this step is magnesium dependent, 
exhibiting a low KMg2+ value. Recent crystal structures of LIG1 illustrate the involvement of the 
5’-phosphate in the coordination of the catalytic magnesium, so it is plausible that Trp742 would 
be sensitive to these interactions. The fact that the TFAM reporter seems unable to report on this 
phase is consistent with this proposed model, as it is unlikely the TFAM reporter on the 3’ end of 
the nick would be sensitive to the changes in the active site or at the 5’ end. 
 
Addition of ATP demonstrates the presence of a product-release step 
Finally, we wanted to confirm whether the final phase in our stopped-flow traces 
corresponds to product release. While we did note that the final observed rate in the TFAM 
fluorescence traces is consistent with kcat, indicating a possible rate-limiting product release, we 
wanted to probe this step directly. Based on the idea that deadenylylated LIG1 should prefer 
binding ATP to remaining bound to the sealed DNA product, we expected the addition of ATP to 
enhance the rate constant for a product-release step. Since tryptophan fluorescence should also 
be sensitive to the DNA-independent steps of ligation, we wanted to test whether we could 
observe LIG1 transitioning from a DNA-bound to an ATP-bound state.  
We repeated stopped-flow experiments, rapidly mixing the LIG1•DNA complex with 
MgCl2 and increasing amounts of ATP (Figure 2.9, Table 2.2). To prevent multiple turnovers, 
we performed these experiments with a slight excess of LIG1. We observed a hyperbolic 
dependence of the phase on the concentration of ATP, giving a KATP value of ~10 µM and a 
maximal rate constant of ~0.4 s-1, both of which are consistent with steady-state KM,ATP and kcat 
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values41. With only the data presented here, it is difficult to know whether this rate constant is a 
consequence of slow product release or slow ATP-binding, although ATP-binding by other 
ligases is rapid121. 
 
Figure 2.9. ATP enhances the rate of LIG1 product release. (a) To probe the product release step, a complex of 1.1 µM 
[LIG1] and 1 µM of the 28mer substrate was mixed with 1 mM Mg2+ and increasing amounts of ATP. Each representative trace 
was normalized to its initial fluorescence signal for clarity. (b) Exponential fits of the final phase in each trace are plotted as a 
function of increasing ATP, illustrating a hyperbolic dependence on ATP concentration. The data are the result of duplicate 









Table 2.2. Best-fit parameters from real-time and equilibrium fluorescence assays. Parameters obtained from stopped-flow 
experiments using either TFAM-44mer (a) or tryptophan residues (b) as the fluorescence reporter. In a, ,kon and koff values 
represent the averages of the values obtained from experiments with and without magnesium. In b, the values shown were 
obtained with either the 28mer and a ribonucleotide derivative of the 28mer (R28mer). Values that were not determined are 






Since this study remains a work-in-progress, several questions about the binding 
mechanism of LIG1 remain. However, we have described the first direct observation of nick-
binding by a human DNA ligase. Although the deoxythymidine-conjugated reporter appears to 
adversely affect the chemical steps of ligation, we have demonstrated its potential as a reporter of 
DNA-binding and catalysis by LIG1. Additionally, we were able to observe a previously-
uncharacterized event preceding chemistry, possibly corresponding to a conformational change 
in the DNA or the protein.  
Despite some perturbations to DNA ligation caused by the presence of the TFAM 
reporter, most of the conclusions drawn from its use were validated using intrinsic tryptophan 
fluorescence. LIG1 has a single tryptophan residue—W742—in its active site, which we 
presumed to be sensitive to interactions between the protein and the nicked DNA. Although 
LIG1 contains additional tryptophan residues, W742 is the only one in proximity to a 
LIG1•DNA contact. Using tryptophan fluorescence and an unmodified 28mer substrate, we were 
able to repeat stopped-flow experiments in the absence of any perturbations caused by the TFAM 
fluorophore. Additionally, tryptophan fluorescence enabled us to monitor the DNA-independent 
steps of the ligation catalytic cycle. By adding ATP into our stopped-flow experiments, we were 
able to demonstrate that the final observed phase in our data corresponds to a product-release 
step, followed by rapid binding to ATP. 
Monitoring tryptophan fluorescence traces as a function of increasing magnesium 
concentrations revealed the existence of two distinct exponential phases in our stopped-flow 
experiments. While further characterization of these two phases is still necessary, we believe that 
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this points to a two-step remodeling event, where LIG1 distorts the nick site to position both 
ends of the nick in the active site for catalysis. Using a modified substrate containing a full 
ribonucleotide upstream strand, we demonstrated the possibility that at least one of these 
uncharacterized phases may correspond to a helical distortion at the 3’ end of the nick. 
Considering the presented data, we believe that our initial model presented in Figure 2.1 
is valid, with a few amendments (Figure 2.10 and 2.11). First, we are not able to observe LIG1 
translocation across the DNA helix in search of a nick with either TFAM or tryptophan 
fluorescence. Considering that the LIG1 domains span the length of the entire 18bp DNA 
substrate in crystal structures of the LIG1•DNA complex, we would need a significantly longer 
substrate to slow down a putative finding step for observation. In the current study, we can 
consider the nick-finding step to be very fast, making the first observable event direct association 
with the nick. Second, we believe that the remodeling step proposed in the initial model can be 
further expanded. Remodeling likely consists of the alignment of the 5’-PO4 in the active site 
pocket, which is followed by a distortion of the upstream helix to position the 3’-OH for 
catalysis. While experiments with the upstream RNA substrate provide evidence for the presence 










Figure 2.10. Unified model for both TFAM and tryptophan fluorescence experiments. Rate constants for the proposed steps 
following initial binding are derived from experiments in the presence of 20 mM Mg2+ to allow a direct comparison of TFAM 
and tryptophan fluorescence experiments. Values for the tryptophan fluorescence mechanism were obtained using the 28mer 








Figure 2.11. Revised model for the full catalytic cycle of LIG1. The estimated rates of each step are derived for the data in 
Table 2.2 and are ranges of the data collected using either TFAM or tryptophan fluorescence. The model mostly reflects the 
proposed model in Figure 2.1, except for the remodeling step, which we believe is a two-step process. This model was used in 
Berkeley Madonna to fit experimental data collected using tryptophan fluorescence and the resulting fit is shown in Figure S2.6. 
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Figure S2.1. Representative single-turnover traces. Traces are shown for ligation of the 28mer (a), TFAM-44mer (b) and 
44mer (c) substrates in the presence of 1 mM Mg2+. Product formation is indicated with closed circles, while intermediate 
formation and decay is represented with open circles. The corresponding fits from Berkeley-Madonna are shown as solid 












Figure S2.2. Rapid mixing of a preformed LIG1•TFAM-44mer complex with magnesium. Same experiments as in Figure 
2.5 except DNA and increasing amounts of LIG1 were incubated together prior to mixing with magnesium. A trace amount of 
EDTA (0.1 mM) was added to the complex solution to prevent premature catalysis. The resulting traces (a) show the same 
features as in Figure 2.5 except for the absence of the initial binding phase corresponding to kobs,1. Traces were fit to three 
exponentials and the resulting rates are plotted as a function of [LIG1] in b-d. The corresponding values were averaged together 
with the experiments in Figure 2.5 and the resulting means ± S.D. are displayed in Figure 2.5 and in Table 2.
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Figure S2.3. LIG1 has a single tryptophan residue in its active site pocket. (a) Cartoon representation of the active site of 
LIG1 highlighting Trp742 (red) and the adenylylated lysine in stick representation. (b) Surface representation of the active site 
with the location of Trp742 highlighted in red. (c-d) Cartoon representation of the full LIG1 structure with all tryptophans 
represented as space-filling models. Trp742 remains highlighted in red while the other five tryptophan residues are shown in 














Figure S2.4. Magnesium does not noticeably affect initial binding. (a) Same experiment as in Figure 2.7A shown with two 
other tested concentrations of magnesium. The blue box highlights the region corresponding to kobs,1, which does not appear to 
change in response to an increasing concentration of added magnesium. (b) Magnified view of the traces in a to highlight the low 











Figure S2.5. Overlay of kobs,4 and ktransfer. Data for kobs,4 (Figure 2.7) and for ktransfer (Figure 2.3b, 28mer) superimposed to 















Figure S2.6. Berkeley-Madonna model fitting. Berkeley-Madonna was used to fit traces observed with tryptophan fluorescence 
to a simplified version of the model in Figure 2.10 (top). Since a nick-finding step was not observed, the model here assumes 
direct binding to the nick site by LIG1. Additionally, both adenylyl transfer and nick sealing are condensed down to just a single 
chemical step, since individual signals resulting from the two steps were not observed. Finally, product release is omitted from 
the model, as it was not observed under the conditions used. A plot of the resulting fit is shown with the experimental data in the 































Figure S2.8. Oligonucleotides used for this study.  
 
METHOD RK4 
STARTTIME = 0.001 
STOPTIME=5 
DT = 0.02 
 
d/dt(E) = koff*ES - kon*E*S 
d/dt(S) = koff*ES - kon*E*S 
d/dt(ES) = kon*E*S - koff*ES - k5r*ES 
d/dt(ES5) = k5r*ES - k3r*ES5 
d/dt(ES3) = k3r*ES5 - kchem*ES3 
d/dt(EP) = ES3*kchem 
 
init(E) = 1e-6 
init(S) = 5e-6 
init(ES) = 0 
init(ES5) = 0 
init(ES3) = 0 
init(EP) = 0 
 
F = FA*E + FB*ES + FC*ES5 + FD*ES3 + FE*EP + os 
FA = 8e7 
FB = 7.5e7 
FC = 7.7e7 
FD = 8e7 
FE = 8.6e7 




kon = 3e7 
koff = 14 
k5r = 86 
k3r = 6 





kon = 3e7 
koff = 14 
k5r = 40 
k3r = 6 




Mechanism for Hi-Fidelity Ligation: Discrimination Against 3’ Mismatches 
 
Most efforts to understand the overall fidelity of DNA metabolism have focused on the 
DNA polymerization steps, proofreading, and sanitization of the nucleotide pool. However, it is 
known that DNA ligases also contribute to the fidelity of these pathways by discriminating 
against mismatches and damaged bases at the 3’ side of DNA nicks. X-ray crystal structures of 
the three mammalian DNA ligases (LIG1, LIG3 and LIG4) in complex with DNA have revealed 
encirclement of the DNA nick by a conserved ligase three-domain core architecture15,24,25. Yet, 
despite these similarities, these ligases display different fidelity profiles. LIG1 and its homologs 
are tuned as high-fidelity enzymes (e.g., human DNA ligase 1 homologs)122-124, while LIG4 
homologs repair have relaxed stringency for correct DNA base-pairing during DNA nick 
sealing125. However, the molecular underpinnings of ligation fidelity remain unknown. 
 The ability of LIG1 to discriminate against 3’ mismatches has been previously shown to 
be more stringent than discrimination by LIG3, indicating a feature of LIG1 that allows for high-
fidelity ligation123. Discrimination by LIG1 has also been shown with the ligation of substrates 
containing 8-oxo-deoxyguanosine (8oxoG) nucleotides at the 3’ end of the nick, resulting in a 
significant decrease in formation of the sealed DNA product124. Ligation of these oxidized 3’ 
ends results in increased abortive ligation behavior by LIG1, which releases the adenylylated 
intermediate DNA species prior to nick sealing.  
The work reported in Chapter 3 is adapted, with permission from the authors, from an unpublished manuscript entitled Two-
Tiered Enforcement of High-Fidelity DNA Ligation. The authors are as follows: Percy Tumbale#, Thomas Jurkiw#, Matthew 
J. Schellenberg, Amanda Riccio, Patrick O'Brien*, and R. Scott Williams*. The crystal structures presented here represent 
preliminary structures obtained by P.T., M.J.S. and A.R. under the guidance of R. Scott Williams at the National Institute of 
Environmental Health Sciences. 
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The product of abortive ligation is the substrate for the HIT-family hydrolase, aprataxin 
(APTX)112,126. Loss-of-function mutations in APTX cause a neurodegenerative disease known as 
ataxia with oculomotor ataxia 1 (AOA1), suggesting that unrepaired abortive ligation products 
can be cytotoxic114,115. 
In this work we establish a foundation for understanding high-fidelity DNA ligation by 
LIG1. We report a series of high resolution-structures of wild-type and mutant LIG1 bound to 
correctly base-paired or damaged DNA. The unexpected finding of a conserved Mg2+ binding 
site forming a junction between DNA ligase domains and the 3’-strand led us to investigate the 
contribution of this enforced conformation to catalysis and to substrate discrimination. We find 
that this site is dispensable for both adenylyl transfer and nick sealing, but critical to the 
discrimination against improper base pairs at the 3’ end of the nick. Steady-state and pre-steady 
state kinetic analysis reveals that this high-fidelity (HiFi) Mg2+ architecture allows for 
discrimination, leading to slower DNA adenylylation and increased abortive ligation, which 
competes with nick sealing to restrict improper ligation. We show that coupling between LIG1 
and aprataxin (APTX) provides a second tier of discrimination by preferentially hydrolyzing 
AMP-DNA intermediates that contain improper 3’ termini. Conservation of the HiFi site in LIG1 
homologs across species points to the importance of high-fidelity DNA ligation throughout 
evolution. Additionally, the absence of the HiFi site in LIG3 and LIG4 could contribute to 






Materials and Methods 
 Preparation and purification of synthetic oligonucleotides. The sequences of all oligos 
used in the study for both crystallization and kinetic experiments are listed in Figure S3.9. 
Oligonucleotides were purchased from IDT, Midland Certified Reagent Company, or the Keck 
Center at Yale University and purified by denaturing PAGE as previously described41. For 
purification of 8oxoG-containing oligonucleotides, 10 mM 2-mercaptoethanol was included in 
the loading buffer and gel. 
 Preparation and purification of recombinant enzymes. WT and H260N human APTX 
were expressed and purified as previously described122. Expression and purification of the 
minimal catalytic domain of human LIG1 (232–919) used in all kinetic assays was performed as 
previously described106. The E346A/E592A LIG1 mutant was constructed using site-directed 
mutagenesis with synthetic primers, and successful mutagenesis was confirmed by sequencing of 
the coding region. Protein concentrations were estimated using absorbance at 280 nm. Active 
enzyme concentrations were determined using single-turnover ligation reactions, in which 
increasing concentrations of LIG1 were incubated with a fixed concentration of the fluorescein-
labeled nicked 28mer substrate 41.  
 LIG1 constructs consisting of either residues 232-916 (∆232) or 262-904 (∆262) were 
used for crystallographic experiments. Mutations in either the ∆232 or ∆262 LIG1 proteins were 
created using site-directed mutagenesis. E. coli Rosetta 2 (DE3) cells containing the expression 
vectors were grown at 37ºC in Terrific Broth supplemented with ampicillin (100 µg/mL) and 
chloramphenicol (34 ng/mL) until the OD600nm reached 1, at which 50 µM IPTG was added. 
Protein expression was carried out at 16ºC overnight. Cells were harvested by centrifugation 
(5000 rpm, 20 min). Cell pellet was suspended and lysed in 30 mL lysis buffer (50 mM Tris, pH 
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8.5, 500 mM NaCl, 10 mM imidazole, 0.1 g lysozyme/1L pellet, 1 tablet Roche mini EDTA-free 
protease inhibitor cocktail) at 4ºC for 30 min, followed by sonication. The cell lysate was 
fractionated by centrifugation (13000 rpm, 20 min, 4ºC). The soluble fraction was applied to Ni-
NTA resins (5 ml packed volume) which has been equilibrated with 15 ml (50 mM Tris, pH 8.5, 
500 mM NaCl, 10 mM imidazole). The column was washed with 100 ml (50 mM Tris, pH 8.5, 
500 mM NaCl, 10 mM imidazole), 15 ml (50 mM Tris, pH 8.5, 500 mM NaCl, 30 mM 
imidazole), and the His-tagged protein was eluted in 15 ml (50 mM Tris, pH 7.5, 500 mM NaCl, 
300 mM imidazole). The His-tag was removed by TEV protease at 4ºC overnight. The untagged 
protein was purified on HiLoad 16/600 Superdex 200 gel filtration column in buffer (25 mM 
Tris, pH 7.5, 150 mM NaCl, 1 mM TCEP, 0.1 mM EDTA), followed by HiTrap SP HP 5 ml 
cation exchange column (low salt buffer: 20 mM Tris 7.5, 0.2 mM EDTA, 1 mM TCEP; high 
salt buffer: 20 mM Tris 7.5, 1 M NaCl, 0.2 mM EDTA, 1 mM TCEP). The quality of the purified 
proteins was analyzed by SDS PAGE. Freshly purified proteins were used immediately in 
crystallization experiment. 
Crystallization of wildtype and mutant LIG1 complexes. Crystals of the 
LIG1•DNA•EDTA complex were grown by hanging drop method. The protein•DNA complex 
was formed with 20 mg/mL of either E346A/E592A or wildtype ∆262 LIG1 and the nicked 
18mer oligo at a 1.5:1 DNA:LIG1 molar ratio in a solution consisting of 1 mM ATP, 150 mM 
NaCl, 20 mM Tris-HCl, pH 7.5, and 1 mM TCEP. 1µL of the complex solution was mixed with 
an equal volume of precipitant solution (100 mM MES, pH 6, 100 mM lithium acetate, 12-15% 
(w/v) polyethylene glycol 3350) at 20°C. The crystallization drops containing the mutant LIG1 
protein were allowed to equilibrate for 30 minutes before micro-crystal seeds prepared from the 
WT crystals were streaked into the drops.  
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Crystals of the LIG1 constructs in complex with Mg2+ were prepared similarly except the 
protein•DNA complex solution contained 100 mM MgCl2 and a variant of the 18mer nicked 
DNA substrate that is blocked at the 3’ end of the nick with a dideoxycytidine. Crystals of 
E346A/E592A LIG1 in complex with the nicked 3’-8oxoG:A substrate were grown in the 
presence of EDTA and the 8oxoG:A variant of the 18mer substrate. The crystallization drops 
were allowed to equilibrate for 30 minutes before micro-seeding with crystals of the 
E346A/E592A LIG1•DNA•EDTA complex. Crystals grew in 1-2 days and were washed in cryo-
protectant (40% PEG3350 in precipitant solution) before being flash frozen in liquid nitrogen for 
data collection. X–ray diffraction data was collected on beamline 22-ID of the Advanced Photon 
Source at a wavelength of 1.000 Å.  X-ray diffraction data were processed and scaled using the 
HKL2000 suite127. WT LIG1 structures were solved by molecular replacement using PDB entry 
1X9N as a search model with PHASER128,129. The remaining structures were solved by 
refinement in PHENIX130 using PDB entry 1X9N as a starting model. Iterative rounds of model 
building in COOT131 and refinement with PHENIX were used to produce the preliminary models 
shown in the study. 
Gel-based Ligation Assay. Ligation assays were carried out at 37 °C in a standard 
reaction buffer consisting of 50 mM NaMOPS at pH 7.5, 1 mM dithiothreitol, 0.05 mg/ml BSA, 
and sufficient NaCl to maintain a constant ionic strength of 150 mM. Concentrations of ATP, 
MgCl2, 28mer substrate and LIG1 were varied as indicated below. For reactions stated to be at 
physiological conditions, final concentrations of 1 mM ATP and 2 mM MgCl2 were used. The 
free magnesium concentration for these reactions was calculated to be 1 mM using the 
dissociation constants for the Mg2+•ATP complex41,132 . Unless noted otherwise, reactions were 
quenched in the standard loading buffer (50 mM EDTA/90% formamide/0.01% xylene 
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cyanol/0.01% bromophenol blue). Quenched samples were heated to 95 °C and separated on 
either a 15 or 20% (w/v) polyacrylamide gel containing 8 or 6.6 M urea, respectively. The 
fluorescein-labeled oligonucleotide was detected using an Amersham Typhoon 5 imager (GE), 
and gel images were analyzed using ImageQuant TL software (GE). Rate constants are reported 
as the average ± standard deviation for at least three independent experiments. 
Single-turnover ligation assays. To determine the individual rates of the adenylyl-transfer 
and nick-sealing steps, single-turnover reactions were performed with 800 nM Δ232 LIG1 and 
80 nM DNA substrate. Reactions to determine Mg2+ dependence of the chemical steps were 
performed in a KinTek RQF-3 quench-flow apparatus, where WT or mutant Δ232 LIG1 was 
loaded in a separate sample loop from the 28mer-G:C substrate, both at double the desired final 
concentrations to account for dilution upon mixing. Both ligase and DNA solutions were 
prepared with the standard reaction buffer supplemented with desired concentrations of MgCl2. 
Drive syringes were loaded with the standard reaction buffer and reactions were quenched using 
a solution of 1 N H2SO4 and 0.25% SDS. Upon quenching, 20 µL of the quenched sample was 
immediately neutralized in a solution containing 300 mM Tris base, 15 mM EDTA and 0.5X 
loading buffer. Reactions used to measure the rates of ligation for the 28mer-8oxoG:A substrate 
were also performed in the RQF-3 but were quenched with the standard quench solution. 
Reactions containing the 28mer-8oxoG:C substrate were carried out in a heat-block set at 37°C 
and quenched with the standard quench solution. Rates were obtained from fits to the single-
turnover data using a two-step irreversible model in Berkeley-Madonna as previously 
described41. 
Determining the steady-state dependences of ligation. Steady-state dependences were 
performed using the standard reaction buffer and 0.1-10 nM WT or mutant Δ232 LIG1. For both 
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the Mg2+ and ATP dependences, 500 nM of the 28mer substrate was used along with either 200 
µM ATP or 20 mM MgCl2, respectively. For the DNA substrate dependences at saturating levels 
of MgCl2 and ATP, reactions contained 20 mM MgCl2 and 200 µM ATP. DNA substrate 
dependences were also performed under physiological conditions. Initial rates for all steady-state 
reactions were determined by linear regression, and the rates were fit with the Michaelis-Menten 
equation (Chapter 2, Equation 2.1) For reactions in which an accumulation of both intermediate 
and product was observed, the initial rates of total substrate disappearance were used. The 
fraction of observed abortive ligation events was determined by dividing the rate of intermediate 
accumulation (Vintermediate) by the rate of total substrate disappearance (Vproduct + Vintermediate). 
Determining the effect of APTX on ligation. Both steady-state and single-turnover 
reactions for measuring the effect of APTX on ligation were carried out under physiological ATP 
and Mg2+ concentrations. Steady-state reactions contained 0 or 10 nM APTX, 1 nM WT or 
mutant Δ232 LIG1, and 500 nM nicked DNA substrate. Using initial rates (V) for total substrate 
disappearance in the presence and absence of APTX, the percentage of suppressed ligation was 
calculated as follows: 
Equation 3.1  Suppressed Ligation (%) = V-APTX - V+APTX
V-APTX
× 100%  
Single-turnover reactions were initiated by 1:1 mixing of a solution containing 1600 nM 
WT or mutant Δ232 LIG1, 160 nM DNA substrate and 0.1 mM EDTA with a separate solution 
containing 0 or 1600 nM H260N APTX and 4 mM MgCl2. Both the ligase and APTX solutions 
contained the standard reaction buffer supplemented with 1 mM ATP. Reactions were quenched 
as stated above for single-turnover reactions. Data was fit in Berkeley-Madonna to a modified 
two-step model, wherein LIG1 partially dissociates and is displaced from the adenylylated 
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intermediate by H260N APTX (Figure 3.7, S3.8). The rates determined from the fits were used 
to calculate the catalytic commitment factor as follows:   











Figure 3.1. X-ray structure of LIG1•Mg2+•adenylylated nicked DNA complex. (a)Domain structure of LIG1. The N-terminal 
domain (gray) contains a nuclear localization signal (NLS) that facilitates nuclear localization, and a conserved PIP box motif 
that mediates interactions with PCNA. The DNA binding domain (DBD, blue), Adenylation domain (AdD, green), and OB-fold 
domain (OBD, yellow) comprise the catalytic core, mapping to residues 232-919. (b)X-ray structure of LIG1•Mg2+•AMP-DNA 
complex. The DBD (blue), AdD (green), and OBD (yellow) domains encircle the nicked DNA substrate (pink). The 5′-phosphate 
of the nick is adenylylated (orange) and a Mg2+ (gray) are bound in the active site. The HiFi Mg2+ (brown) is bound in the HiFi 
junction highlighted in a dash-line box. (c) A side view of the LIG1•Mg2+•AMP-DNA intermediate. (d) Protein sequence 
alignment of LIG1 and homologs, and human ligases generated by Clustal Omega shows HiFi site residues E346 and E592 are 
absolutely conversed among LIG1 homologs but diverse in LIG3 and LIG4. Crystal structure of wildtype LIG1 in complex 











Metal-reinforced engagement to the DNA substrate by human LIG1 
 To define the molecular basis of LIG1 substrate recognition and fidelity we sought 
conditions suitable for high-resolution structural determination. We tested 16 different nicked 
DNA duplexes that systematically varied length and nick placement and formed complexes with 
two protein constructs, ∆232 and ∆262 LIG1. Sparse matrix screens covered more than 36,000 
conditions, ultimately identifying orthorhombic crystal forms of LIG1 that diffracted to high 
resolution. Structure determination revealed that these complexes were trapped as the 
adenylylated-DNA intermediate, poised for nick sealing. As expected, the enzyme completely 
envelopes the DNA with the DNA binding domain (DBD), adenylylation domain (AdD), and 
oligonucleotide binding domain (OBD) encircling the nicked DNA. It was possible to locate 
individual octahedrally coordinated Mg2+ ions in the metal-soaked crystals. In addition to an 
active site Mg2+ (Figure 3.1b-d), 5 additional octahedrally coordinated Mg2+ ions could be 
identified with confidence. Of these non-catalytic Mg2+ ions, our attention was drawn to an 
intriguing Mg2+ ion that is coordinated at the three-way juncture of the AdD, DBD, and the DNA 
phosphodiester backbone. We refer to this metal ion as the high-fidelity Mg2+ ion (MgHiFi) for 
reasons described herein.  
Although the active site Mg2+ was sometimes absent from crystals soaked at lower Mg2+ 
concentration, the MgHiFi was present in all crystal structures, suggesting tight binding. The 
octahedral coordination of the partially hydrated MgHiFi involves inner sphere interactions with 
the phosphodiester backbone between the -3 and -4 nucleotides (relative to the 3’-OH of the 
nick) as well as two glutamate residues from the protein. The AdD (Glu 346) and DBD (Glu 
592) MgHiFi coordination residues are stringently conserved in LIG1 homologs including budding 
 57 
yeast Cdc9p and fission yeast cdc17, but they are not found in vertebrate LIG3 or LIG4, 
suggesting that this site differentiates LIG1 from these other DNA ligases. The location at the 
junction between the AdD and the DBD and the direct interaction with the DNA implicates the 
metal ion in binding to DNA, defining the conformation of the protein and DNA substrate in the 
reactive complex.  
Close examination of the MgHiFi site and its connectivity to the rest of the protein 
structure provides insight into the structural contributions that this site makes to the engagement 
of DNA by LIG1. The MgHiFi ion appears to make key interactions with the 3′-hydroxyl (3′-OH) 
strand, and these interactions restrict its conformation in the ligase active site. The metal-
reinforced DNA binding mode secures the 3′-end in an A-form-like geometry, with the three 
terminal nucleotides exhibiting C3′-endo sugar puckers (Figure 3.1d). Moreover, analysis of the 
surface complementarity of binding in the active site shows that MgHiFi, and DNA binding loops 
bearing MgHiFi ligands from the DBD (E346) and AdD (E592) form a network of close contacts 
with the 3′ strand. These considerations suggested that the MgHiFi architecture would be 
necessary to properly recognize the 3′–OH strand of a DNA nick and may play a role in the 
correct placement of the nucleophilic hydroxyl within the active site. We hypothesized that the 
metal may be key to controlling the ability of LIG1 to discriminate against nicks adjacent to an 
upstream damaged or mismatched base.  
 
The MgHiFi metal site confers intrinsic Lig1 catalytic fidelity 
To define the functional contribution of the MgHiFi, we purified a double alanine mutant 
(E346A/E592A) of LIG1 that removes both of the MgHiFi ligands (LIG1EE/AA; Figure S3.1a). 
Using a gel-based ligation assay (Figure 3.2), we determined the concentration of active enzyme 
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and found that the extent of adenylylation of the purified enzyme was comparable to that of the 
WT LIG1 (Figure S3.1b-c). We then performed a comprehensive survey of steady-state kinetic 
experiments with LIG1EE/AA and compared these to the WT enzyme to discern any changes in the 
biochemical behavior that occur upon disruption of the MgHiFi site (Figure S3.1d-g). LIG1EE/AA 
demonstrates an ~3-fold reduction in kcat as compared to WT LIG1, with little or no change in 
the kcat/KM value for ATP or in the Mg2+ dependence. Remarkably, the KM value for the DNA 
substrate is improved by 24-fold for the mutant relative to the WT LIG1 enzyme, resulting in a 
~10-fold improvement in catalytic efficiency for LIG1EE/AA (Figures 3.2d and S3.2). Collectively 
these results suggest that the MgHiFi ion is dispensable for the ATP-dependent step 1, but it plays 
a role in tuning the interaction of LIG1 with the DNA substrate. 
 
Figure 3.2. Effects of HiFi site on steady-state ligation kinetics. (a) Schematic of ligation assay. DNA substrates are 
fluorescein-labeled at the 3’-end (yellow) and the bases at the -1 nt position are either C or 8oxoG (red) or G, C, or A (orange). 
(b)Representative denaturing gel image of steady-state ligation reactions under physiological conditions. Reactions contained 5 
nM of WT or E346A/E592A Δ232 LIG1 and 500 nM DNA substrate with a G:C, 8oxoG:C or 8oxoG:A pair at the -1 nt position. 
(c)The fraction of abortive ligation events determined from steady-state ligation reactions containing 1 or 10 nM LIG1 and 2 µM 
DNA substrate with 2 mM MgCl2 and 1 mM ATP. (d) Relative kcat/KM values for ligation of the various DNA substrates 
determined by steady-state ligation dependences (see Figure S3.2) performed under physiological concentrations. All data are 
reported as the mean ± S.D. of N ≥ 3 replicates.  
 
To test whether the MgHiFi plays a role in substrate discrimination, we investigated the 




28mer substrate. It has been previously demonstrated that LIG1 discriminates against both 8-
oxoG:C and 8-oxoG:A base pairs at this position124,133,134. Consistent with previous reports, LIG 
is greatly compromised in its ability to complete ligation of the 8-oxoG:C substrate, instead 
aborting catalysis and leading to an accumulation of the AMP-DNA intermediate (Figure 3.2b-
c). Although LIG1 can catalyze ligation of the 8-oxoG:A substrate, it does so slowly, with a 
significant (~60%) accumulation of the adenylylated DNA intermediate. In contrast, the 
LIG1EE/AA mutant enzyme has dramatically enhanced activity on the 8-oxoG-containing 
substrates. This mutant fully ligates the 8-oxoG:A substrate and ligates approximately half of the 
8oxoG:C substrate that it engages (Figure 3.2c). Congruent with this decrease in abortive 
ligation, the LIG1EE/AA mutation substantially increases the catalytic efficiency for ligation of 
both 8oxoG-containing substrates (Figure 3.2d and S3.2). These observations demonstrate that 
the MgHiFi contributes to the discrimination against abnormal base pairs immediately upstream of 
the nick and raises the question of how disruption of the HiFi site increases the catalytic 
efficiency of LIG1.  
We next characterized the single-turnover ligation kinetics of the LIG1EE/AA mutant using 
a rapid chemical quench approach. Two chemical steps occur subsequent to DNA binding, 
adenylyl-transfer and nick sealing (Figure 3.3a). By following the time course for formation of 
ligated product and for build-up and consumption of the adenylylated DNA intermediate, both 
rate constants can be determined (Figure 3.3b). LIG1 WT and mutant were purified as the 
adenylylated intermediate, and therefore no ATP is required in these reactions. 
By performing rapid-quenching experiments over a range of Mg2+ concentrations with 
the 28mer-G:C substrate, we were able to obtain the maximal rates of both adenylyl-transfer 
(ktransfer) and nick sealing (kseal). Remarkably, both enzymes exhibited similar maximal rates for 
 60 
both chemical steps (Figure 3.3c). These data demonstrate that the LIG1 EE/AA mutations do 
not perturb catalysis with a normal DNA substrate and suggests that the slower multiple-turnover 
ligation by the LIG1EE/AA mutant is due to a step prior to or following the phosphoryl transfer 
reactions. The transient kinetic experiments were extended to investigate the microscopic rates of 
ligation for both 8oxoG substrates at a physiological concentration of Mg2+. These data reveal 
that the WT LIG1 discriminates strongly against 8oxoG:C at both adenylyl transfer and nick 
sealing steps. Discrimination against 8-oxoG:A also occurs in both steps, but LIG1 has a reduced 
ability to exclude this damaged substrate as compared to 8oxoG:C, especially in the adenylyl 
transfer step (Figure 3.3d). The kinetics of adenylyl transfer and nick sealing are not significantly 
perturbed for the LIG1EE/AA mutant with both 8oxoG-containing substrates (Figure 3.3d). These 
data demonstrate that the HiFi Mg2+ site is dispensable for the chemical steps, but the intact site 
influences other steps that precede or follow the chemical steps of the ligation reaction. 
 
  
Figure 3.3 Single turnover ligation kinetics of undamaged and 8oxoG-containing substrates. (a) Mechanism of ligation by 
LIG1. Adenylylated LIG1 transfers an AMP group to the 5’-phosphate (ktransfer)  at the nick and subsequently catalyzes attack of 
the 3’-hydroxyl to form a new phosphodiester bond (kseal) and release AMP. (b) Representative single-turnover reactions for the 
ligation of the G:C substrate by WT and E346A/E592A LIG1 in the presence of 1 mM MgCl2 (product formation, closed 
symbols, and intermediate formation, open symbols, are shown). (c) Mg2+-dependence of the rates of adenylyl transfer and nick 
sealing determined by fitting the data with a two-step model in Berkeley-Madonna. The maximum rates and Mg2+ affinities of 
both steps were obtained by hyperbolic fits to the data. Only a limit could be obtained for the Mg2+ affinity in the adenylyl 
transfer step with the E346A/E592A mutant. (d) Rate constants for adenylyl transfer and nick sealing were determined for WT 
and mutant LIG1 with 1 mM Mg2+ (see Figure S3 for kinetic data with 8-oxoG substrates). All data are reported as the mean ± 





Constrained 3′ strand binding is scaffolded by the HiFi Mg2+  
Inspection of the LIG1 nicked DNA complex shows that protein binding widens the 
major and minor groove around the nick site, inducing the DNA upstream of the nick (the 3′–
hydroxyl side) to adopt an A-form like geometry of the 3′-hydroxyl (3′-OH) strand (Figure 3.1d). 
An extensive network of interactions links the protein-DNA contacts along the 3’-strand to the 
positioning of the 3’-OH nucleophile in the active site and the coordination with the active site 
Mg2+ ion (Figure 3.4a-c). We were able to determine the crystal structure of the LIG1EE/AA 
mutant in complex with the ddC-blocked DNA nick (Figure 3.4d-f). The 2Fo-Fc map verifies the 
predicted absence of the HiFi Mg2+ ion and a large cavity that is created by the EE/AA mutations 
(Figure 3.4d). The 3’-strand is repositioned, and the network of protein-DNA van der Waals 
contacts along this strand have been extensively rearranged (Figure 3.4e).  
Figure 3.4. X-ray structures of HiFi variant E346A/E592A and structural comparison to WT.  (a) Omit 2Fo-Fc electron 
density for the HiFi site in the WT structure illustrates the bound HiFi Mg2+. (b) Ribbon and stick representation of protein-DNA 
contacts at the HiFi site extending to the active site in WT LIG1. DBD is in blue, AdD in green, DNA in pink, adenylate in 
orange, both active site and HiFi Mg2+ are in gray. (c) Space filled representation of Figure 2B displays enforcement for correct 
conformation of bound DNA substrate by complementarity of protein domains and DNA backbone. (d) Omit 2Fo-Fc electron 
density for the HiFi site in E346A/E592A double mutant illustrate absence of bound metal. (e) Ribbon and stick representation of 
protein-DNA contacts at the HiFi site extending to the active site in E346A/E592A double mutant. (f) Space filled representation 
of Figure 3.4E displays a cavity at the HiFi site due to the absence of bound metal. 
a b c 






Figure 3.5. X-ray structure of 
E346A/E592A•8-oxoG:A DNA 
complex. (a) Omit 2Fo-Fc electron 
density for the 8-oxoG:A 
nucleotide pair bound in 
E346A/E592A double mutant 
structure shows the pairing is in (A 
anti: 8-oxoG syn) conformation. 
The N2 and N3 atoms of the 8-
oxoG make additional contacts 
with the phosphate backbone. (b) 
Modelling of the bound 8-oxoG:A 
DNA in E346A/592A•8-oxoG:A 
structure (red) in the WT structure 
(light gray) shows the 
conformation of the DNA would 
create a clash at the HiFi site. (c) 
X-ray structure of E346A/592A•8-
oxoG:A complex shows the 8-
oxoG:A DNA is accommodated 
and fits in the metal-free cavity at 
the HiFi site.  
 
Molecular basis of mutagenic ligation by the HiFi site mutant  
Attempts to crystalize WT LIG1 in complex with 8oxoG-containing DNA substrates 
were not successful, but we obtained a crystal structure of the LIG1EE/AA mutant in complex with 
8oxoG:A (Figure 3.5). As predicted by previous structures of DNA polymerases with 8oxoG•A 
base pairs at their active sites, the 8oxoG:A 3’-terminal pair adopts Hoogsteen base pairing 
geometry. The syn geometry of the 8oxoG is stabilized by hydrogen bonding between the 
exocyclic 2-amino group and the phosphodiester backbone. The space-filling representation 
demonstrates how the cavity in the LIG1EE/AA mutant is partially filled by the rearrangements in 
the 3’ strand (Figure 3.5c). The DNA conformation that accommodates the 8oxoG:A pair in the 
LIG1 active site is predicted to cause a steric clash with the HiFi Mg2+ site (Figure 3.5b). The 





with an 8oxoG:A pair in the active site, providing a structural rationale for the discrimination by 
LIG1.  
 
APTX suppresses LIG1 reactions with 8-oxoG containing substrates  
The biochemical characterization of LIG1 3’-end recognition demonstrated the 
importance of abortive ligation as a bypass mechanism to limit the sealing of 
damaged/mismatched termini. If adenylylation of an improper nick occurs, then the MgHiFi site 
architecture leads to enhanced partitioning away from erroneous ligation and towards abortive 
ligation. Abortive ligation on damaged nicks could provide additional time for other DNA repair 
pathways to operate. However, it is necessary for the 5’-AMP group to be removed to restore a 
5’-phosphate for ligation after 3’-proofreading and gap filling. Aprataxin (APTX) is a hydrolase 
that has been shown to catalyze the hydrolysis of 5’-5’ adenylylated DNA and RNA. We 
hypothesized that the interplay between LIG1 and APTX would be especially important for 
controlling the pathway choice between erroneous ligation and abortive ligation. Therefore, we 
performed steady-state ligation assays in the presence or absence of human APTX.  
Indeed, APTX is able to fully suppress abortive ligation by WT LIG1 with an 8oxoG:C 
substrate and a 1:10 ratio of APTX:LIG1 (Figure 3.6a, left panel). In contrast, the LIG1EE/AA 
mutant was only partially suppressed by APTX under these conditions and ligation of the 
damaged 8oxoG:C continued at ~50% the rate when APTX was present (Figure 3.6a, right panel 
and 3.6b). The same trend was observed for the 8oxoG:A substrate, with APTX effectively 
suppressing the reaction catalyzed by WT LIG1, but being unable to affect the reaction catalyzed 
by the LIG1EE/AA mutant (Figure 3.6b and Figure S3.4). These data suggest that the HiFi Mg2+ 
produces strain in the LIG1•DNA complex that induces increased abortive ligation with 
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damaged termini, and subsequent processing by APTX. This fidelity comes at a cost to overall 
ligation efficiency, as APTX causes modest, but readily detectable suppression of ligation by 
WT LIG1 with the undamaged substrate. In all cases, disruption of this metal site (LIG1EE/AA) 
leads to increased catalytic efficiency and decreased fidelity of ligation.  
 
Figure 3.6. APTX suppresses LIG1-catalyzed ligation of 8-oxoG-containing DNA. (a) Representative time courses from 
steady-state ligation reactions in the absence (solid symbols, solid lines) or presence (open symbols, dashed lines) of APTX. (b) 
The percentage of suppressed ligation was calculated as the percent change in initial rate from steady-state reactions in the 
absence of APTX to those in the presence of APTX. All data are reported as the mean ± S.D. of N ≥ 3 replicates. 
 
For APTX to engage with the adenylylated intermediate, it must be given access to the 
intermediate by LIG1, making it important to consider a mechanism for how LIG1 may present 
the intermediate to APTX. In single-turnover assays with the 8oxoG-containing substrates, we 
observed that ATP induced an extended lifetime for the adenylylated DNA intermediate, 
suggesting that the presence of ATP slows down nick sealing (Figure S3.5). This observation led 
us to believe that LIG1 can transiently bind to ATP during ligation of the damaged substrate. 
This could serve as a mechanism for abortive ligation, where LIG1 would pause at the damaged 
nick and transiently bind to ATP. The presence of excess DNA substrate would then increase the 
likelihood of complete dissociation of LIG1 from the adenylylated intermediate. Such a delay 
would allow APTX the opportunity to compete with LIG1 for the adenylylated intermediate.  
To test the accessibility of the adenylylated intermediate to APTX, we made use of the 
APTXH260N mutant, which is catalytically-dead but retains the ability to bind adenylylated 
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ligation intermediates. ATPXH260N was included in single-turnover ligation experiments 
containing physiological concentrations of both Mg2+ and ATP to assess the ability of both 
LIG1WT and LIG1EE/AA to remain committed to catalysis on the various substrates. In the 
presence of APTXH260N, any adenylylated intermediate that is accessible to the APTX mutant 
should be sequestered and prevented from re-associating with LIG1 (Figure 3.7a). In control 
reactions with the 28mer-G:C substrate, both WT LIG1 and LIG1EE/AA remained fully committed 
to ligating the substrate (Figure 3.7d and S3.6 a,d). With either of the two 8oxoG-containing 
substrates, however, both ligases performed the initial adenylyl-transfer step but were no longer 
able to perform nick-sealing to completion due to trapping of the intermediate by APTXH260N 
(Figure 3.7b-d, Figure S3.6). LIG1EE/AA remained ~80% committed to catalysis with the 
8oxoG:A substrate and ~40% committed with the 8oxoG:C substrate. 
WT LIG1, however, exhibited a much more dramatic decrease in catalytic commitment 
with both substrates, with about only 40% of ligation events with the 8oxoG:A substrate and 
about 20% of ligation events with the 8oxoG:C going to completion. Along with structural data 
detailing flexibility in the upstream strand when substrate is bound by LIG1EE/AA, the ability of 
LIG1EE/AA to protect ligation intermediates from APTX sequestration implies that the MgHiFi may 
be functioning to help enforce a rigid upstream DNA structure. When a damaged nick is 
encountered, this upstream rigidity may cause LIG1 to sample a more “open” conformation, 




Figure 3.7. Catalytic commitment of LIG1 on the 8-oxoG:C substrate. (a) Kinetic model for trapping of the AMP-DNA 
intermediate by the H260N APTX catalytically inactive mutant. Partial dissociation of LIG1 gives APTX the opportunity to 
sequester the intermediate. (b) Single-turnover reactions with the 8-oxoG:C substrate were carried out by mixing a solution 
containing LIG1, 8oxoG:C DNA and ATP with a separate solution containing MgCl2 and ATP. These reactions were also 
performed with the H260N APTX mutant in the MgCl2-containing solution (c). Product formation is represented by closed 
symbols and intermediate formation is denoted by open symbols. (d) Catalytic commitment was determined as the proportioning 
between nick sealing and dissociation from the AMP-DNA intermediate. Data for the catalytic commitment to ligation of the G:C 
and 8oxoG:A substrates were also measured (Figure S3.6). These data demonstrate that the E346A/E592A mutant, which 
disrupts the HiFi Mg2+ site, has a greater commitment to nick sealing when bound to an 8oxoG:C substrate. All data are reported 
as the mean ± S.D. of N ≥ 3 replicates. 
 
Discussion 
The fidelity of DNA ligation has long been an underappreciated component of the 
faithful replication and repair of genomic DNA. In this work we have used quantitative 
biochemical approaches to elucidate the mechanisms by which the replicative DNA ligase, LIG1, 
discriminates against improper 3' termini at multiple steps of DNA ligation. High resolution 
crystal structures reveal the existence of a novel MgHiFi ion that plays an integral role in 
enforcing recognition of the 3' strand and biases improper nicks towards abortive ligation. We 
further establish that APTX accesses the stalled AMP-DNA intermediate leading to dissociation 
of LIG1 and restoration of the 5'-phosphate terminus. Mutagenesis that removes the MgHiFi ion 
(Lig1EE/AA) significantly reduces the ability of the enzyme to discriminate against improper nicks 
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and causes an increase in ligation efficiency on both undamaged and damaged nicks. This MgHiFi 
site is predicted to be conserved in other eukaryotic replicative DNA ligases, but it is notably 
absent in the human LIG3 and LIG4 enzymes. Our study suggests that the MgHiFi architecture of 
LIG1 is a distinguishing structural feature that is integral to the unique biochemical activities of 
the different DNA ligases. 
 Although this study focuses primarily on the characterization of this metal site with 
respect to discrimination against a damaged end, our preliminary data suggests that this 
mechanism of discrimination is also applicable to mismatches not arising from oxidative 
damage. In an attempt to demonstrate the ability of LIG1 to discriminate against an undamaged 
but mismatched end, we repeated a number of the key experiments with a G:T mismatch at the 3’ 
end of the nick. G:T mismatches are among the more prevalent mismatches found in nature, 
arising from the deamination of 5-methylcytosine to thymine135. Steady-state ligation of a G:T 
28mer substrate by both wildtype and EE/AA LIG1 exhibits similar behavior to ligation of the 
8oxoG:C substrate (Figure S3.7a-b). In the absence of the MgHiFi site, we observe efficient 
ligation of the G:T substrate. Additionally, ligation of the substrate by wildtype LIG1 is 
susceptible to interruption by APTX in both steady-state and single-turnover assays (Figure 
S3.7c-f). These results recapitulate our findings with ligation of the 8oxoG-containing substrates, 
highlighting the importance of the metal site in allowing LIG1 to readily abort ligation of a 
damaged or mismatched substrate. Our findings here are consistent with the observation of a 
multi-step remodeling process in Chapter 2, where we believe LIG1 induces a number of 
conformational changes in the DNA substrate to position the nick for catalysis. Although the 
MgHiFi mutant remains to be tested in our DNA-binding assay, we hope that monitoring the 
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Chapter 3 Appendix 
Figure S3.1. Initial characterization of the E346A/E592A LIG1 mutant. (a) Purity of recombinant WT (lane 1) and mutant 
(lane 2) Δ232 hLIG1 was assessed using SDS-PAGE (~1 µg of LIG1 and a protein ladder (lane M) were loaded on a 15% 
polyacrylamide/SDS gel). (b) The concentration of active, adenylylated Δ232 LIG1 was confirmed by quantifying the amount of 
ligated DNA in the absence of added ATP. The nicked DNA substrate was fixed at 150 nM and the nominal concentration of 
LIG1 protein was varied from 0-300 nM. These data gave active concentrations that deviated ~4% and ~8%, respectively, from 
the estimated concentrations determined via UV-absorbance. (c) Pre-steady state burst experiments were performed to assess the 
adenylylation state of the recombinant enzymes. Mixes containing 50 nM LIG1 and either 0 (closed symbols) or 1 µM (open 
symbols) ATP were allowed to incubate at 37°C for 5 minutes before reactions were initiated with the addition of 500 nM LIG1 
nicked DNA. Differences in the burst amplitude between the ATP-containing and no ATP reactions indicate the presence of 
deadenylylated enzyme. The ~30% deadenylylated enzyme population was considered when calculating kcat in steady-state 
reactions. The steady-state Mg2+ (d), ATP (e) and 28mer-G:C DNA dependences (f) were determined for WT and E346A/E592A 
LIG1. Both the ATP and the DNA dependences were performed with 20 mM MgCl2. The values obtained from fitting these 



















Figure S3.2. Steady-state substrate dependences for ligation catalyzed by WT and E346A/E592A LIG1. Steady-state 
substrate dependences were performed for all 28mer substrates at 1 mM Mg2+ (a) with WT and E346A/E592A LIG1. The data 
were fit by the Michaelis-Menten equation, which was used to determine the steady-state constants shown in b. All data are 





Figure S3.3. Single-turnover reactions with 8oxoG-containing substrates. WT and E346A/E592A were assayed under single-
turnover conditions with both the 8oxoG:C 28mer (a) and the 8oxoG:A 28mer (b) substrates. Accumulation of product (closed 
symbols) and intermediate (open symbols) species are shown as a function of time (mean ± S.D.; N ≥ 3). Rate constants for 












Figure S3.4. Effect of APTX on steady-state ligation. Steady-state ligation reactions contained 10 nM LIG1 and 500 nM of the 
28mer substrate with a G:C (a) and 8oxoG:A (b) pair at the -1nt position. APTX was either absent (closed symbol, solid line) or 
added at a concentration of 1 nM (open symbol, dashed line). Total reacted substrate for each reaction is plotted as a function of 
time for reactions containing either WT or E346A/E592A mutant LIG1 (mean ± S.D.; N ≥ 3). The amount of ligation suppressed 













Figure S3.5. Effect of ATP on single-turnover ligation of 8oxoG substrates. Intermediate formation from single-turnover 
ligation of the 8oxoG:A (a,c) and 8oxoG:C (b,d) 28mer substrates by WT (gray) or EE/AA (green) LIG1. Traces are shown from 













Figure S3.6. Catalytic commitment of WT and mutant LIG1 under single turnover conditions. Single-turnover reactions 
were carried out by mixing a solution containing either 800nM WT or E346A/E592A LIG1, 80nM 28mer-G:C (a,d) or 28mer-
8oxoG:A (b,e) and with a separate solution containing 2mM MgCl2. Reactions were performed in the presence (d-e) or absence 
(a-b) of 800nM H260N APTX to the MgCl2 solution. Product formation is represented by closed symbols, while intermediate 
formation is denoted by open symbols (mean ± S.D.; N ≥ 3). Curve fits shown for both product (solid line) and intermediate 
(dashed lines) formation were obtained by fitting the data using Berkeley-Madonna with a two-step irreversible model with an 
added dissociation step after adenylyl-transfer (Figure 3.7c). The catalytic commitment for both WT and E346A/E592A LIG1 





Figure S3.7. Ligation of a G:T mismatched substrate. The key experiments performed for showing discrimination of the 
8oxoG-containing substrates were repeated with a 28mer variant containing a G:T mismatch at the 3’ end of the nick. (a-b) 
Steady-state substrate dependence demonstrating the effect of the G:T mismatch is similar to what was observed with the 
8oxoG:C substrate. (c-e) Repeat of the experiments outline in Figure 3.6, demonstrating APTX-dependent suppression of 
wildtype ligation of the G:T mismatch. All steady-state experiments in a-e are shown as the mean ± S.D. of three or more 
replicates. (f) Preliminary single-turnover results showing that ligation of the G:T mismatch is susceptible to interruption by 










Figure S3.8. Berkeley Madonna model for single turnover ligation in the presence of H260N APTX 
METHOD RK4 
STARTTIME = 0 
STOPTIME=100 
DT = 0.02 
 
d/dt(ES) = -ktransfer*ES 
d/dt(EI) = ktransfer*ES - EI*(kseal + koff) 
d/dt(EI2) = koff*EI 
d/dt(EP) =  kseal*EI 
 
init ES = 78 
init EI = 0 
init EI2 = 0 
init EP = 0 
 
ktransfer = 0.01 
kseal = 0.008 
koff = 0.008 
 
Product = EP 





















Mechanism for Hi-Fidelity Ligation: Discrimination Against 5’ Ribonucleotides 
 
Ribonucleotides have long been known to play a large role in DNA replication as the 
macromolecule used to prime DNA polymerization. Since discontinuous replication requires 
constant repriming, lagging strand DNA is the source of most incorporated ribonucleotides in 
cellular DNA136. While ribonucleotide priming is essential for initiating DNA replication, 
ribonucleotides can also be misincorporated into replicating strands by DNA polymerases137.  
Although DNA polymerases strongly discriminate against ribonucleotide insertion in vitro, the 
large abundance of rNTPs in the cell can impede this selectivity138,139. Allowing ribonucleotides 
to persist in DNA presents a significant risk for the cell. The most notable impact of 
ribonucleotide insertion is on the stability of a DNA strand due to the 2’-OH in ribonucleotides 
increasing the likelihood of spontaneous hydrolysis of the phosphodiester backbone140. 
Additionally, the difference in sugar pucker makes ribonucleotides more likely to adopt A-form 
helical structure, potentially impacting how proteins interface with the double helix141,142. 
Due to the potential consequences of ribonucleotide misincorporation, cellular 
mechanisms have evolved to cleanse DNA strands of ribonucleotides to preserve genomic 
integrity. The major pathway for removal of ribonucleotides, known as ribonucleotide excision 
repair (RER), is initiated by the action of RNaseH2143. RNaseH2 incises RNA-DNA junctions 
creating a nick containing a 5’-ribonucleotide monophosphate. The ribonucleotide-containing
The work reported in Chapter 4 is a part of an ongoing collaboration with Percy Tumbale and Matthew J. Schellenberg 
working under the guidance of R. Scott Williams at the National Institute of Environmental Health Sciences. Neha Bokil 




strand is then displaced by the replicative polymerase, allowing for the displaced strand to be 
fully excised by the flap endonuclease (FEN1). In the absence of RNaseH2, DNA topoisomerase 
can also catalyze the removal of ribonucleotides from DNA, although this secondary pathway is 
limited to the leading strand and is sometimes mutagenic144,145. 
The ubiquity of DNA ligases in replication and repair pathways makes them important 
enzymes to consider with respect to ribonucleotide incorporation. The product of RNase H 
incision is a potential substrate for DNA ligases, possibly leading to ligation of the site before the 
ribonucleotide can be fully excised. Studies of DNA/RNA ligation by DNA ligases, however, 
suggest that DNA ligases have an inherent mechanism for discriminating against 5’ 
ribonucleotides15,116,122. Although the exact mechanism behind this type of discrimination has not 
yet been characterized, human DNA ligase 1 (LIG1) has been demonstrated to ligate DNA-RNA 
hybrids with a reduced catalytic rate15,122. Adenylylated ligation intermediates containing 5’ 
ribonucleotides are readily repaired by aprataxin (APTX), suggesting that discrimination against 
5’ ribonucleotides involves interplay between LIG1 and APTX, similar to our observations with 
ligation of 3’ damaged or mismatched ends described in Chapter 3.  
Though the molecular mechanism behind the abortive ligation seen with a 5’ 
ribonucleotide was previously unknown, the crystal structure of LIG1 provides some possible 
answers15. In the LIG1 structure, a conserved phenylalanine residue—F872—is positioned 
upstream of the nick, where it lies close to the deoxyribose moiety of the nucleotide at the 5’ end 
(Figure 4.1). The proximity of F872 to the sugar indicates that the presence of a ribonucleotide at 
this position would cause a steric clash between the residue and the 2’-OH from the ribose. 
While a past study demonstrated that this residue is important for normal ligation by the 
Chlorella virus DNA ligase146, the role of the phenylalanine in ribonucleotide discrimination has 
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not yet been examined. Here we present the first characterization of the mechanism underlying 
ribonucleotide discrimination by a DNA ligase. While mutations of F872 cause substantial 
catalytic deficiencies, substitution of the residue for alanine renders LIG1 unable to discriminate 
between DNA and RNA at the 5’ end of the nick. Additionally, the residue also appears to be 
integral to positioning the end for adenylyl transfer by LIG1. 
Materials and Methods 
 Preparation and purification of materials. The catalytic domain of human DNA ligase 1 
(residues 232-919) was used in all assays and was expressed and purified as detailed 
previously106. The F872A and F872L mutants were constructed using site-directed mutagenesis, 
which was confirmed through sequencing of the expression vectors. Oligonucleotide substrates 
were synthesized by Integrated DNA Technologies (IDT), the Midland Certified Reagent 
Company and the Keck Biotechnology Resource Laboratory at Yale University. All 
oligonucleotides were purified via gel-purification as previously described (Chapter 2 and 3). 
The sequences of the oligonucleotides used in this study are shown in Figure S4.4. 
 Gel-based ligation assays. All ligation assays were performed at 37°C and with the 
standard ligation buffer (Chapter 2). Reactions were quenched using a quench solution 
containing 90% formamide and 50 mM EDTA. The different ligation species were separated on 
15-20% polyacrylamide gels containing either 8 or 6.6 M urea. Prior to loading, all quenched 
samples were heated at 95°C for 5 minutes. The individual DNA species were detected using 
either a Typhoon Trio+ or a Typhoon 5 imager (GE Healthcare) and quantified using the 
ImageQuant software (GE Healthcare), as previously described41. 
 Steady-state ligation assays. Steady-state ligation dependences were performed using 
0.1-50 nM wildtype or mutant LIG1. For reactions with varying amounts of magnesium, the 
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concentrations of the 28mer DNA substrate and ATP were fixed at 0.5 µM and 0.2 mM, 
respectively. The steady-state dependence on the concentration of ATP was performed with 
varying amounts of ATP and concentrations of the 28mer substrate and MgCl2 fixed at 0.5 µM 
and 20 mM, respectively. Steady-state DNA dependences were either performed in the presence 
of 20 mM MgCl2 and 0.2 mM ATP or 2 mM MgCl2 and 1 mM ATP. As stated previously 
(Chapter 3), reactions containing 2 mM MgCl2 and 1 mM ATP are labeled as having 1 mM 
Mg2+free due to chelation of magnesium by ATP. Initial rates were determined by linear 
regression and were plotted as a function of the concentration of whichever component was 
varied. kcat and KM values were derived from fitting the initial rates using the Michaelis-Menten 
equation. 
 Single-turnover ligation assays. Single-turnover assays were performed with LIG1 held 
at 0.8 or 1.6 µM and the DNA substrate at a concentration of either 80 or 160 nM. All single-
turnover reactions were performed in a heat-block on the benchtop. Reactions were performed in 
the presence of either 1 mM or 20 mM MgCl2 and in the absence of ATP to prevent multiple-
turnovers of the enzyme. The individual rates of adenylyl transfer and nick sealing were derived 





Figure 4.1. F872 is a conserved residue near the 5’ nucleotide. (a) Crystal structure of LIG1 (PDB: 1X9N15)  showing the 
proximity of the F872 residue (salmon red) to the 5’-adenylylated nucleotide in the nicked DNA intermediate. A sequence 
alignment of LIG1 to the other human DNA ligases (LIG3 and LIG4), as well as the Chlorella virus DNA ligase (ChVLIG) and 
the LIG1 homologue in S. cerevisiae (Cdc9), indicates that this phenylalanine is well-conserved in ATP-dependent DNA ligases. 
(b) Representative steady-state ligation assay showing the decrease in catalytic rate of LIG1-dependent ligation when the F872 




Mutation of the conserved phenylalanine residue causes defects in ligation 
To interrogate the contribution of F872 to the overall fidelity of ligation by LIG1, we 
used site-directed mutagenesis to create F872A and F872L LIG1 mutants. Following expression 
and purification of the mutants, their concentration and activity were confirmed through active 
site titrations (Figure S4.1). Preliminary reactions with the two F872 mutants demonstrated a 
~20-fold decrease in their steady-state rates of ligation relative to wildtype, indicating a catalytic 
defect in ligation by the two mutants (Figure 4.1). This effect is unsurprising, as the alanine 
mutation should allow for more flexibility and, therefore, less stable interaction between the 
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protein and the 5’ nucleotide. In contrast, the presence of a leucine presumably enforces rigidity 
at this position, hindering efficient alignment of the 5’ end in the active site.  
To further characterize the defects in the two LIG1 mutants, we performed kinetic 
experiments to investigate the catalytic efficiency of ATP utilization (Figure 4.2a-b). As we saw 
in our initial steady-state experiments, the two phenylalanine mutants are ~20-fold slower than 
wildtype, with the F872A mutant acting about two-fold faster than F872L (Table 4.1). Both 
mutants have a slightly tighter KM,ATP than seen with wildtype LIG1, which makes the overall 
change in kcat/KM,ATP less than 10-fold relative to wildtype (Figure 4.2b). The modest change in 
KM,ATP is consistent with F872 not being positioned near the putative ATP-binding site, implying 
that the effect on kcat/KM,ATP is likely due to a defect in the DNA-dependent steps of ligation. 
Figure 4.2. Effects of the F872 mutations on ATP- and DNA-dependences. (a) Steady-state ATP-dependence demonstrates 
that F872A and F872L LIG1 mutants exhibit slower kcat, but no significant defect in KM,ATP . Reactions contained 5 nM [LIG1], 
500 nM [DNA] and 20 mM [MgCl2] with varying concentrations of ATP.  (b) Plot showing the relative kcat/KM,ATP of the 
phenylalanine mutants to wildtype LIG1, highlighting a < 10-fold decrease in overall catalytic efficiency for ATP. Steady-state 
DNA-dependences were determined for the F872A and F872L mutants in the presence of either 20 mM (c) or 1 mM (d) Mg2+. 
Reactions contained 0.1-10 nM [LIG1] and either 0.2 mM (c) or 1 mM ATP (d).  (e) Plot showing the relative kcat/KM for the 
28mer substrate of the phenylalanine mutants to wildtype LIG1. All initial rates were fit to the Michaelis-Menten equation and 
best fit parameters are reported in Table 4.1. Data for wildtype LIG1 used to create relative kcat/KM plot in c was adapted from the 
data presented in Chapter 3. All values are reported as the mean ± S.D. of N ≥ 3 replicates. 
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To assess the ability of the F872 mutants to engage the nicked DNA substrate, we next 
examined the steady-state DNA substrate dependence of the two mutants. In the presence of 
saturating amounts of both ATP and Mg2+, there is almost no change in KM,DNA for either mutant 
relative to wildtype, suggesting the phenylalanine residue has little impact on engagement of the 
nicked DNA substrate (Figure 4.2c). The same holds true when both ATP and Mg2+ are held at 1 
mM (Figure 4.2d). Although there is a noticeable drop in the kcat/KM,DNA values for the two 
mutants relative to wildtype, the absence of a change in KM,DNA suggest that this decrease in 
catalytic efficiency could be due to the decrease in kcat (Figure 4.2c-e). Interestingly, the relative 









Figure 4.3. F872 mutations adversely affect catalytic efficiency of ligation. (a) The steady-state Mg2+-dependence with the 
two F872 mutants demonstrates decreased catalytic efficiency, highlighted in the relative kcat/KMg2+ in b. All initial rates were fit 
to the Michaelis-Menten equation and best fit parameters are reported in Table 4.1. Data for wildtype LIG1 used to create relative 
kcat/KM plots in b and d was adapted from the data presented in Chapter 3. All values are reported as the mean ± S.D. of N ≥ 3 
replicates. 
 
Crystal structures of LIG1 in complex with both substrate and the adenylylated 
intermediate reveal coordination of the catalytic magnesium ion by both the protein and the 5’-
phosphate (Chapter 5), highlighting the importance of the F872 residue in stabilizing the 5’ end. 
Since both mutants seem to have a significant impact on ligation, we reasoned that this may be 
due to a weakened Mg2+-affinity resulting from misalignment of the 5’ end. To assess how loss 
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of the phenylalanine residue impacts steady-state magnesium affinity, we performed steady-state 
Mg2+-dependences with saturating amounts of both DNA and ATP (Figure 4.3a).  Both F872A 
and F872L demonstrated slight defects in magnesium binding compared to wildtype, amounting 
to ~2-3-fold changes in KMg2+. The decrease in magnesium affinity results in a nearly 50-fold 
decrease in kcat/KMg2+, indicating a weakened catalytic response to magnesium ions (Figure 
4.3b).  
Table 4.1 Best-fit parameters 
for steady-state ATP and Mg2+ 
dependences. Values for WT 
LIG1 are adapted from the data 






F872A does not discriminate against a 5’ ribonucleotide 
Results from the steady-state substrate and magnesium dependences are all consistent 
with the mutations of F872 causing a misalignment of the 5’ end of the nick, whether by 
increasing or restricting the flexibility of the end. Since DNA ligases are known to discriminate 
heavily against 5’-ribonucleotides, we believed that the F872 residue is likely acting as a gate, 
occluding the 2’-hydroxl of a ribose sugar at this position. If this is true, then we believed that 
the two mutations should have contrasting impacts on the selectivity of the 5’ end. To test this 
idea, we constructed a variant of our 28mer DNA substrate with a single ribonucleotide 
substitution at the 5’-end of the nick, referred to herein as R28mer.  
 84 
The R28mer substrate has been previously shown to undergo ligation by LIG1 at a 
significantly reduced catalytic rate15,122. In agreement with these results, we observed a roughly 
150-fold slower kcat with the R28mer substrate than observed with the all-DNA 28mer (Figure 
4.4a). This decrease in kcat is more pronounced in the presence of physiological magnesium, 
which results in a ~350-fold decrease in the steady-state rate of ligation (Figure 4.4b). Compared 
to the 28mer, the R28mer is ligated with a significantly lower catalytic efficiency, suggesting 
discrimination against the 5’-ribonucleotide (Figure 4.4c). 
Figure 4.4. F872A LIG1 mutant drastically increases downstream RNA ligation. Steady-state substrate dependences were 
repeated for wildtype LIG1 and the mutants in the presence of either 20 mM (a) or 1 mM (b) Mg2+ with the R28mer substrate, 
containing a single ribonucleotide at the nick in 5’ position. As in the 28mer dependences, reactions contained 0.1-10 nM [LIG1] 
and either 0.2 mM (a) or 1 mM ATP (b).  (c) Plot showing the relative kcat/KM for the R28mer substrate to the value for wildtype 
LIG1. (d) Plot showing the amount of abortive ligation observed in the steady-state R28mer dependences. All initial rates were 
fit to the Michaelis-Menten equation and best fit parameters are reported in Table 4.2. All values are reported as the mean ± S.D. 
of N ≥ 3 replicates. 
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A similar effect is seen with ligation of the R28mer substrate by the F872L mutant. As 
observed with wildtype LIG1, F872L performs ligation of the R28mer with little change in KM 
but with a 100-fold slower catalytic rate as compared to ligation of the canonical 28mer (Figure 
4.4a-c).  Initial comparison of the relative kcat/KM values for wildtype and F872L LIG1 indicated 
that there is no significant change in substrate discrimination caused by the leucine mutation 
(Figure 4.4c). However, initial velocities are typically calculated as the amount of substrate 
reacted over time and, therefore, consider both sealed and adenylylated DNA as products. While 
this is valid for addressing how well a substrate is engaged by the enzyme, it does mask the 
presence of abortive ligation events where the adenylylated DNA is released by the ligase before 
being fully converted into sealed DNA. With this in mind, we calculated the fraction of all 
catalytic events that ended in abortive release of the adenylylated intermediate (Figure 4.4d). 
This type of analysis illustrates that nearly all collisions between the R28mer substrate and the 
F872L mutant end with the release of the adenylylated intermediate and the formation of 
negLIG1ble amounts of the sealed DNA product. This contrasts with wildtype LIG1, which can 
fully ligate the R28mer substrate in ~15% or ~80% of all catalytic events in the presence of 1 or 
20 mM Mg2+, respectively (Figure 4.4d). These results validate our prediction that the added 
rigidity of the leucine substitution would enforce stricter discrimination against ligation when 
there is a ribonucleotide present at the 5’ end of the nick. 
The ability of both wildtype and F872L LIG1 to discriminate against the 5’-
ribonucleotide is essentially absent in the alanine mutant. In the presence of saturating amounts 
of ATP and Mg2+, F872A ligates the R28mer substrate with the same efficiency as it does the 
28mer (Figure 4.4a,c). Additionally, there is no observable abortive ligation in the presence of 
high magnesium (Figure 4.4d). Ligation of the R28mer is similarly unchanged when magnesium 
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concentrations are lower, although almost half of the catalytic events under this condition end 
with abortive ligation, which is still less than what is observed with either wildtype or F872L. 
However, this amount of abortive ligation is also observed in reactions between the mutant and 
the DNA-only substrate under the same conditions, indicating that abortive ligation of the 
R28mer substrate by F872A is likely indicative of a global ligation defect at low magnesium and 
not due to the presence of the ribonucleotide. Altogether, the data suggest that F872 is likely 
responsible for disfavoring ligation of a 5’-ribonucleotide by LIG1 and can be tuned by 




Table 4.2. Best-fit parameters for steady-state substrate dependences. Data for the wildtype LIG1 28mer dependences at high 
and low magnesium are adapted from the data in Chapter 3.  
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Figure 4.5. Single-turnover characterization of ligation of the 28mer and R28mer. Microscopic chemical rates were 
determined from single-turnover ligation assays containing 800 nM [LIG1] and 80 nM of either the 28mer (a-b) or the R28mer 
(c-d) substrate. The rates of adenylyl transfer and nick sealing are displayed as relative values, with all rates normalized to the 
values for WT LIG1.  Reactions were performed in the presence of both 1 mM and 20 mM Mg2+. Representative plots of the data 
are shown in Figure S4.3. Reaction traces were fit using a two-step irreversible model in Berkeley-Madonna and the best-fit 
values are shown in Table 4.3. All values are reported as the mean ± S.D. of N ≥ 3 replicates.  
 
F872A increases the chemical rates of ligation of the R28mer substrate 
To gain a deeper insight into how these phenylalanine mutations are affecting ligation of 
the R28mer substrate, we determined the microscopic rates of the individual chemical steps of 
ligation. To do this, we performed single-turnover ligation assays, in the absence of ATP, using a 
rapid-quench apparatus for rapid mixing of the LIG1 enzymes and either the 28mer or R28mer 
substrate. Unsurprisingly, the F872A and F872L mutants have diminished activity on the 28mer 
substrate (Figure 4.5a-b). The F872L mutation has a pronounced effect on the individual rates, 
most notably on the nick-sealing step at low magnesium, where the rate is nearly 500-fold slower 
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than wildtype LIG1. F872A performs the adenylyl-transfer and nick-sealing steps slightly faster 
than F872L, but still demonstrates significantly slower ligation kinetics than wildtype LIG1. 
The single-turnover assays were then repeated with the R28mer, which severely hinders 
ligation by F872L—especially in the presence of 1 mM Mg2+—to a similar extent as in the 
steady-state reactions (Figure 4.5c-d). Wildtype LIG1 also exhibits slower adenylyl transfer and 
nick sealing rates, although nick sealing is affected slightly less. The impact of the R28mer on 
adenylyl transfer is ~10-fold more severe than on nick sealing, indicating that the presence of the 
2’-OH likely hinders the ability of LIG1 to properly align the 5’ phosphate for adenylylation. 
Consistent with the findings in our steady-state assays, the 5’-ribonucleotide causes no 
significant impact on ligation by the F872A mutation, with both adenylyl-transfer and nick-




Table 4.3. Best-fit parameters for single-turnover ligation assays. Data for the wildtype LIG1 at high and low magnesium are 










To uncover the molecular mechanism underlying the ability of LIG1 to faithfully 
discriminate against ligation of a nicked end containing a 5’ ribonucleotide, we characterized the 
biochemical effects of two mutations of a conserved phenylalanine residue. While F872 had not 
previously been implicated in ribonucleotide discrimination, its proximity to the deoxyribose of 
the 5’ nucleotide in LIG1 crystal structures indicated its possible involvement in preventing 
misligation of a ribonucleotide (Figure 4.1). Our steady-state assays indicate that mutations of 
this residue adversely affect the catalytic efficiency of LIG1. Slight defects in steady-state 
ligation indicate that the F872 residue likely plays a general role in DNA ligation. Due to its 
proximity to the nick site, F872 could be serving to position the 5’ nucleotide and, therefore, 
facilitate interactions between the catalytic magnesium and the 5’ phosphate.  
 To characterize the contribution of F872 to the ability of LIG1 to perform high-fidelity 
ligation, we performed steady-state and transient kinetic experiments to characterize ligation of a 
5’ ribonucleotide substrate by wildtype LIG1. While wildtype LIG1 can ligate the R28mer 
substrate, it does so with a significant decrease in efficiency. Additionally, under conditions of 
low magnesium, wildtype LIG1 aborts ligation of the R28mer more than it catalyzes the 
formation of the sealed product, consistent with a prior report122. Meanwhile, the F872L variant 
demonstrates severely diminished ligation of the R28mer substrate. Whereas the abortive ligation 
burden observed with wildtype LIG1 was partially alleviated when the magnesium concentration 
was raised to 20 mM, F872L LIG1 almost never catalyzed product formation in steady-state 
reactions with the R28mer, indicating that the leucine mutation increases selectivity at this 
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position. Unlike both wildtype and F872L LIG1, the F872A mutant was able to ligate the 
R28mer substrate with the same efficiency as the 28mer. The lack of selectivity in the F872A 
mutant was also obvious in single-turnover assays, where no effect was observed in the 
microscopic ligation rates with the R28mer substrate as compared to the 28mer substrate. 
 Along with the biochemical experiments presented here, we are working in collaboration 
for this project with Scott Williams at NIEHS, whose group is working to obtain crystal 
structures of wildtype and mutant LIG1 in complex with a ribonucleotide-containing substrate. 
Additionally, alongside Tom Kunkel’s lab at NIEHS, we are working to characterize the cellular 
effects of the phenylalanine mutations in Cdc9, the LIG1 homolog in S. cerevisiae. If the 
phenylalanine residue is indeed allowing LIG1 to discriminate against ribonucleotide ligation, 
we expect that mutations of the residue could result in genomic instability and, therefore, growth 
defects in the yeast model. However, it will be important to assess if such an effect is due to the 
inability to discriminate against ribonucleotide ligation or just due to the slower rate of all 
ligation events, as observed in our in vitro assays. Additionally, we may see no effect from 
mutation of Cdc9 unless ribonucleotide excision repair is impaired, which will require us to test 
the mutations in a yeast strain lacking RNase H2.  
 If the results from these structural and cellular experiments agree with our biochemical 
characterization, we will have substantial evidence for a fidelity mechanism for enabling DNA 
ligases to discriminate against ligation of downstream ribonucleotides. This fidelity mechanism 
is distinct from the mechanism described in Chapter 3 for discrimination against upstream 
mismatches, suggesting that DNA ligases have multiple intrinsic fidelity mechanisms. The 
mechanism of ribonucleotide discrimination reported here is similar to the mechanism utilized by 
DNA polymerases, where a conserved methionine residue is used as a “steric gate” to prevent to 
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avoid incorporation of ribonucleotide monophosphates (rNMPs) into DNA 147. Altogether, this 
demonstrates that multiple steps in DNA repair and replication can prevent the stable 
incorporation of ribonucleotides. Further characterization of the fidelity mechanism used by the 
different enzymes involved in repair and replication will allow us to better understand how these 
enzymes work in concert to maintain genomic fidelity. 
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Figure S4.1. Active site titration of the F872A and F872L 
mutants. The concentration of active protein was estimated from 
active site titrations, where increasing amounts of LIG1 were 







Figure S4.2. Representative traces from steady-state ligation reactions. Steady-state ligations contained either 2 nM [LIG1] 
(WT and F872A) or 100 nM [LIG1] (F872L) and 500 nM [R28mer]. Reactions were carried out in the presence of 0.2 mM ATP 
and 20 mM MgCl2. A large amount of the adenylylated ligation intermediate accumulates in reactions with the F872L mutant, 








Figure S4.3. Representative traces for single-turnover ligation of the R28mer substrate. Single-turnover ligation reactions 
between wildtype (gray), F872A (gold) and F872L (green) LIG1 and the R28mer substrate. Reactions contained either 20 mM 
(a-c) or 1 mM (d-f) MgCl2. The ligation product and intermediate DNA species are represented by closed and open circles, 
respectively. Berkeley-Madonna fits are shown for both product formation (solid lines) and the buildup and decay of intermediate 








Identification and Role of Mg2+ Ions in DNA Ligation 
 
 In considering how DNA ligases achieve tight binding and high fidelity, it is important 
for us to understand the role of the catalytic magnesium throughout the ligation reaction. The 
binding mechanism of human DNA ligase 1 (LIG1) outlined in Chapter 2 suggests that 
magnesium stimulates conformational changes prior to catalysis. Magnesium is also required for 
all chemical steps of ligation. However, LIG1 has varying magnesium affinities throughout 
ligation, suggesting that there are unique interactions with Mg2+ during the different chemical 
steps41. 
 Early observations of the structure of LIG1 suggested that the enzyme harbors two 
metal ions in the active site15. The approximate locations of these metals are consistent with the 
chemical steps of ligation, with one metal positioned to be able to activate the nucleophilic 3’-
OH and the other near the 5’-PO4, where it could both activate a hydroxyl group on the 
phosphate for adenylyl transfer and later stabilize the 5’-AMP leaving group for nick sealing. In 
contrast to this, the recent high-resolution crystal structures of LIG1 presented in Chapter 3 show 
a single magnesium coordinated in the LIG1 active site.  This lone magnesium ion is observed in 
the active site when adenylylated LIG1 is bound to the nicked substrate and after the AMP has 
been transferred to the 5’PO4 (Figure 5.1), suggesting that a single magnesium ion is used for 
both adenylyl transfer and nick sealing. 
The work reported in Chapter 5 is the result of work done by multiple previous lab members. The project was originally 
undertaken by Neha Bokil as an undergraduate student working under the direction of Mark Taylor during his graduate 
studies. April Kaneshiro helped me re-purify some of the mutants presented here and performed early characterizations of the 
E720Q mutant as a graduate rotation student. Sydney Rosenblum performed many of the experiments for D570N and E720D, 
also as a graduate rotation student. Structural insights from the work of Percy Tumbale and Matthew Schellenberg in the lab 
of Scott Williams also contributed to the study presented here. 
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 In both structures, a network of conserved residues is involved in the coordination of 
magnesium (Figure 5.1). The three central residues, D570, E621 and E720, have all been 
previously demonstrated to be important for ligation by the Chlorella virus DNA ligase 
(ChVLIG), in which mutagenesis of the analogous residues led to significant catalytic 
defects21,22. However, these ChVLIG studies predated the first structure of a DNA ligase bound 
to DNA and, perhaps because of this, did not address if mutation of these conserved residues 
impacts magnesium binding. In an attempt to confirm these conserved residues as metal ligands, 
we biochemically characterized mutations of each of the three residues in LIG1. In doing so, we 
found that mutation of any of the three residues leads to dramatic catalytic defects but 
differentially impact the magnesium affinity of LIG1. Although none of the mutations tested 
appear to significantly impact the apparent affinity for the DNA substrate, mutation of E621 
drastically decreases the KM for ATP, suggesting a unique role for this residue in stabilizing the 
ATP and AMP moieties. Although, we did not find evidence to exclude a one- or two-metal 
mechanism, we present some structural evidence supporting the one-metal mechanism that we 
hope to probe with future experiments. 
Materials and Methods 
 Preparation and purification of materials. Oligonucleotide substrates used in this study 
were synthesized by Integrated DNA Technologies (IDT) and the Keck Biotechnology Resource 
Laboratory at Yale University. Purification of the oligonucleotides by gel-purification is 
described in Chapter 2. Mutagenesis of the putative metal ligands was accomplished using site-
directed mutagenesis of the Δ232 LIG1 expression vector and the mutants were all purified as 
described previously106. The total concentration of purified protein was estimated using UV 
absorbance and the active concentration was verified through active site titration41. The standard 
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gel-based ligation assay was used for all kinetic characterizations in this study and is described 
elsewhere41. All assays were performed at 37°C and in solutions with a constant ionic strength 
held at 150 mM. 
 Steady-state ligation dependences. The concentration of LIG1 ranged from 0.1-10 nM 
for all steady-state ligation assays. In order to determine the steady-state magnesium dependence, 
ATP and DNA substrate concentrations were held at 0.2 mM and 0.5 µM, respectively. To 
characterize ATP utilization by the various mutants, the concentration of magnesium was held at 
20 mM and the DNA substrate was maintained at 0.5 µM. The DNA substrate dependence was 
performed in the presence of 20 mM MgCl2 and 0.2 mM ATP. In all cases, product formation 
was plotted as a function of time and initial rates were derived from linear fits to the data. In 
cases where both product and intermediate ligation species were observed, both species were 
considered as product formation so that resulting kcat measurements reflect all catalytic events 
that occurred. All kcat and KM values were determined using the Michaelis-Menten equation. 
 Single-turnover ligation assays. All single-turnover assays were performed in the 
absence of ATP and in the presence of 80 nM 28mer substrate. Single-turnover assays for 
D570N, E621D and E720D were all performed with the enzyme concentration held at either 0.8 
or 1.6 µM. For the preliminary single-turnover assays for the E621Q and E720Q mutants, the 
enzyme concentrations were held at either 1.6 or 3.2 µM, while the substrate remained at 80 nM. 
Reactions with the E621Q and E720Q enzymes were performed in a 37°C incubator to maintain 
a consistent temperature over the long timescale.  
 Fluorescence anisotropy pilot experiment. Fluorescence anisotropy was measured using 
a Tecan Safire plate reader with the excitation and emission wavelengths set to 495 and 515 nm, 
respectively. A master-mix containing the standard ligation buffer, 0.1 mM EDTA and 10 nM of 
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the TFAM-44mer substrate (Chapter 2) was put into the wells of a black 96-well, flat-bottomed 
microplate in 20 µL aliquots. Increasing amounts of the enzymes were titrated into each 
individual well and the plate was gently mixed for 30 seconds in the plate reader before 
measurements were taken. Resulting fluorescence traces (y) were all fit to a quadratic binding 
model as shown below. 















Figure 5.1 Crystal structures of LIG1 in complex with a lone magnesium. Crystal structures from Chapter 3 illustrating the 
interactions between the conserved carboxylate residues and a single magnesium ion both before (a) and after (b) adenylyl 
transfer. D570, E621 and E720 are all involved in water-mediated contacts with the magnesium ion. E621 also contacts the 2’-
OH of the AMP both before and after adenylyl transfer.  
 
Mutations of the putative metal ligands result in variable levels of activity 
 From previous studies of the Chlorella DNA ligase (ChVLIG), mutagenesis of the 
putative metal ligands to alanine residues seemingly abrogated all ligation activity. With this in 
mind, we chose to express and purify less deleterious mutations of the three residues. The two 
glutamate residues—E621 and E720—were each mutated either to aspartate or glutamine, in 
hopes that either the shorter sidechain or the nitrogen substitution would disrupt metal 
coordination while retaining measurable activity. Similarly, we substituted an asparagine residue 
for D570. We chose not to make a D570E mutation since ChVLIG appeared to be largely 
unaffected by the analogous mutation148. 
 With all mutants purified to homogeneity, we verified ligation activity through a series of 
active site titrations (Figure 5.2a-b). Recombinant wildtype LIG1 predominantly purifies as an 
adenylylated species, routinely yielding ~90% of the adenylylated enzyme in purified stocks. 
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Similar behavior was observed for the D570N, E621D, and E720D mutants, with all three 
enzymes performing ligation in the absence of ATP within 90% of the concentration estimates 
determined by UV absorbance (Figure 5.2a). Both glutamine mutations—E621Q and E720Q—
also showed ligation activity in these assays, albeit on a much slower timescale, requiring the 
reactions to progress overnight instead of the typical assay timescale of 15-30 minutes (Figure 
5.2b). Even following an overnight incubation, E621Q was unable to form more than ~40% 
product, indicating that the glutamine mutation severely impacts the kinetics of ligation. Indeed, 
both E621Q and E720Q ligate the nicked DNA substrate at a rate that is >10,000-fold slower 
than wildtype LIG1 in ligation assays containing a large excess of enzyme and saturating 
amounts of magnesium (Figure 5.2c). Due to this, we chose to not characterize the glutamine 
mutants further, instead focusing on the characterization of the three more active mutants. 
Nonetheless, the dramatic effect of the glutamine mutations indicates that the E621 and E720 
residues are likely essential for efficient DNA ligation. 
 
 
Figure 5.2. Determination of the active enzyme concentration. (a) Active site titrations of the D570N, E621D and E720D 
mutant LIG1 constructs. The active concentration is within 80-90% of the concentration estimated by UV absorbance. The 
enzymes were titrated against the 28mer substrate held at 150 nM in the absence of ATP and reactions were allowed to proceed 
to completion, which typically took 30 minutes. (b) Active site titrations of the E720Q and E621Q mutants were performed as in 
a but reactions were allowed to proceed overnight due to severe defects in the catalytic rate. E621Q only catalyzed ~50% product 
formation in the timeframe tested. The slow kinetics observed here were confirmed in single-turnover reactions (c) containing 1.6 
or 3.2 µM E621Q or E720Q and 80 nM of the 28mer substrate. All data is shown as the mean ± S.D. of at least three independent 
replicates, except for b, for which only one replicate is shown. 
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Metal-ligand mutants exhibit magnesium-dependent defects in ligation 
 We first wanted to assess how the mutations impacted steady-state ligation and metal 
binding by LIG1. For this, reactions were performed in the presence of increasing amounts of 
magnesium and an excess of the DNA substrate over LIG1. Additionally, we included ATP—
which is necessary to allow for multiple turnovers—at a constant concentration of 0.2 mM, 
which is a saturating amount for wildtype LIG1 (Figure 5.3). Resulting Michaelis-Menten plots 
for the magnesium dependences demonstrate a significant decrease in kcat for all three mutants 
compared to wildtype LIG1. The most significant decrease in catalytic rate is seen with the 
E621D mutation, which is nearly 60-fold slower than wildtype, while D570N and E720D are 
only ~30- and ~20-fold slower, respectively. While D570N only has a ~3-fold weaker KMg2+ 
value, both E621D and E720D have KMg2+ values that are ~14-fold weaker, indicating a 
significant weakening of the magnesium affinity for these two enzymes. Altogether, these 
mutations cause a ~100-1000-fold decrease in kcat/KMg2+—with the E621D mutation causing the 
most severe impact—indicating that all three mutations result in a decrease in the efficiency of 
magnesium utilization by LIG1 (Figure 5.3b).  
 To look at which steps of ligation are specifically affected by the three mutations, we 
performed ligation assays under single-turnover conditions with varying amounts of Mg2+. Plots 
showing the formation of the ligation intermediate and its subsequent breakdown into the sealed 
DNA product were fit by a two-step irreversible model, from which the individual rates of 
adenylyl transfer and nick sealing were derived (Figure S5.1). Interestingly, the three mutants all 
perform adenylyl transfer at the same maximal rate, which is ~40-fold slower than wildtype 
(Figure 5.4a). The magnesium affinity for the adenylyl-transfer step is also similar for all three 
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mutants, exhibiting a substantial ~40-fold decrease in KMg2+, reducing the overall ktransfer/KMg2+ 
by more than 1,600-fold (Figure 5.4c, Table 5.1).  
Figure 5.3. D570N, E621D and E720D exhibit large decreases in kcat/KMg2+. (a) Steady-state magnesium dependences for the 
three mutants. Initial rates are plotted as a function of magnesium concentration and were fit using the Michaelis-Menten 
equation. The best-fit parameters are shown in Table 5.1. (b) The kcat/KMg2+ values for the three mutants relative to wildtype 
LIG1 were determined using the data for wildtype LIG1 presented in Chapter 3. All three mutants show large decreases in 
catalytic efficiency. Data is shown as the mean ± S.D. of three or more replicate experiments. 
 
 Both the D570N and E720D mutations affect the nick-sealing step to a similar degree, 
slowing down the maximal rate nearly 100-fold (Figure 5.4b). D570N and E720D catalyze nick 
sealing with KMg2+ values of 18 and 35 mM, respectively, compared to ~3 mM for the wildtype 
enzyme (Table 5.1). Since the rate of nick sealing reached a maximum in the presence lowest 
tested magnesium concentration—0.3 mM—we are only able to place a limit of ≤ 0.3 mM for 
KMg2+ for the E621D mutant (Table 5.1). Additionally, nick sealing is significantly slower than 
adenylyl transfer for the E621D mutant, leading to a rapid accumulation of the adenylylated 




Figure 5.4. Mutation of the putative metal-ligands impacts both chemical steps. Single-turnover reactions were performed 
over a range of magnesium concentrations and with the mutants held in excess of the 28mer DNA substrate. Individual single-
turnover traces were fit using a two-step irreversible model in Berkeley-Madonna, from which we derived the microscopic rates 
of ligation. The rates of adenylyl transfer (a) and nick sealing (b) are plotted as a function of magnesium concentration. Maximal 
rates and magnesium affinities were derived from hyperbolic fits of the data. (c) The kmax/KMg2+ values for the individual mutants 
are represented as relative values to the corresponding kmax/KMg2+ for wildtype LIG1. Data for wildtype LIG1 is adapted from the 
study in Chapter 3. The high kmax/KMg2+ value for nick sealing by the E261D mutant is due the dramatic decrease in KMg2+ caused 
by the mutation. Since a true KMg2+ was not measured for nick sealing by E261D, this value only represents a lower limit. All 
data is shown as the mean ± S.D. of three or more replicate experiments. 
 
Table 5.1 Best-fit parameters for steady-state and single-turnover magnesium dependences. 
 
E621D displays severe defects in ATP utilization 
 Having confirmed the weakened metal affinity for the three mutants, we were interested 
in how this potentially affects utilization of the two ligation substrates, ATP and DNA. We first 
probed the ability of the enzymes to perform enzyme adenylylation by performing steady-state 
ATP dependences (Figure 5.5a). We held both the nicked DNA substrate and magnesium at 
concentrations deemed saturating for wildtype LIG1, 500 nM and 20 mM, respectively. Since all 
three enzymes exhibit a significantly weaker KMg2+, choosing a single magnesium concentration 
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for steady-state assays is potentially problematic, as 20 mM Mg2+ is saturating for D570N, but 
not for either E621D or E720D (Table 5.1). However, increasing the Mg2+ concentration to a 
saturating concentration for the E621D and E720D mutants requires a concomitant increase in 
the ionic strength of the solution, complicating comparisons of the two mutants to D570N or 
wildtype LIG1.  
 Michaelis-Menten plots of the ATP-dependence of the three enzymes are shown in 
Figure 5.5A. The curves for both D570N and E720D follow a similar trend to one another, 
giving fits with KM,ATP values in the low micromolar range (~1-4 µM). The overall change in 
ATP utilization caused by the D570N and E720D mutations is a decrease of about 6- or 10-fold, 
respectively, which could be due solely to the defects in the DNA-dependent steps. The E621D 
mutation impedes enzyme adenylylation to a much larger degree, causing a 600-fold decrease in 
the catalytic efficiency of ATP utilization (Figure 5.5a-b). The large effect of the E621D 
mutation on enzyme adenylylation indicates that the E621 residue may play an outsized role in 
the initial enzyme adenylylation step.  
Figure 5.5. E621D severely impacts steady-state ATP affinity. (a) Steady-state ligation assays were performed with varying 
amounts of ATP, 20 mM MgCl2 and 0.5 µM 28mer DNA substrate. Initial rates are plotted as a function of ATP concentration 
and were fit using the Michaelis-Menten equation. The full ATP-dependence for E621D is shown in b. Data is shown as the 
mean ± S.D. of three or more replicate experiments. (c) The crystal structure of an RNA ligase from Naegleria gruberi 
highlighting conserved residues in the active site (PDB: 5COU149). D172, E227 and E312 are analogous to D570, E621 and E720 




 Although no structural information about the enzyme adenylylation step exists for a 
mammalian DNA ligase, the residues required for this step are conserved in all known ATP-
dependent DNA and RNA ligases. Recent structures of an RNA ligase from Naegleria gruberi 
(NgrRnl) captured the enzyme primed for enzyme adenylylation, showing coordination of the 
ATP substrate in the adenylylation core149. Figure 5.5c highlights residues D172, E227 and E312 
in the RNA ligase, which correspond to D570, E621 and E720 in LIG1. The carboxylate moiety 
of E312 moiety coordinates two water-mediated contacts to the catalytic manganese, possibly 
explaining why mutation of the analogous residue in LIG1—E720—yields a significant decrease 
in catalytic efficiency for ATP. E227—E621 in LIG1—is also involved in a water-mediated 
contacts with the metal ion, but more notably contacts the 2’-OH of the bound ATP molecule 
(Figure 5.5c). This is similar to the contact observed between E621 and the 5’-AMP in the LIG1 
crystal structure, indicating that this residue is likely contacting the AMP group throughout the 
ligase catalytic cycle (Figure 5.1).  
Figure 5.6. Mutations do not appear to cause significant DNA-binding defects. (a) Steady-state dependences were performed 
with 20 mM Mg2+ and 0.2 mM ATP. The initial rates were determined over a range of concentrations of the 28mer DNA 
substrate and were fit using the Michaelis-Menten equation. (b) Relative kcat/KM,DNA values for the individual mutants compared 
to the values for wildtype determined in Chapter 3 under the same conditions. All values reflect the mean ± S.D. of at least three 
independent replicates and are shown in Table 5.2. (c) Anisotropy values obtained with a titration of increasing amounts of the 
different LIG1 enzymes against a fixed concentration of the TFAM-44mer reporter substrate (10 nM). All traces were fit using a 






The metal-ligand mutations do not appear to impact affinity for DNA 
 Steady-state DNA dependences were performed similar to the ATP dependences, with 
magnesium and ATP held at concentrations deemed saturating for wildtype LIG1 (Figure 5.6a). 
Under these conditions, the three mutants exhibit decreased kcat values compared to wildtype 
LIG1, showing the same ~20-60-fold decreases observed in the other steady-state dependences 
and leading to an overall decline in catalytic efficiency (Figure 5.6b). Remarkably, all three 
mutants have low KM,DNA values, ranging from 20 to 40 nM. This is nearly equal to the KM,DNA 
value obtained with wildtype LIG1 under the same conditions, which is close to 60 nM (Chapter 
3)  
 To directly test for any defects in DNA-binding, we titrated increasing amounts of the 
LIG1 constructs against a fixed amount of the TFAM-44mer substrate—characterized in Chapter 
2—to detect binding via anisotropy (Figure 5.6c). In addition to the three characterized mutants 
of LIG1, we also measured the binding affinity of the two glutamine mutations—E621Q and 
E720Q—to test whether the large defects in ligation by the two mutants are partially due to a 
DNA-binding defect. The resulting binding curves for the different LIG1 enzymes were all fit to 
a quadratic binding model in order to account for ligand depletion. All of the tested LIG1 
enzymes exhibit tight binding affinity for the DNA substrate in the low nanomolar range (Table 
5.3). With the exception of E720D and E621D, the mutants show a similar affinity for the 
substrate as wildtype, with KD values around 3-5 nM. E621D has a ~3-fold weaker affinity while 
E720D exhibits a binding affinity that is ~3-fold tighter than that of wildtype. Since the binding 
data is still preliminary, no definitive conclusions can be drawn from this assay, however it does 
 106 
appear that mutations of the putative metal ligands do not significantly impact DNA binding by 
LIG1.  







Table 5.3. Preliminary KD values for DNA binding by wildtype and mutant LIG1. 
The relative KD values were calculated by dividing the obtained KD values by the value 





 D570, E621 and E720 have all been recently identified as putative metal ligands in the 
crystal structure of LIG1 (Chapter 3). Therefore, we sought to biochemically characterize 
mutants of the three conserved residues to gain insight into the mechanism underlying DNA 
ligation. Mutagenesis of either E621 or E720 to glutamine resulted in severely diminished 
enzymatic activity, especially for the E621Q mutant. D570N, E621D and E720D all displayed 
significant DNA ligation defects but were still able to ligate the 28mer substrate to completion. 
All three mutations caused significant defects in steady-state utilization of magnesium by LIG1. 
Additionally, the mutations all similarly impact the adenylyl-transfer step of ligation, resulting in 
decreases in both the rate of adenylyl transfer and the magnesium affinity for the step. While 
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both D570N and E720D exhibited significant decreases in their KMg2+ values for nick sealing, the 
apparent magnesium affinity of E621D was tighter than what is observed with the wildtype 
enzyme. E621D also catalyzed nick sealing with a much slower rate than either of the other two 
mutants, suggesting that this residue may play a unique role during the nick-sealing step. E621D 
also exhibited significantly diminished ATP utilization, consistent with E621 being essential for 
helping to properly position ATP or AMP in the active site through interactions with the 2’-OH. 
 During our biochemical characterization of the two mutants, we did not find evidence to 
suggest that LIG1 preferentially uses one or two magnesium ions for catalysis. While enzyme 
adenylylation has been demonstrated to require two metal ions, with one of the two coordinated 
between the β and γ phosphates of ATP (Figure 5.5c)41,149, the number of metal ions required for 
the DNA-dependent steps of ligation remains unclear. In both the original crystal structure of 
LIG1 and the more recent structures described in Chapter 3, a metal ion is observed near the 
upstream 3’-OH. The absence of a second metal in the recent structures near the downstream 5’-
PO4 suggests that a metal ion may not be required for stabilization of the AMP. Further 
examination of the LIG1 active site reveals a conserved lysine residue (Lys744) interacting with 
an oxygen atom from the AMP moiety, both before and after adenylyl transfer (Figure S5.2 and 
S5.3). Substitution of the analogous residue in ChVLIG to alanine results in a loss of 98% of 
ligation activity relative to the wildtype enzyme, indicating that the residue likely plays an 
important role in catalysis22. Additionally, the mutation disproportionately affected the final step 
of ligation, nick sealing, where stabilization of the AMP leaving group would be most important.  
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Figure 5.7. Hypothetical one-metal mechanism for DNA ligation. The lone metal ion observed in crystal structures of LIG1 is 
coordinated by the three residues characterized in this study: D570, E621 and E720. K744 is positioned near the upstream end, 
where it is seen contacting an oxygen from the AMP group, possibly helping to stabilize AMP as the leaving group during nick 
sealing. The interaction between E621 and the AMP ribose is omitted for clarity but also appears to be important for the final 
sealing step.  
 
 The ChVLIG studies and positioning of K744 in the LIG1 crystal structures leads us to a 
hypothetical one-metal mechanism, where the lysine residue would be responsible for stabilizing 
the AMP leaving group for attack by the 3’-OH (Figure 5.7). Proper positioning of the AMP 
moiety in the active site could be achieved by E621, which contacts the 2’-OH of the ribose ring 
throughout the DNA ligation reaction (Figure 5.5c and S5.2). This interaction appears to be 
important for enzyme adenylylation, as the E621D mutant exhibited a large decrease in efficient 
ATP utilization, but could also be key for positioning the AMP for interactions with K744. Since 
the available crystal structures of LIG1 complexed with DNA after the adenylyl-transfer step 
have all been solved with an upstream dideoxy-block, the exact positioning of the metal prior to 
nick sealing is unclear. However, it is possible that the active site metal is only necessary for 
activation of the nucleophilic 3’-OH during nick sealing and that stabilization of the leaving 
group is accomplished directly by the protein. A deeper characterization of the K744 residue 






Chapter 5 Appendix 
Figure S5.1. Representative single-turnover traces. Representative traces for single-turnover reactions with D570N (a), 
E621D (b) and E720D (c). Reactions shown here contained 20 mM Mg2+ and 80 nM of the 28mer substrate. 
 
Figure S5.2. Lys744 contacts the AMP moiety before and after adenylyl transfer. Crystal structures from Chapter 3 
illustrating the interactions between the conserved carboxylate residues and a single magnesium ion both before (a) and after (b) 







Figure S5.3. Conservation of the lysine-AMP interaction. Crystal structures from LIG1 (a), LIG3 (b), LIG4 (c) and ChVLIG 
(d) show the conservation of a lysine-mediated contact between the ligase and the phosphate moiety of AMP. Structures were 






Biochemical Characterization of LIG1-Syndrome Mutations 
 
 The mammalian DNA ligase family is a group of highly conserved enzymes with 
essential functions in most DNA-dependent cellular processes. The three mammalian DNA 
ligases share a conserved catalytic core but have diverse N- and C-termini that define their 
specific cellular roles36,37. DNA ligase I (LIG1) is directed to the DNA repair and replication 
machinery through interactions between its N-terminus and PCNA, where it engages in single-
strand break repair and in Okazaki fragment maturation. DNA ligase 3 (LIG3) is the only DNA 
ligase found in mammalian mitochondria but is also found in the nucleus where it interacts with 
the nuclear scaffolding protein XRCC149,81,150. LIG3 participates in both single-strand and 
double-strand break repair, occasionally acting in a redundant manner with the other two 
ligases71,93,94. Unlike LIG1 and LIG3, DNA ligase IV (LIG4) does not appear to participate in 
single-strand break repair. Instead, LIG4 is a core member of the non-homologous end joining 
pathway (NHEJ), which repairs double-strand breaks in the absence of homologous 
recombination96,151.   
 The functions of all three mammalian DNA ligases—DNA ligases I, III and IV—have 
been implicated in the onset and/or maintenance of cancer, mainly due to their vital role in 
maintaining genomic integrity152-154. DNA ligases I (LIG1) and IV (LIG4) have also been 
implicated in immunological diseases. For LIG4, the connection to proper immune system
Some of my work reported in Chapter 6 was included in the following citation: Maffucci, P. et al. Biallelic mutations in DNA 
ligase 1 underlie a spectrum of immune deficiencies. J Clin Invest 128, 5489-5504, doi:10.1172/JCI99629 (2018). 
 
The crystal structures presented here are preliminary structures adapted from unpublished work by Percy Tumbale and 





function is obvious, as it plays a key role in the NHEJ pathway that concludes the V(D)J 
recombination pathway, which is involved in the adaptive immune response155. LIG4 syndrome 
is characterized by a collection of immunodeficiencies caused by disparate mutations in the 
LIG4 gene107,108. Those afflicted by LIG4 syndrome can also exhibit hypersensitivity to UV-
radiation and developmental disorders, owing to the role of NHEJ in DNA repair.  
 LIG1 syndrome was first characterized in the early 90’s when a patient exhibiting signs 
like of developmental defects, UV sensitivity and immunodeficiency was initially misdiagnosed 
as having Bloom’s syndrome103,104,156. The cause of these symptoms was identified as deficient 
LIG1 activity, caused by a E566K mutation in one allele and a R771W mutation in the other105. 
Biochemical studies of the E566K mutation showed that it is a catalytically dead enzyme157. A 
later crystal structure of LIG1 revealed that the E566 residue lies in the enzyme active site15. The 
effect of the R771W mutation on LIG1 activity was unclear at the time, although studies noted 
delayed Okazaki fragment maturation in the patient-derived 46BR cell line indicating decreased 
LIG1 activity105. Attempts to biochemically characterize the R771W variant were previously 
unsuccessful due to an apparent instability of the recombinant LIG1 mutant. 
 Recently, five additional patients harboring biallelic LIG1 mutations were identified as 
exhibiting similar symptoms as the original patient described in the literature106. Exome 
sequencing showed that two to the patients share the same heterozygous mutations in LIG1, 
despite no familial connection between the two. One of the shared variants—T415Mfs*10—is a 
truncated version of LIG1, only containing the N-terminal region and a portion of the DNA-
binding domain (DBD). The other shared variant harbors a R641L mutation, which lies in the 
nucleotidyl-transferase (NTase) domain of LIG1. The other three patients, who all share a 
maternal grandmother, are homozygous for a LIG1 variant containing a R771W, the same 
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mutation found in the original LIG1 syndrome patient, and a P529L mutation in the DBD. Initial 
biochemical characterization of P529L LIG1 indicated a negLIG1ble change in activity for this 
mutant compared to wildtype106. Engineered cell lines containing the patient-derived R641L and 
T415Mfs*10 mutants of LIG1 exhibited increased DNA damage sensitivity, as did isolated 
lymphoblastoid β cells from the patients. Additionally, one of the patients harboring both the 
R641L and T415Mfs*10 mutations, as well as their mother who only has the R641L mutation, 
exhibited a decrease in somatic hypermutation, consistent with the observed 
immunodeficiencies. 
 To contribute to the understanding of a link between aberrant LIG1 activity and the onset 
of disease, we were interested to investigate the biochemical consequences of these mutations. 
Due to the severity of the effects of the R641L and R771W mutations in cell-based experiments, 
we focused solely on these two mutants for biochemical characterization. The two mutations 
both effect DNA-binding surfaces on the protein. Surprisingly, while we did observe noticeable 
defects in catalytic efficiency on a nicked DNA substrate, there were no obvious defects in 
DNA-binding. Instead we observed many abortive ligation events catalyzed by the two mutants 
and an unexpected decrease in magnesium affinity. Crystal structures of the two mutant LIG1 
proteins uncovered many distortions in both the phosphodiester backbone of the substrate and 







Materials and Methods 
Preparation and purification of materials. The catalytic core of human DNA ligase I 
(residues 232-919) was expressed in E. coli and purified as previously reported106. Recombinant 
enzymes harboring the patient-derived mutations were made using site-directed mutagenesis and 
the mutagenesis was confirmed by sequencing the expression vector. Concentration of the 
adenylylated enzyme was determined by active site titration against a fixed concentration of the 
nicked 28mer substrate. Substrate oligonucleotides were synthesized by Integrated DNA 
Technologies (IDT) and the Keck Biotechnology Resource Laboratory at Yale University. 
Lyophilized oligos were gel-purified on denaturing polyacrylamide gels and annealed as 
previously described41. The sequences of both the 28mer and the TFAM-44mer substrates are 
described in Chapter 2. 
Gel-based ligation assays. All ligation assays were performed at 37°C with a standard 
reaction buffer containing 50 mM NaMOPS pH 7.5 (adjusted at 25°C), 0.1 mM dithiothreitol, 
0.05 mg/mL BSA and varying amounts of NaCl to maintain a constant ionic strength of 150 mM. 
Ligation assays were performed at 37ºC and quenched with an equal volume of the gel-loading 
solution containing 50 mM EDTA/90% formamide. Quenched reactions were heated to 95°C 
prior to loading on 15-20% (wt/vol) polyacrylamide gels containing 6.6-8 M urea. The 
fluorescein-labeled species were detected using either a Typhoon Trio+ or a Typhoon 5 imager 
(GE Healthcare) and quantified using the ImageQuant software (GE Healthcare) as previously 
described41.  
Steady-state ligation assays. Steady-state ligation reactions were typically performed 
with 0.1-10 nM LIG1. DNA-dependences were performed in the presence of either 20 mM 
MgCl2 and 0.2 mM ATP or 2 mM MgCl2 and 1 mM ATP. Reactions with 2 mM MgCl2 contain 
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1 mM Mg2+free due to chelation of magnesium by ATP41. For reactions with varying amounts of 
ATP, the concentrations of MgCl2 and the 28mer substrate were held at 20 mM and 0.5 µM, 
respectively. For the magnesium dependence, ATP was held at 0.2 mM and the 28mer substrate 
was held at 0.5 µM. Initial rates of reaction were obtained from the slopes of linear fits to the 
fraction of product as a function of time, which were then plotted as a function of the 
concentration of the varied component. Values for kcat and KM were obtained from fits of the data 
to the Michaelis-Menten equation. 
Rapid-quench flow ligation assays. Single-turnover assays were carried out at 37ºC either 
in a heat block or by using a KinTek RQF-3 quench-flow apparatus. Ligation reactions in the 
quench-flow were prepared by loading one sample syringe with 1.6 µM LIG1 and the other with 
160 nM of the DNA substrate. Both syringes contained varying amounts of MgCl2. Ligation was 
initiated upon mixing of the solutions in a 1:1 ratio, followed by quenching of the reaction at 
various timepoints with the gel-loading solution. For reactions not requiring rapid-quenching, the 
solutions were made similarly but were mixed 1:1 (v/v) using a micropipette. Rates for the 
adenylyl-transfer and nick-sealing steps were obtained from fits of the data using a two-step 
irreversible model in Berkeley-Madonna as previously described41. 
Steady-state fluorescence binding assays. Fluorescence intensity and anisotropy 
measurements were collected using a FluoroMax 3 fluorometer (Horiba) controlled by the 
DataMax software. Data was collected using excitation and emission wavelengths of 495 nm and 
515 nm, respectively. Binding assays were performed by titration of increasing amounts of LIG1 
against a 2.5 mL solution containing 1-2 nM of the TFAM-44mer and the standard reaction 
buffer with 0.1 mM EDTA. After addition of LIG1, samples were allowed to equilibrate for 30 
seconds to 1 minute before measurements were taken. Anisotropy and relative fluorescence are 
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plotted as a function of added [LIG1] and the data was fit to a hyperbolic binding curve as shown 
in Equation 2.2 (Chapter 2). 
Stopped-flow kinetic experiments. Transient kinetic experiments were performed using 
the Hi-Tech SF-61DSX2 stopped-flow instrument controlled by the Kinetic Studio (TgK 
Scientific) software. Data from both PMT detectors were combined and averaged for each shot. 
A minimum of 5-6 shots were performed and averaged for each concentration tested. Fluorescein 
fluorescence was measured using an excitation wavelength of 495 nm and two 515 nm longpass 
filters. For experiments looking at tryptophan fluorescence, an excitation wavelength of 295 nm 
and two 320 longpass filters. All stopped-flow reactions were performed in the standard ligation 
buffer, except for experiments monitored by tryptophan fluorescence, for which BSA was 
omitted from the buffer. The resulting traces were fit to a single exponential (Equation 2.3). All 
observed rates were plotted as a function of either [LIG1] or [DNA]. The resulting data plots 
were fit using linear regression to determine kon.  
Crystallization of mutant LIG1 complexes. A ∆262 LIG1 construct (amino acids 262-904) 
and an 18mer substrate were used for crystallization, as described in Chapter 3. Crystals of the 
LIG1•DNA•EDTA complex were grown by hanging drop method. The protein•DNA complex 
was formed with 20 mg/mL ∆262 LIG1 and the nicked 18mer oligo at a 1.5:1 DNA:LIG1 molar 
ratio in a solution consisting of 1 mM ATP, 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, and 1 mM 
TCEP. 1µL of the complex solution was mixed with an equal volume of precipitant solution (100 
mM MES, pH 6, 100 mM lithium acetate, 12-15% (w/v) polyethylene glycol 3350) at 20°C. The 
crystallization drops containing the mutant LIG1 protein were allowed to equilibrate for 30 
minutes before micro-crystal seeds prepared from the WT crystals were streaked into the drops.  
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Results 
Figure 6.1. R641 and R771 are positioned within DNA-binding loops. (a) Schematic of the human LIG1 domain architecture 
(top). The approximate locations of the mutated residues (R641 and R771) and the active site lysine (K568) are indicated. The 
crystal structure of WT LIG1 showing the locations of the R641 (red) and R771 (dark red) residues is shown below. (b) Close-up 
view of the loop in the nucleotidyl transferase domain containing the R641 residue. A salt bridge between R641 and D600 helps 
to stabilize the loop, allowing for residues 642-644 to make direct and water-mediated contacts with the phosphodiester backbone 
of the DNA. (c) Close-up view of R771 intercalating into the minor groove of the DNA helix. R771 is involved in water-
mediated interactions with the DNA, while K770 directly contacts the adjacent nucleotide. R768 forms a salt-bridge with D351 in 
the DBD. 
 
R641 and R771 appear to be important for LIG•DNA interactions 
 Both R641 and R771 lie within regions of LIG1 that contact the DNA substrate (Figure 
6.1). R641 forms a salt-bridge with D600, stabilizing a looped-region within the nucleotidyl 
transferase (NTase) domain (Figure 6.1b). A network of contacts between LIG1 and the DNA 
are present in the R641 loop, with adjacent residues K642, R643 and K644 all making either 
direct or water-mediated contacts with the DNA. R771 also lies within a loop region—this time 
in the OB-fold domain—where it engages in water-mediated contacts with an adenine in the 
major groove (Figure 6.1c). The adjacent K770 forms contacts with both the deoxyribose sugar 
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and base of a guanine nucleotide. The R771 loop is stabilized by a salt bridge between R768 in 
the loop and D351 in the DNA-binding domain (DBD).  
 Based on these observations, we expected that the patient-derived mutants would be 
defective in the DNA-dependent steps of ligation and may show decreased DNA-affinity. The 
R641L mutation would eliminate the salt-bridge that stabilizes the loop in the NTase domain, 
abrogating contacts between the region and the DNA. Similarly, substitution of a tryptophan for 
R771 will ablate water-mediated interactions between the residue and the DNA, possibly causing 
a distortion of the loop itself. 
 
Substrate dependences of LIG1 mutants 
To determine the biochemical consequences of the patient-derived mutations, we used 
site-directed mutagenesis to create recombinant Δ232 LIG1 mutants containing either the R641L 
or R771W mutation. Both mutations resulted in an overall decrease in catalytic activity with the 
canonical nicked DNA substrate (Table 6.1). The dependence of steady-state ligation on the 
concentration of ATP demonstrated only modest changes in kcat/KM,ATP, which is mostly due to 
the kcat defect (Table 6.1, Figure S6.1). The absence of a significant defect in ATP utilization is 
unsurprising due to the proximity of the mutations near the DNA-binding surface and not near 
the putative ATP-binding residues. 
Since we believed the mutants to be deficient in DNA-binding, we sought to characterize 
the behavior of steady-state ligation over a range of DNA substrate concentrations (Figure 6.2a). 
Indeed, in the presence of saturating concentrations of ATP and Mg2+, the mutants have a ~2-to-
3-fold increase in KM,DNA relative to wildtype. The increase in KM,DNA results in a ~5- and ~10-
fold decrease in catalytic efficiency for R641L and R771W, respectively (Figure 6.2C, Table 
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6.1). Since both enzymes catalyze ligation at a slower rate relative to wildtype, this defect in 
catalytic efficiency is due in part to a global reduction in catalytic rate and not solely due to 
weakened KM,DNA values.  
Figure 6.2. R641L and R771W demonstrate reduced catalytic efficiency for nicked DNA. Steady-state DNA dependences 
were carried out by mixing 0.1-10 nM LIG1 with increasing concentrations of the nicked DNA substrate, ranging from 0-2 µM 
DNA. Reactions were carried out in the presence of either 20 mM Mg2+free and 0.2 mM ATP (a) or 1 mM Mg2+free and 1 mM 
ATP (b). Initial rates are plotted as a function of [DNA] and fit using the Michaelis-Menten equation, from which kcat/KM values 
were derived for all three enzymes at either high or low [Mg2+]free (c). Data are shown as the mean ± S.D. of at least three 
independent replications. Data are summarized in Table 6.1. 
 
 
While we observed an obvious decrease in catalytic efficiency for the DNA substrate, this 
effect seemed somewhat modest considering the drastic consequences of the mutations in vivo106. 
To reconcile this, we repeated the substrate dependence in the presence of more physiological 
concentrations of both ATP and Mg2+(Figure 6.2b). We define our physiological assay condition 
as containing 1 mM of both Mg2+free and ATP, based on literature estimates158. Under these 
physiological conditions, the catalytic efficiency of ligation by the wildtype LIG1 enzyme 
changes very little. However, for both patient-derived mutations, the ligation defects were much 
more pronounced than under saturating conditions (Figure 6.2c, Table 6.1). Compared to 
wildtype, we observed a ~30- and 40-fold decrease in catalytic efficiency for R641L and 
R771W, respectively, corresponding to a 10-fold change in the efficiency compared to the 




Table 6.1. Best-fit parameters for 
steady-state substrate dependences. 
Parameters were obtained from 
Michaelis-Menten fits to both the 
steady-state ATP (Figure S6.1) and 
DNA (Figure 6.2) dependences. Data 
are shown as the mean ± S.D. of at 






R641L and R771W do not exhibit significant DNA-binding defects 
To look at any changes in DNA affinity more directly, we measured the binding affinity 
using fluorescence anisotropy. To investigate this, we made use of the reporter substrate 
containing a fluorescein-tagged thymine base (TFAM) at the site of the nick in the 3’ position 
(Chapter 2)14. Binding to the TFAM substrate was monitored by both fluorescence quenching 
and increases in anisotropy (Figure 6.3a). Utilizing this method provides a KD of ~6 nM for 
wildtype LIG1. The measurement is nick-specific, as binding to the TFAM substrate lacking a 
phosphate group at the 5’ end of the nick abolishes tight binding by wildtype LIG1 (Chapter 2). 
Despite steady-state KM,DNA values for R641L and R771W being significantly higher than that of 
wildtype, the measured KD values were nearly identical between all three enzymes, suggesting 
no apparent defect in DNA-binding affinity (Figure 6.3b).  
 121 
Figure 6.3. Clinical mutations of LIG1 have minimal impact on binding. (a) The reporter substrate used in binding studies 
makes use of a fluorescein conjugated to a deoxythymidine (TFAM) incorporated at the -1 position of the nicked DNA. The 
fluorescence signal is quenched upon nick-recognition and binding by LIG1. (b) Equilibrium-binding experiments using the 
TFAM substrate were performed by titration of increasing amounts of the LIG1 constructs against 1 or 2 nM of the TFAM 
substrate. Data were fit using a saturation binding curve and KD values are reported as the mean ± SD of ≥ 3 replicates. (c) The 
schematic and representative traces from stopped-flow experiments performed to monitor real-time fluorescence changes 
resulting from LIG1 binding the TFAM-DNA reporter. Rates obtained from single-exponential fits of the data are plotted as a 
function of [LIG1] in d. The dependence of kobs on [LIG1] was fit using linear regression and the slopes of these fits are reported 
as the observed on-rate (kon) ± SD of ≥ 3 replicates.  
 
To test for a possible effect on binding kinetics, we monitored binding to the TFAM 
substrate in real-time using stopped-flow spectroscopy (Figure 6.3c-d). Binding to the reporter 
substrate by wildtype LIG1 gives a time-dependent fluorescence quenching, which is best fit to a 
single exponential to obtain kon,obs (Figure 6.3c). The apparent on-rate increases linearly with 
increasing [LIG1], suggesting a bi-molecular association occurring at ~5x107 M-1s-1 (Figure 
6.3d). Enzyme concentration dependences for both the R641L and R771W mutants behaved 
similarly, with kon,obs values close to 4x107 M-1s-1 and 6x107 M-1s-1, respectively. To ensure that 
the absence of an observable binding defect is real and not an artifact of the reporter substrate, 
we also monitored binding by performing stopped-flow experiments monitoring tryptophan 
fluorescence (Figure S6.2). LIG1 contains a conserved tryptophan residue in the active site that 
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we proposed would be sensitive to the enzyme accommodating the nick in the active site. Indeed, 
experiments with wildtype LIG1 and increasing unlabeled DNA substrate exhibited similar 
behavior to the TFAM experiments, giving a kon,obs of ~4x107 M-1s-1. Monitoring binding by 
tryptophan fluorescence for both R641L and R771W also mimicked the behavior seen in the 
TFAM experiments, suggesting that the mutations do not affect the binding rate (Figure S6.2b,c). 
Figure 6.4. Clinical mutations of LIG1 weaken metal affinity. (a) Steady-state Mg2+ dependence demonstrates that R641L and 
R771W LIG1 mutants exhibit weakened Mg2+ affinity. Reactions contained 1-5 nM LIG1, 500 nM DNA and 0.2 mM ATP with 
varying concentrations of MgCl2. Initial rates were fit to the Michaelis-Menten equation and best fit parameters are reported in 
Table 6.2 (b) The fraction of abortive ligation events observed in the steady-state reactions from a. The physiologically-relevant 
[Mg2+]free (~1 mM) is marked by a dashed line. Both R641L and R771W exhibit enhanced rates of abortive ligation compared to 
WT at low Mg2+free. (c-d) The rates of adenylyl transfer (c) and nick sealing (d) were determined from single-turnover 
experiments containing 800 nM LIG1, 80 nM DNA and increasing [MgCl2]. The maximal rates and KMg values for both ktransfer 
and kseal were determined by hyperbolic fits to the single-turnover data (Table 6.2). All values are reported as the mean ± S.D. of 






R641L and R771W exhibit Mg2+-dependent effects  
Despite the absence of an observable defect in DNA-binding, we saw a large reduction in 
catalytic efficiency in the presence of low [Mg2+] (Figure 6.2c) and posited that there may be a 
magnesium-dependent defect in the mutants. To test this, we performed a steady-state 
magnesium dependence in the presence of saturating amounts of ATP and magnesium (Figure 
6.4a). Since neither of the mutations lie near the active site or putative metal-binding sites, we 
did not expect to see a large change in the apparent Mg2+ affinity compared to wildtype LIG1.  
Surprisingly, the mutants exhibited significant decreases in their apparent magnesium affinities 
compared to wildtype, with both R641L and R771W displaying a 5-fold increase in KMg2+ 
(Figure 6.3a, Table 6.2). Moreover, at Mg2+free concentrations ≤ 5 mM, there was a noticeable 
increase in the frequency of abortive ligation events, where the adenylylated intermediate is 
released before nick-sealing can occur (Figure 6.3b). At physiological concentrations of Mg2+free 
(1 mM), the ratio of abortive ligation to ligation events is roughly 1:1, with abortive ligation 
events making up roughly half of all observed catalysis by the two mutants. At the lowest MgCl2 
concentration tested—about 50 µM Mg2+free—all catalysis by R641L and R771W resulted in 
abortive ligation, while only ~10% of catalytic events by wildtype LIG1 ended with release of 
the adenylylated intermediate, indicating that the mutants undergo abnormally high amounts of 
abortive ligation (Figure 6.3b).  
The surprising magnesium-dependent defects led us to believe that the two chemical 
steps may be impacted by the two mutations. To characterize the individual chemical rates of 
adenylyl transfer and nick sealing, we performed single-turnover ligation assays using a rapid-
quench apparatus over a range of magnesium concentrations (Figure 6.3c-d). Wildtype LIG1 
binds magnesium tightly for adenylyl transfer and has a much weaker association—about 6-
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fold—for the catalytic magnesium involved in nick sealing (Figure 6.3c-d, Table S6.2).  KMg2+ 
values for the adenylyl transfer step are also tighter than for nick sealing in the mutants, but this 
affinity is ~40-50-fold weaker relative to wildtype. Meanwhile, KMg2+ for nick sealing is only ~2-
3-fold weaker in the mutants compared to wildtype, while the maximal rates of both chemical 
steps are 3-6-fold slower. These results indicate that the mutations may have a substantial impact 
on the initial binding and positioning of the catalytic magnesium ion required, causing 
observable defects in the DNA-dependent steps of ligation.  
Table 6.2. Best-fit parameters for steady-state and single-turnover magnesium dependences. Steady-state parameters were 
obtained from magnesium dependences (Figure 6.4a) fit by the Michaelis-Menten equation. Single-turnover parameters were 
obtained using curve-fitting to a two-step irreversible model in Berkeley-Madonna. Maximal rates and KMg values were derived 
from hyperbolic curve fits of the data as a function of magnesium concentration (Figure 6.4c,d). Data are shown as the mean ± 
S.D. of at least three independent replicates.  
 
DNA-binding interactions are perturbed in R641L and R771W LIG1 crystal structures 
Due to the mutants having perturbed KM,DNA and KMg2+ values, we hypothesized that 
these mutations may be affecting how the DNA helix is oriented for chemistry, especially since 
the mutated residues reside in DNA-binding regions.  To address this, we obtained crystal 
structures of the two mutant LIG1 enzymes in complex with DNA. For crystallization, a Δ262 
LIG1 construct was used to minimize disordered regions in LIG1 observed in the published 
LIG1 crystal structure. R641L and R771W Δ262 LIG1•DNA complexes were solved in the 
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presence of EDTA, limiting the scope of any observations gained from the structures due to the 









Figure 6.5. R641- and R711-mediated 
DNA contacts are critical for maintaining 
helical architecture. Surface and cartoon 
representations of the R641L (a,b) and 
R771W (c,d) crystal structures highlighting 
the absence of LIG1•DNA contacts 
observed in the WT structure (cyan). The 
DNA double helix from the WT LIG1 
crystal structure is shown in all panels. 
 
The structures of both the R641L and the R771W mutants reveal several distortions in 
both the protein and DNA helix. As predicted, both mutants lack extensive interactions seen 
between wildtype LIG1 and the DNA substrate (Figure 6.5). In the R641L structure, elimination 
of the salt-bridge interaction between R641 and D600 in the NTase domain loop region causes 
this region to buckle inwards (Figure 6.5a,b). The entire loop region is shifted ~3 Å inwards 
towards the interior of the NTase domain, where it can no longer contact the DNA helix. A 
similar effect is noted in the R771W structure, where a region of the OB-fold is rotated away 
from the DNA helix, relative to its position in the wildtype structure (Figure 6.5c,d). The R771W 
mutation causes a nearly 70º rotation of this region away from the DNA helix. Additionally, the 
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R771W mutation pushes R768 out of the range to form a salt-bridge with D351 in the DBD 
(Figure 6.6d), which may result in the inability of LIG1 to stably encircle the DNA substrate.   
 
R641L and R771W do not cause apparent active site perturbations 
Based on our biochemical results, we posited that the active site of LIG1 is somehow 
influenced by these mutations. Due to the apparent involvement of the R641 and R771 residues 
in contacting the DNA helix, we hypothesized that the nicked DNA may not be properly aligned 
in the active site due to the mutations. To our surprise, there are no apparent rearrangements of 
any of the known catalytic residues in the active site (Figure 6.6a). Additionally, the positioning 
of both the 5’ and 3’ ends of the nick are unchanged in the mutant structures.  
In both mutants, the phosphodiester backbone near the mutation kinks outwards, partially 
filling the void created in the absence of the R641 and R771 loops (Figure 6.5b,d). Distortions in 
the phosphodiester backbone of the DNA are also observed upstream of the nick, near a known 
metal-binding site (Figure 6.6b-e). We have previously shown residues E346 and E592 to 
coordinate a magnesium ion (Chapter 3). Although much remains to be known about this site—
known as the HiFi metal site—we believe this metal to be important for proper positioning of the 
nick for catalysis; mutagenesis of the HiFi site results in deficient substrate discrimination and a 
distorted phosphodiester backbone near the site. Based on this, we believe that the R641L and 
R771W mutations can perturb the HiFi metal site, which may cause changes in how LIG1 
accommodates a nicked DNA substrate after binding. Although no DNA-binding defect was 
observed, it is reasonable to believe that these mutants are deficient in a magnesium-dependent 
step that precedes adenylyl-transfer. Nonetheless, the extensive phosphodiester backbone 
distortions observed in the two mutants imply that mutations cause improper positioning of the 
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DNA substrate, possibly explaining the high abortive ligation burden observed in biochemical 
assays. 
Figure 6.6. R641L and R771W cause extensive structural changes outside of the active site. (a) Stick representation of the 
active site metal ligands in LIG1 (D570, E621 and E720), showing little-to-no change as a result of the R641L or R771W 
mutations. Additionally, no apparent changes are observed in the positioning of the active site lysine (K568) or the 5’-
adenylylated nick. (b) Stick representation of the individual residues in the R641 loop in both the WT (cyan) and R641L (red) 
crystal structures. Contacts to the DNA strand by residues K642, R643 and K644 are disrupted in the R641L structure. The 
distorted loop causes numerous kinks in the phosphodiester backbone, including one near the HiFi metal ligands, E346 and E592 
(c). Stick representation of the loop in the OB-Fold domain in both the WT (cyan) and R771W structures (d). The R771W 
mutation causes a rotation of residues 770 and 771 away from the DNA helix. Additionally, R768 is no longer within salt-
bridging distance with D531 in the R771W structure. Like the R641L structure, several kinks in the phosphodiester backbone are 




Much remains to be known about the link between mutations in DNA ligase I and the 
onset of an immunological disorder. Here, we have addressed some of the key biochemical 
consequences of two of the most severe LIG1 mutations identified in immunodeficient patients. 
Due to the positioning of the two mutated residues—R641 and R771—we believed we would 
uncover a severe DNA-binding defect in the recombinant mutants of LIG1. While we did 
observe a decrease in catalytic efficiency for the mutants, we did not see any indication of a 
decrease in binding affinity. By employing our TFAM reporter substrate, we measured KD,DNA 
values for the R641L and R771W mutants, which are not significantly different than the KD,DNA 
measured for wildtype LIG1. Additionally, using the TFAM reporter in conjunction with 
stopped-flow spectroscopy allowed for measurements of kon , which is also similar between 
wildtype and mutant LIG1 enzymes. This result was verified by monitoring binding using 
tryptophan fluorescence and an unlabeled DNA substrate.  
Unexpectedly, we found a significant decrease in magnesium affinity in the R641L and 
R771W mutants. Under steady-state conditions, there is a roughly 5-fold decrease in KMg2+ for 
both mutants compared to wildtype. Along with decreased affinity for magnesium, the mutants 
appeared to affect the ability of LIG1 to stay committed to catalysis. While catalysis by R641L 
and R771W LIG1 enzymes in the presence of 20 mM MgCl2 leads to almost complete sealing of 
nicked DNA, when the concentration of Mg2+free is dropped to near-physiological concentrations, 
most ligation events are abandoned after adenylyl-transfer.  
The increase in abortive ligation could have severe consequences in the cell, where a 
large buildup of 5’-adenylylated nicks in the genome could overwhelm the DNA repair 
machinery. While the base excision repair (BER) pathway and aprataxin (APTX) are both able to 
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remove the 5’-adenylyl group from abortive ligation products, the large burden created by these 
LIG1 mutants may exceed the ability of these pathways to efficiently recognize and repair the 
adenylylated nicks. It remains to be known if the abortive products resulting from these LIG1 
mutants persist in vivo, although initial studies into the consequences of the R771W mutation 
report delayed Okazaki fragment maturation in the mutated cells105. It is worth noting that 
mutations in APTX or in FEN1—which is essential for long-patch BER—were not observed in 
any of the recently identified patients, indicating that aberrant LIG1 activity alone is the cause of 
the disease onset. 
Crystal structures of the R641L and R771W LIG1 mutants did not show any significant 
changes in the enzyme active site due to the mutagenesis. The structures presented here were 
obtained in the absence of Mg2+, which, due to the Mg2+-dependence of the abortive ligation 
defect, may limit the conclusions that can be drawn. Nonetheless, we did note several changes 
outside of the active site. The R641 loop region collapses upon mutation of the residue to 
leucine, which eliminates the salt-bridging interaction present in the wildtype structure. The 
R771W mutation causes a complete rotation of the R771 loop region away from the DNA. This 
results in a loss of interactions between the enzyme and the DNA substrate. Additionally, the 
R771W mutation seems to affect a salt-bridging interaction between the OB-fold and DNA-
binding domains, which could affect the ability of the enzyme to stably encircle the substrate.  
Although we did not observe a significant effect on the binding affinity, the crystal 
structures illustrate that the mutants appear to bind to a distorted DNA helix. The phosphodiester 
backbones near the regions of the R641L and R771W mutations are unsurprisingly extend 
outward relative to their position in the wildtype structure, presumably to fill the space vacated 
by the mutated loop regions. The phosphodiester backbone distortions, however, are not limited 
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to the backbones adjacent to the mutation. In both structures, a region of the DNA adjacent to a 
recently-characterized metal binding site in LIG1 is also distorted. Our initial characterization of 
this metal binding site demonstrated that it has some importance in imposing rigidity in the 3’ 
end of the nick to disallow ligation of mismatched or damaged substrates (Chapter 3). While the 
exact impact of these mutations on the function of this so-called HiFi site is unclear, perturbing 
the phosphodiester backbone in this region could lead to destabilization of the LIG1•DNA 
complex. Along with the collapsed loop in the R641L mutation and the absence of a salt-
bridging interaction between the OB-fold and DBD, a dysfunctional HiFi site may be the cause 
of these mutants being more prone to abortive ligation.  
Our understanding of the defects in the clinical mutants necessitates a more thorough 
understanding of the binding mechanism employed by wildtype DNA ligase I. Using 
fluorescence signal from either fluorescein or internal tryptophan residues, we have been able to 
gain some understanding of the Mg2+-dependent steps subsequent to binding but preceding 
chemistry (Chapter 2). Using these techniques could potentially further our understanding of the 
clinical mutations. Pilot experiments in the presence of saturating magnesium show that is a 
significant lag between the initial binding phase and the phase corresponding to chemistry 
(Figure S6.3a). We also observe a similar change in the behavior of the stopped-flow traces 
when monitoring catalysis of our canonical substrate by the mutants using internal tryptophan 
fluorescence, although the effect is less severe (Figure S6.3b). Nonetheless, these initial 





Chapter 6 Appendix 
 
Figure S6.1. Initial biochemical characterization of the R641L and R771W mutants. (a) The concentration of active protein 
was estimated from active site titrations, where increasing amounts of LIG1 were titrated against a fixed amount of DNA. (b) 
Steady-state ATP dependence in the presence of saturating Mg2+ (20 mM) and DNA (500 nM). (c-d) Representative single-











Figure S6.2. Tryptophan fluorescence as a binding reporter. (a) Crystal structure showing location of putative reporter 
tryptophan (W742). (b) The schematic and representative traces from stopped-flow experiments performed to monitor real-time 
fluorescence changes resulting from LIG1 binding the TFAM-DNA reporter. Rates obtained from single-exponential fits of the 
data are plotted as a function of [LIG1] in c. The dependence of kobs on [LIG1] was fit using linear regression and the slopes of 









Figure S6.3. Pilot experiments using real-time fluorescence to monitor catalysis. (a) Stopped-flow traces resulting from the 
rapid mixing of 500 nM LIG1 with 20 nM TFAM reporter substrate in the presence of 20 mM Mg2+. As noted in Chapter 2, the 
large fluorescence increase is largely due to the chemical steps of ligation. Here we note a lag between the initial binding and 
catalysis with the two patient-derived mutations. (b) A similar experiment to a, except the reaction is monitored using tryptophan 
fluorescence. For robust signal, DNA is held in excess at 600 nM, while 200 nM of the LIG1 enzymes are added. ATP is omitted 
in both a and b to prevent multiple turnovers.  
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Chapter 7 
Conclusions and Future Directions 
 
The work presented here represents a comprehensive study of the binding and fidelity 
mechanisms underlying DNA ligation by human DNA ligase 1. Due to the ubiquity of DNA 
ligases in DNA replication and repair pathways, we sought to better understand how a DNA 
ligase is able to capture its substrate and faithfully restore phosphodiester bonds. DNA ligases 
are known to contribute to the overall fidelity of replication and repair, although the mechanisms 
behind high-fidelity ligation were previously unclear. We uncovered two distinct mechanisms for 
discriminating against unfavorable nucleotide modifications at both the downstream and 
upstream ends of a nick. Since magnesium ions are vital to DNA ligation, we also investigated 
the interactions between LIG1 and magnesium, illustrating a complex network of interactions 
between magnesium and both the protein and its substrates. Finally, we demonstrated how 
perturbations of this intricate network caused by patient-derived mutations leads to enzymatic 
dysfunction, connecting the molecular mechanism of LIG1 to human health. 
 
Binding mechanism of LIG1 
 In Chapter 2, we describe the first investigation into the mechanism of DNA-binding by a 
human DNA ligase. In order to study the binding mechanism, we first characterized a binding 
assay to monitor binding interactions between LIG1 and its nicked DNA substrate. A previous 
study into the T4 DNA ligase binding mechanism made use of an internally-labeled DNA
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 substrate14. Using the internal fluorescein label, the authors were able to monitor binding and 
catalysis by T4 DNA ligase using stopped-flow spectroscopy. With this in mind, we used a 
similarly labeled substrate for investigation of the LIG1 binding mechanism. Although the 
internal label did impact the kinetics of ligation, as compared to ligation of our canonical 
substrate, the reporter substrate enabled direct measurements of the initial interactions between 
LIG1 and the nick site. 
 Aside from direct measurements of the DNA-binding affinity of LIG1, we uncovered 
evidence of an unknown step following the initial association but preceding the chemical ligation 
steps. To rule out possible artifacts caused by the internal label, we performed stopped-flow 
experiments using intrinsic tryptophan fluorescence. By using tryptophan fluorescence, were 
able to repeat our binding assays with an unmodified substrate. We found evidence suggesting a 
two-step remodeling event preceding catalysis. Preliminary results further define these two steps 
as conformational changes of the upstream and downstream ends of the nick by LIG1. 
 
Molecular mechanisms underlying high-fidelity ligation 
In Chapters 3 and 4, we dissected the underlying mechanisms for maintaining ligation 
fidelity at both ends of the nick. Recent crystal structures of LIG1 revealed a novel magnesium-
binding site in LIG1 in close proximity to the upstream DNA strand. Chapter 3 focuses on 
characterization of this metal site through mutagenesis of the conserved metal ligands observed 
in the crystal structures. The mutant, referred to as LIG1EE/AA, exhibits increased ligation 
efficiency with our canonical DNA substrate. Additionally, the mutant is able to efficiently ligate 
oxidatively-damaged upstream ends, containing an 8-oxoguanine base paired with either cytidine 
or adenine. The metal site mutation appears to affect the ability of LIG1 to perform abortive 
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ligation, which results in release of the adenylylated ligation intermediate and is considered a 
mechanism for maintaining ligation fidelity. We demonstrate that this effect is not due to a 
change in the chemical steps of ligation, as LIGEE/AA catalyzes adenylyl transfer and nick sealing 
of damaged and undamaged DNA substrates with a similar rate to wildtype LIG1. To connect 
these findings to the larger cellular context, we performed ligation assays in the presence of the 
deadenylase aprataxin (APTX). The addition of APTX to steady-state reactions suppresses the 
activity of wildtype LIG1 on the oxidatively damaged substrates. However, APTX is ineffective 
at suppressing ligation by LIG1EE/AA, indicating that APTX is unable to compete with the mutant 
for binding to the adenylylated intermediate. 
Finally, we observed that inclusion of ATP into single-turnover reactions causes a 
noticeable decrease in the rate of nick sealing for wildtype LIG1-dependent ligation of the 
damaged substrates. We posited that this ATP-dependent slowing of ligation may be important 
for maintaining fidelity. We therefore proposed that, when presented with a damaged substrate, 
LIG1 is able to catalyze adenylyl transfer, after which free ATP will cause the enzyme to briefly 
pause and partially dissociate from the DNA. In the absence of excess substrate or another 
protein, LIG1 can then re-associate with the ligation intermediate to finish nick sealing. In the 
presence of another repair protein, however, we hypothesize that the adenylylated ligation 
intermediate gets sequestered away from LIG1 during this partial dissociation. Using a 
catalytically-deficient form of APTX that retains binding activity, we demonstrated that the 
adenylylated ligation intermediate is sequestered away from wildtype LIG1 in single-turnover 
reactions containing ATP and the damaged DNA substrates, while the intermediate is only 
partially sequestered from the HiFi site mutant. Our results suggest that the HiFi site is critical 
for allowing LIG1 to disengage the ligation intermediate, where it is quickly bound and 
 137 
processed by APTX to remove the 5’-AMP. In the cell, this would allow other DNA repair 
proteins to remove either the damaged or mismatched end to maintain genomic integrity. 
Chapter 4 focuses on a different mechanism of substrate discrimination at the 
downstream end of the nick. Since DNA ligases are known to discriminate against ligation of 
downstream ribonucleotides15,122, we sought to define the structural determinants for 
ribonucleotide discrimination. We identified a highly-conserved phenylalanine residue near the 
downstream end of the nick as a possible candidate for imposing ribonucleotide discrimination 
due to its proximity to the deoxyribose of the 5’ nucleotide. In order to determine the role of the 
phenylalanine residue, we mutated the residue to both alanine and leucine. Initial 
characterization of both mutants demonstrated a significant decrease in catalytic efficiency. The 
mutations primarily affect kcat, as we only observed small changes in the KM values for both ATP 
and DNA.  
Under both steady-state and single-turnover conditions, wildtype LIG1 performs ligation 
of a downstream ribonucleotide at a significantly decreased rate. During ligation of the 
downstream ribonucleotide by F872L, we observed a large increase in the abortive ligation 
burden, resulting in almost no product formation. In contrast to both wildtype and F872L LIG1, 
F872A performs efficient ligation and is unable to discriminate against the ribonucleotide 
substrate. This data suggests that the conserved phenylalanine serves as a gate for 
ribonucleotides, preventing ligation of DNA-RNA hybrids.   
 
Characterization of the LIG1 metal ligands 
 Although magnesium has long been known as an essential cofactor for DNA ligation, the 
metal ligands in the active site of a DNA ligase have not previously been characterized. 
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Additionally, the number of metal ions used for the DNA-dependent steps of ligation remains 
unknown, although the original LIG1 structure proposed a two-metal ligation mechanism15. 
More recent crystal structures of LIG1 show a lone metal ion coordinated by a number of 
conserved amino acids in the enzyme active site. To address these observations, we performed 
mutagenesis of the three conserved amino acids to examine the effects of perturbing the 
interactions between LIG1 and the active site metal. Two of the mutants, E621Q and E720Q, 
exhibited severe defects in DNA ligation and were not characterized. The three other mutations, 
E621D, D570N and E720D, also exhibited defective ligation, but retained enough ligation 
activity to biochemically characterize. 
 As expected, all three of the mutants displayed decreased magnesium affinity in both 
steady-state and single-turnover assays. Additionally, the three mutants all performed ligation 
with a significantly decreased rate. Of the three mutants, E621D caused the most severe impact 
on the rate of nick sealing, suggesting that it plays an important role during the final step of 
ligation. While both D570N and E720D did not seem to have significant impacts on the affinity 
of LIG1 for ATP, the E621D mutation results in dramatic decreases in KM,ATP. In support of this 
finding, structures of an ATP-dependent RNA ligase indicate that the E621 residue likely 
contacts the 2’-OH of ATP during the enzyme adenylylation step149. The E621 residue is also 
observed contacting the 2’-OH before and after adenylyl transfer in the LIG1 structures (Chapter 
3), possibly explaining why the E621D mutation had a larger impact on nick sealing than 
adenylyl transfer, as the residue may help in stabilizing the AMP leaving group for nick sealing. 
Finally, none of the tested mutations appear to affect DNA-binding, supporting the finding from 




Biochemical characterization of LIG1 Syndrome mutations 
 Chapter 6 describes our biochemical characterization of mutations in LIG1 derived from 
patients suffering from immunological deficiencies. The exact connection between LIG1 
dysfunction and the onset of immunodeficiencies has long been a lingering question in the 
field102,103,156. Since the biochemical consequences of patient-derived mutations in LIG1 are 
unknown, we created recombinant versions of two of the identified LIG1 mutants, R641L and 
R771W. Due to both of the residues being located near the DNA-binding interface of LIG1, we 
expected to see defects in the DNA-binding ability of the two mutants. In steady-state ligation 
assays, we observe a modest decrease in catalytic efficiency for the two mutants with our 
canonical ligation substrate. However, direct binding assays did not reveal a large effect on the 
overall DNA-binding affinity of the two mutants.  
 Under conditions of low magnesium, we observed that the R641L and R771W mutations 
undergo a large abortive ligation burden. To investigate this further, we performed both steady-
state and single-turnover magnesium dependences to probe any magnesium-dependent effects of 
the mutations. Since the mutations are not near the enzyme active site, we were surprised to 
observe significant decreases in magnesium affinity for both the R641L and R771W mutations. 
Preliminary crystal structures of the two mutants revealed that the R641L and R771W mutations 
cause distortions in the DNA helix, most notably near the HiFi metal site described in Chapter 3. 
In addition, preliminary stopped-flow experiments demonstrated delayed kinetics of the 
conformational changes described in Chapter 2, indicating that these mutations may be affecting 





Mechanism of substrate binding by LIG1 
 Further study of the binding mechanism is still needed to fully define the remodeling 
events. To address the upstream remodeling event, we performed our stopped-flow assay using a 
substrate with a ribonucleotide upstream strand, which resulted in a twofold increase in the rate 
of one of the two putative remodeling steps. While this experiment suggests one of the two steps 
is affected by modifications to the upstream strand, we have yet to demonstrate that the other 
step can be perturbed with changes to the downstream strand. To directly confirm the existence 
of a downstream remodeling event, a suitable modification to the downstream end would need to 
be tested. If a downstream reporter is well-tolerated, this could help unify observations made 
with the TFAM-44mer substrate and those made using intrinsic tryptophan fluorescence.   
 Although our study is primarily focused on the DNA-binding mechanism of LIG1, we 
also demonstrated that tryptophan fluorescence can be used to monitor binding of ATP by LIG1. 
A similar method has been used to define the ATP-binding mechanism for T4 RNA and DNA 
ligases121 and would provide the first direct measurements of LIG1 self-adenylylation. 
Additionally, there is a large conformational change that must occur between enzyme 
adenylylation and DNA-binding13,15,149,159,160. A thorough understanding of the steps before and 
after this conformational change would help us better understand how this conformational 
change is triggered. Although it is outside of the scope of this study, determination of the LIG1 
structure in an ATP-bound state would also be pivotal to dissecting the conformational transition 




Substrate specificity of LIG1 
 The fidelity mechanisms explored in Chapters 3 and 4 were tested using substrates that 
represent only a small subset of the possible damaged or mismatched ends. To look at fidelity 
mechanisms in more depth, it would be advantageous to know how broadly these fidelity 
mechanisms apply. Studies profiling the extent of ligation fidelity have been performed with 
other DNA ligases, where all possible base combinations were tested at either side of the 
nick119,120. A similar approach could be performed with LIG1, defining how different sequence 
contexts at and around the nick may impact ligation. We also do not know how relevant these 
apparent fidelity mechanisms are to ligation in the cell. Repeating the mutagenesis studies in 
living cells would help to confirm that these fidelity mechanisms are contributing to cell 
survival. Since the amino acid residues underlying the mechanisms described in Chapters 3 and 4 
are conserved in the LIG1 homolog in yeast, Cdc9, the effects of the mutations could be assessed 
using yeast as a model system.  
 In addition to F872, another conserved phenylalanine residue is situated near the 
upstream end, where it is positioned near the sugar moiety of the 3’ end. Since upstream 
ribonucleotides are known to be well-tolerated by DNA ligases, F635 likely plays a different role 
in than the F872 residue. Since the F635 residue is positioned near the same side of the nick as 
the HiFi metal site, it is possible that the phenylalanine residue works in concert with the HiFi 
site to induce and stabilize the upstream A-form-like helix. Cooperativity between the two sites 
could involve an initial “pushing” of the upstream end by F635, resulting in a conformational 
change in the upstream strand that is stabilized by interactions between MgHiFi and the 
phosphodiester backbone. Mutations of F635 have been characterized in the Chlorella virus 
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DNA ligase, demonstrating that mutations of the residue ablate the ability of ChVLig to 
complement a ligase-deficiency in yeast cells, possibly due to significant defects in the DNA-
dependent ligation steps161. This underscores the importance of the F635 residue, but any 
possible role the residue plays in substrate discrimination remains untested. 
Impact of DNA ligase research 
 The specific aims of my dissertation research focused on dissecting the molecular 
mechanisms employed by a human DNA ligase to maintain genomic integrity. However, DNA 
ligation is only a single step in DNA replication and repair in the cell. Considering how my 
research fits into the broader context of these pathways is an essential step towards the goal of 
understanding genomic maintenance. My work highlights unique features of LIG1 that seem to 
be key in maintaining fidelity during the last step of DNA replication and repair. By tweaking 
these features in cellular LIG1, future research should be able to elucidate how mis-ligation can 
impact the cell at-large. Additionally, LIG1 is known to associate with the proliferating cell 
nuclear antigen (PCNA) in the cell, suggesting that it is important to understand how tethering 
LIG1 to PCNA impacts the fidelity mechanisms highlighted in my work. Since the three human 
DNA ligases share a conserved catalytic core, it will also be essential going forward to know if 
my findings hold true for the other two human DNA ligases. Past research has illustrated the 
divergent cellular functions of DNA ligases I, III and IV, suggesting that the three DNA ligases 
may also have different degrees of substrate tolerance. While expanding the scope of this work is 
a substantial undertaking, it has the potential to alter our current understanding of genomic 
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